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Abstract 
  GCN4 is a yeast transcriptional factor, which binds sequence selectively to DNA 
as a homodimer. Two domains are required to achieve this, an N-terminal basic 
domain, which interacts with the target site directly, and the C-terminal leucine 
zipper responsible for dimerisation. The latter can be replaced by chemically 
linking together two basic domains, to retain similar DNA binding. This work 
investigates using a ferrocene complex as the dimerization unit due to its 
flexibility and its characteristic electrochemical redox properties. 
  A strategy was proposed which took advantage of coupling to the thiol side 
chains of two cysteine residues, and detailed studies on dimerising two 
equivalents of Cys, or the tripeptide glutathione, were performed. 
  Design of five peptides based on GCN4, which were synthesized and dimerized 
with a ferrocene linker molecule, to combine the attractive redox electrochemistry 
of the stable ferrocene and the DNA binding ability of GCN4 dimerized basic 
domain. Molecular dynamic models were produced for four of the ferrocene 
peptide dimer complexes bound to target DNA over 10 ns. Their DNA binding 
ability was investigated by circular dichroism, and electrochemistry was studied 
in the absence and presence of non-specific and target DNA respectively.  
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1.1 DNA binding molecules 
  DNA contains the genetic information of life and can adopt various three 
dimensional structures, the most common of which is B-DNA.  In B-DNA, two strands 
are held together tightly as a double helix, which is stabilised by intermolecular 
hydrogen bonds formed between complementary base pairs as well as the 
hydrophobic interactions holding the apolar base surfaces away from the aqueous 
solution.1, 2  
  Binding to B-DNA provides a method for the inhibition of transcription. This can 
therefore ultimately be used to control gene expression. Binding to B-DNA can be 
achieved through alkylation or metalation by covalent or dative bond formation, or 
through intercalation or groove binding by the formation of non-covalent bonds.  
Agents which bind directly to DNA or alkylate it, have found applications in cancer 
chemotherapy.3 DNA alkylating agents prefer to bind to N-7 of guanine but can also 
bind to N-3 of adenine and some alkylating agents such as nitrogen mustard (e.g. 
mustine, see Figure 1A), have two DNA binding sites and form cross bridges (see 
Figure 1B). Cis-platin is a widely used anti-cancer drug which binds to DNA through 
the formation of dative bonds, as it cross links the nitrogens of DNA base, see Figure 
1C-1D.4 
Figure 1 A) Mustine, B) the cross link formed by nitrogen mustard between the two guanine 
sites of DNA and this can be inter-strand, C) Cis-platin, D) the inter or intra-strand cross link by 
cis-platin, G:guanine. 
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  DNA intercalators bind to DNA by inserting planar aromatic rings between the DNA 
nucleobases, see Figure 2. The binding of intercalators to DNA is not sequence 
specific and is stabilised by π-π stacking, van der Waals and hydrophobic forces. 
Through not sequence specific, intercalation happens more in G/C rich sequences as 
they are more readily unstacked.5  
Figure 2 Structure of two DNA intercalators: quinacrine and ethidium bromide, X-ray crystal 
structure of the acridine-DNA complex, acridine is shown in red (PDB code: 452D).
6 
 
 
  Grooves exist between the two strands and because these are not positioned 
directly opposite each other, the grooves are unequal in size, see Figure 3. The 
major groove is 22 Å wide, whereas the minor groove, is 12 Å wide.7 These grooves 
are adjacent to the base pairs and provide potential binding sites. For example 
pentamidine and netropsin are minor groove DNA binding ligands, see Figure 3.8,9 
Figure 3 X-ray crystal structure of the complex formed between DNA and the minor groove 
binder netropsin (shown in red) (PDB code: 101D).
9
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  Hannon and co-workers prepared a tetracationic metallo-supramolecular cylinder 
[Fe2L3]
4+
 which is a triple helicate through interaction of iron (II) salts with pyridylimine 
ligands, see Figure 4.10 The cylinder has similar size with the recognition domain of 
zinc finger protein. The cylinder binds to the DNA major groove and induces 
intramolecular DNA coiling. 
Figure 4 The [Fe2L3]
4+
 cylinder binds to the DNA major groove, each ligand strand (L) is 
coloured to show its triple helical structure. 
 
 
 
1.2 DNA binding proteins 
  Sequence specific DNA binding proteins generally bind to the major groove of B-
DNA through an α-helix, as this has the correct shape and size to fit into this groove. 
Sequence specific binding is achieved due to the formation of favorable hydrophobic 
and electrostatic interactions, as well as specific hydrogen bonds between amino 
acid side chains and DNA nucleobases exposed in the major groove. The major 
DNA-binding protein motifs, the zinc finger, helix-turn-helix and leucine zipper will be 
described in the following sections. 
 
1.2.1 Zinc finger 
  The zinc finger, is a protein structural motif stabilised by the coordination of one or 
more zinc ions. There are different types of zinc finger proteins including Cys2His2 
zinc finger, gag knuckle, treble clef, zinc ribbon, and Zn2/Cys6 zinc finger. However, 
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the Cys2His2 zinc finger, treble clef and zinc ribbons are the most common.
11 The 
family of the Cys2His2 zinc finger motif is the best-characterised class of zinc finger 
family, and contains many proteins with important functions. They are the most 
common DNA-binding motif encoded for in the human genome, as well as in some 
other multi-cellular organisms. The human genome contains about 700 Cys2His2 zinc 
finger coding genes. Though the majority binds to DNA, some zinc fingers also have 
RNA binding properties.12,13  
  The first zinc finger protein discovered was TFIIIA, a transcription factor with a 
repeat motif of 30 amino acids and a zinc binding site.4 The repeating motif contains 
a conserved sequence of (Tyr Phe)–X–Cys–X2,4–Cys–X3–(Tyr, Phe)–X5 –Leu–X2–
His–X3–5–His (X represents any amino acid), in which Cys and His residues, which 
coordinate the zinc ion were very highly conserved.5 NMR studies revealed that a 
Cys2His2 zinc finger consists of an internal αββ fold, which is stabilised by the 
chelatation of a zinc ion, and various interactions, including hydrogen bonding, 
electrostatic interactions and hydrophobic forces, between the conserved 
residues.14,15 The zinc ion is coordinated by the conserved Cys in a β-turn and the 
conserved His from an α-helix.14 The crystal structure of the DNA–Zif268 complex 
solved at 2.1 Å resolution, revealed that the amino acids at positions 1, 3 and 6 with 
respect to the start of the α-helix in the Cys2His2 zinc finger, contact DNA to 
recognise three continuous base pairs on a sequence of the target DNA. Additionally, 
later studies on the DNA–Zif268 complex solved at 1.6 Å resolution proved the 
importance of the residue at α-helix position 2 in DNA binding, due to the formation of 
a cross-strand interaction with a base on another DNA strand, see Figure 5.16,17 
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Figure 5 A) X-ray crystal structure of Cys2His2 zinc finger-DNA complex, the zinc is shown as a 
red sphere, the α-helix as a green ribbon and the β-turns in blue; B) an upclose of the Zn 
Cys2His2 coordination sphere (PDB code: 1ZAA).
16
 
 
 
 
1.2.2 Helix-turn-Helix 
  The DNA binding helix-turn-helix structural motif consists of an α-helix, a turn region 
which is a short sequence of amino acids which links it with a second α-helix.18,19 
This motif is found in many proteins that regulate gene expression. In most cases, 
the second helix towards the C-terminal of the motif is involved in sequence-specific 
DNA base interactions, and so it is termed the recognition helix.20 The recognition 
helix binds to the DNA major groove through hydrogen bonding, hydrophobic and 
electrostatic interactions with the exposed bases, see Figure 6.21 The first α-helix 
stabilises the protein-DNA interaction, but does not play a direct role in the 
recognition.  
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Figure 6 The X-ray crystal structure of the bacteriophage lambda-Cro protein helix-turn-helix 
domain bond to DNA target site. The recognition helix located in the major groove of DNA is 
shown in blue, and the second α-helix in magentas (PDB code: 6CRO).
22 
 
 
 
1.2.3 Basic region leucine zipper 
 
  The basic region leucine zipper family of DNA binding proteins (bZip) was first 
identified by McKnight and co-workers in 1988.23 They were found to bind specifically 
to target double stranded DNA in the major groove as a dimer. The basic domain of 
the bZip consists of an N-terminal 20-30 amino acid basic region which forms direct 
contacts with the DNA by binding to the major groove as an α-helix and forming 
multiple hydrogen bonds, electrostatic interactions and van der Waals forces with the 
exposed nucleobases (Figure 7). The C-terminal leucine zipper domain is 
characterised by a pattern of leucine residues repeating every 1st and 4th amino acid 
of a heptad repeat. The basic and leucine zipper domains are separated by a hinge 
area of 6 amino acids.24,25 The leucine zipper region mediates dimerisation, by 
forming a two stranded and parallel coiled coil, whilst not interacting directly with the 
DNA, see Figure 6.26-28 The bZip motif forms the focus of this project and will be 
introduced in detail in the following section, using GCN4 as an example. 
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Figure 7 X-ray crystal structure of the bZip domain of GCN4 bound to the CRE DNA target site, 
as homo dimer (pdb code: 2DGC), the leucine zipper domain is shown in yellow, the hinge 
domain is shown in green, basic domain is shown in red and the N terminal cap is shown in 
black.
29 
 
 
1.3 GCN4 
  GCN4 is a basic leucine zipper eukaryotic transcriptional activator protein, which 
binds selectively to the promoters of yeast amino acid biosynthetic genes (Figure 
7).30 The GCN4 leucine zipper has been studied extensively with a large number of 
mutagenesis studies in the literature.31-34 In addition, various peptides have been 
designed and synthesised based on the GCN4 leucine zipper motif, for DNA binding 
activity studies.33-38 
  GCN4 binds selectively to the 9 base pair CRE region, 5’-ATGACTCAT-3’, of the 
HIS3 gene, which encodes for a histidine biosynthetic enzyme regulated in response 
to histidine starvation.1,39,40 A region between 86 and 99 base pairs of HIS3 gene is 
important in positive regulation of HIS3 expression, and this region containing the 
TGACTC sequence is the HIS3 promoter region. GCN4 binds to the HIS3 regulatory 
sequence to activate their transcription.41 GCN4 also binds to activator protein 1 (AP-
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1), which is an important transcriptional regulator in disease pathways including the 
inflammatory response.40 
  Water molecules are an integral component of the DNA peptide interface in the 
complex formed between bZIP and DNA, as they mediate some of the interactions 
between the basic domain and DNA, and thus they contribute to stabilisation of the 
selective binding.29 
  Both the basic and leucine zipper domain of GCN4 are critical for achieving 
selective DNA binding, as is the case for the entire family of bZIP proteins.42 When 
GCN4 binds to the target DNA, the DNA binding of GCN4 is symmetrically arranged 
and thus the activation of transcription on either side is equal.33 
  The GCN4 homodimer can bind to both the AP1 and CRE DNA site, which have 
symmetrical sequences and share the same half site but differ in their spacing.43 
Solution measurements indicate that DNA containing AP-1 is in a linear B form, 
whereas CRE is bent towards the major groove by 8° when bound to GCN4.44,45 
Many variations of these sequences can be efficiently bound by bZIP proteins.43 For 
example,TGA1a have selective binding with C Box; EmBP-a, HBP1a, CPRF1, TAF1 
and OCSBF1 have selective binding with G Box; CPRF2, TGA1b and GBF 1,2,3 
have both selective binding with G Box and C Box. Interestingly, all these binding 
sites contain symmetrical sequences, see Figure 8.43  
Figure 8 AP1, G-BOX, CRE and CBOX binding sites for bZIP proteins, all of which have 
symmetrical sequences.
 43 
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  In the binding of GCN4 with the AP1 site, the GCN4 first contacts the central G in 
the AP1 site with the arginine residue in one monomer asymmetrically; this is 
followed by another four amino acids in each monomer binding to each half site 
symmetrically, in which asparagine (N235) at the center of the peptide forms 
hydrogen bonds with C and G in DNA, while alanine (A238 and A239) and serine 
(S242) also form hydrogen bonds with two T. GCN4 also binds selectively to the CRE 
site which contains an additional central G-C base pair, but with reduced binding 
affinity compared to the AP1 site. The conserved Arg in each GCN4 monomer most 
likely forms contacts with each G base in the first instance.46 CRE can be considered 
as a modified AP-1 site, the addition central G-C base pair rotates the half sites by 36° 
and separates them by 3.4 Å.47 Therefore the ability of GCN4 to bind with both AP-1 
and CRE, requires the flexibility of the hinge domain between the leucine zipper and 
basic region, which has been proved by mutagenesis studies.46-48 The binding 
preference for AP-1 and CRE sites is because of the residues in the hinge domain, 
which control the basic region helices orientation for alignment with either the AP-1 or 
the CRE site.47 The mutagenesis studies indicate that residue Leu247, located in the 
hinge domain, is involved in this binding preference.48 
  Richmond and co-workers obtained the crystal structure of the GCN4 bZip domain-
AP1 complex at 2.2 Å resolution.29 In the basic domain of GCN4, five residues form 
direct contact with DNA bases in the major groove, while another seven residues 
form hydrogen bonds with the phosphate backbone. An important solvent network of 
46 water molecules is involved in both types of interaction (Figure 9). 
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Figure 9 GCN4-CRE DNA interactions; the N-terminal basic domain residues form direct or 
water mediated interactions with the DNA bases and the phosphate backbone. The direct and 
water mediated interactions with nucleobases are shown as in solid lines; the interactions with 
the DNA phosphate backbone are shown as dash lines and hydrophobic interactions are 
shown as dotted lines. The directions of hydrogen bonds are shown in arrows. Figure adapted 
from reference 29, copyright 1995, with permission from Elsevier. 
 
 230         235              243       250 
  N-terminus AL KRARNTEAARRSRARK LQRMKQ Leucine zipper C terminus 
 
 
 
 
1.3.1 Hinge domain 
  Struhl and co-workers designed and synthesised peptides based on GCN4 with 
various amino acids inserted between the leucine zipper region and the hinge 
domain to study how these altered DNA binding.49 Peptides with 2, 4, 6, and 7 amino 
acids inserted were prepared respectively. The 2, 4 and 6 amino acid insertion 
peptides were unable to bind to DNA, due to the spatial disruption of the protein, in 
which the basic domain extension from the leucine zipper is not maintained but 
instead is rotated. In contrast, most of the 7 residue insertion peptides bind with wild 
type affinity or slightly reduced affinity. If the peptide N-terminus continuously extends 
from the leucine zipper region, which is responsible for dimerisation, to the basic 
domain, the spatial relationship between the basic domain and the leucine zipper 
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subdomain is retained, as 7 amino acids correspond to a full heptad repeat and two 
full turns of an α-helix (3.6 residues per turn). The functional 7 residue insertion 
peptides form homo dimers. Though the 2 and 6 residue insertion peptides can 
dimerise, they cannot bind to DNA, due to the wrong spatial alignment of the basic 
domain in these mutants relative to wild type GCN4. The 7 residue insertion peptides 
can form DNA binding homo dimers, but can also dimerise with wild type GCN4 to 
yield hetero dimers. However, these hetero dimers cannot bind to DNA, as the 
spacing between basic region and leucine zipper of these peptides are not mutually 
compatible.49 
 
 
1.3.2 Increasing α-helicity of the basic domain 
  The basic domain of GCN4 is not helical prior to binding to the DNA target site, 
however it becomes α-helical on binding.33 Shin and co-workers simplified the basic 
region of GCN4 by replacing many of the amino acids with alanine. This results in a 
more α-helical structure and therefore allowed the alanine modified GCN4 to probe 
the relationship between helical content and DNA binding affinity, and to identify key 
amino acids crucial for sequence selective DNA binding. The sequences 4A, 11A and 
18A have four, eleven, and eighteen alanine mutations in their basic region 
respectively, see Table 1.50,51 The 11A and 18A sequences are also mutated in the 
hinge region, which separates the basic regions and leucine zipper regions of the 
monomers, and has an effect on DNA-binding.52,53 
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Table 1 Sequences of the basic region of GCN4, 4A, 11A and 18A, investigated by Shin and co-
workers.
50
 Alanine substitutions are underlined.  
 Basic region Hinge Leucine zipper 
 226 252  
Wild-type DPAALKRARNTEAARRSRARK LQRMKQ  
4A ARAAAARARNTAAARRSRARK LQRMKQ   
11A ARAAAARARNTAAARRSRAAK AAAAAA  
18A AAAAAAAAANAAAAAAARAAK AAAAAA  
  
 
  The residues Asn235, Ala238, Ala239, Arg243 and Lys246 were not substituted in the 
three peptides, because they are highly conserved among basic region leucine 
zippers, and can be involved in direct contact with the DNA bases in the crystal 
structures of the GCN4-DNA complexes. Furthermore Lys246 is important for retaining 
sufficient protein solubility.29,50 The most substituted peptide, 18A, only contains four 
conserved residues from GCN4, and thus only the base-specific interactions are 
conserved, while most all of the electrostatic interactions are removed. 4A and 11A 
have fewer alanine substitutions than 18A, so they can contact to the DNA by more 
base specific interactions as well as more non-specific electrostatic interactions with 
the DNA backbone. 4A, 11A and 18A all retain their DNA binding function; but the 
DNA binding affinities of 4A and 11A are about 7-fold lower compared to GCN4, and 
the DNA binding affinity of 18A is 1000-fold lower. This is thought to be due to the 
loss of the electrostatic contacts with DNA. Increasing the alanine content also 
increases the protein α-helicity; the GCN4 basic region is not highly α-helical until 
selective binding to the major groove of target DNA. Therefore peptide with more 
alanine content is closer in form to the active conformation of the GCN4 basic region. 
11A retains specific and non-specific interactions with DNA and its α-helicity 
approaches that of the 18A peptide, so 11A appears to be the best balance between 
Chapter 1 Introduction and background 
14 
 
α-helical preorganisation and required electrostatic interactions with DNA. All the 
helicity was characterised by circular dichroism. The GCN4-DNA binding is 
enthalpically driven, but is unfavourable entropically.54 18A is a preorganised helix 
and therefore will not pay the folding penalty (entropy) on binding to DNA. However, 
at the same time the electrostatic contribution (enthalpy) has also been reduced. The 
1000-fold lower DNA binding affinity of 18A therefore indicates that the 
preorganisation of peptide structure is not sufficient to compensate for the loss of 
favourable electrostatic interactions. It was therefore concluded that the electrostatic 
interactions (enthalpy) are more important than preorganisation (entropy) in 
determining the GCN4-DNA binding affinity.50,51 
 
1.3.3 Moving the basic region towards the C-terminus of GCN4 
  Oakley and co-workers reversed the GCN4 basic domain and leucine zipper 
domain in sequence but the residues in the two subdomains are unchanged, and the 
dimer binds to DNA site contains the inverted CRE DNA half site with GCN4 affinity. 
  They synthesised a GCN4-56 variant with the basic region located towards the C-
terminal instead of the N-terminus where it is located in wild type GCN4.34 In their 
design, the basic DNA binding region containing residues 251-281 towards the N 
terminus was moved the C terminus (Table 2); a 4 amino sequence between the 
basic region and the leucine zipper was introduced as a hinge which would provide 
the required 3-dimensional relationship between the dimerisation interface, the DNA 
interacting residues and the exposed bases on the target DNA. The coiled coil 
leucine zipper was placed at the N terminus.  
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Table 2 The wild GCN4-56 sequence and rGCN4, in which residues 251-281 towards the N 
terminus has been moved the C terminus. 
GCN4-56         
 N-Cap Basic region Hinge Leucine zipper 
MK DPAAL KRARNTEAARRSRARK LQRV KQLEDKVEELLSKNYHLENEVARLKKLVGER 
 
rGCN4         
 Leucine zipper Hinge Basic region C-Cap 
M KQLEDKVEELLSKNYHLENEVARLKKLVGE LQRV KRARNTEAARRSRARK AALKG 
 
  Because the correct spacing between the two subdomains in reversed GCN4 is 
unknown, the reversed GCN4 peptide was investigated with different hinge 
sequences (table 3). High affinity binding was only found for rGCN4-(+3) to the INV2 
DNA site which contains the inverted half site based on CRE. rGCN4-(+3) contains a 
7 amino acid hinge domain, corresponding to an integral number of a heptad repeat. 
Modest DNA binding affinity was only observed for rGCN4-(-1) which is related to 
rGCN-(+3) by close to a single turn of a helix. The worst binding were found for 
rGCN4-(+1) and rGCN4-(+4) which was again related by one turn of α-helix. 
Therefore when the insertion between the two subdomains contains 7 residues, 
which is equal to two turns of an α-helix, it maintains the position of the binding 
residues with the correct orientation with respect to the DNA target site. 
 
Table 3 rGCN4 with various hinge domains were synthesised in order to establish the required 
space between the two subdomains, so as to retain their correct spatial relationship for DNA 
binding.
34 
 
rGCN4    
 N-terminus hinge C-terminus 
rGCN4(-2) Leucine Zipper LV Basic region 
rGCN4(-1) Leucine Zipper LRV Basic region 
rGCN4(0) Leucine Zipper LQRV Basic region 
rGCN4(+1) Leucine Zipper LQRRV Basic region 
rGCN4(+2) Leucine Zipper LQLQRV Basic region 
rGCN4(+3) Leucine Zipper LQKLQRV Basic region 
rGCN4(+4) Leucine Zipper LQKQLQRV Basic region 
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  Because rGCN4 is reversed, its DNA binding site is different from that of wild-type 
GCN4-56. In the GCN4-56-CRE complex, the basic residues towards the N-terminal 
end contact base pairs on the outside of the DNA site, whereas basic residues near 
the leucine zipper domain contact the residues at the center of the DNA site. In 
rGCN4, basic residues which were near to the N-terminus in GCN4-56 are now 
placed towards the leucine zipper domain, while the residues which were near to the 
leucine zipper domain in GCN4-56 are now placed next to the N-terminus; and thus 
the DNA half site should be inverted to maintain the selective DNA contacts (Figure 
10).34 
Figure 10 A) GCN4-56 binding to CRE DNA and B) rGCN4(+3) binding to INV2 DNA. The leucine 
zipper is in shown green and the basic region in yellow, figure adapted from reference 34 with 
permission from Biochemistry. Copyright (2001) American Chemical Society.
 
 
 
1.4 Artificial DNA binding peptide dimers based on GCN4 
  GCN4’s DNA binding is highly dependent on dimerisation. This was illustrated by a 
study which showed that short basic region peptides can bind to DNA with similar 
affinity to native GCN4, when they are covalently linked by a flexible disulfide bond, 
see Figure 11A.35 Various related peptide dimers inspired by this study have 
subsequently been synthesised and investigated for DNA binding, see Figure 11.35-38   
  Kim and co-workers dimerised a short peptide corresponding to the basic region of 
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GCN4 (amino acids 222-252 of GCN4) by the formation of a flexible disulfide linker, 
through an introduced Gly-Gly-Cys sequence towards the C-terminus (see Figure 
11A). Their results revealed that the basic region of GCN4 is sufficiently long for 
sequence-selective DNA binding and that dimerisation is the primary function of the 
leucine zipper domain.35 
Figure 11 Figure summarizing the reported linkers used as artificial dimerisation domains of 
peptides based on the basic region of GCN4 or MyoB for DNA binding. A) disulfide bridge.
35
 B) 
azobenzene linker as photo switch,
36
 C) a β cyclodextrin-adamantyl complex linker
37
 and D) an 
bis(terpyride) iron complex.
38 
 
 
1.4.1 Synthetic peptide dimer with an azobenzene linker based on GCN4 
  Mascarenas and co-worker synthesised a DNA binding peptide dimer based on 
basic region of GCN4, with a light-modulated azobenzene linker, see Figure 11B.36 In 
their design, the linker molecule is coupled to the peptide through the Cys side chain 
of an additional Gly-Gly-Cys sequence at the C terminus. The azobenzene 
compound was synthesised and coupled with the peptide as the trans conformation. 
Irradiation of an aqueous solution of the trans compound at 365 nm yielded a mixture 
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of cis:trans (95:5) isomers due to a light activated trans to cis conformational 
rearrangement. The cis isomer binds to DNA containing target site, with 60-70 times 
more efficiency than the trans isomer. The trans to cis isomerisation can also be 
carried out in the presence of DNA, but was found to be eight times slower than in 
the absence of DNA.  
 
1.4.2 Synthetic peptide hetero dimer with β-cyclodextrin-adamantyl complex 
linker 
  Morri and co-workers reported a peptide dimerised using a non-covalent linker 
which binds DNA containing the CRE site, see Figure 11C.37 The 23 amino acid 
peptide sequence was based on the basic domain of GCN4. The peptide sequence 
with C-terminal β-cyclodextrin (G23-CD) and a peptide with a C-terminal adamantly 
group (G23-AD) form a 1:1 heterodimer. G23-AD cannot bind to CRE DNA, while 
G23-CD appeared to bind to CRE DNA as a homo dimer, but with reduced affinity 
than the G23-AD/G23-CD mixture. The binding of the heterodimer was demonstrated 
by gel electrophoresis and circular dichroism.37 
 
1.4.3 Synthetic peptide dimer with a bis(terpyride) iron (II) complex linker 
  Schepartz and co-workers prepared a series of DNA binding peptide dimers which 
are composed of two 29 amino acid peptides based on the basic region of GCN4, 
joined by disulfide bonds to 2 different positions of a bis(terpyride) iron(II) complex, 
resulting is systems with differing distances between the two DNA binding peptide 
domains (Figure 11D and12).38 
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Figure 12 The peptide dimer with iron complex linker prepared by Sdepartz and co-workers, 
figure is adapted from reference 38. Copyright (1993) the National Academy of Sciences. 
 
 
 
 
  These dimers display different affinities for GCN4 DNA target sites. [G29TS]2Fe 
binds to the CRE site, but no CRE binding occurs with [G29TL]2Fe or [G29TB]2Fe. 
Natural GCN4 binds to the CRE and AP1 sites with comparable affinity, whereas 
[G29TS]2Fe binds to CRE site with a 150-fold preference over AP1. The result is that a 
synthetic molecule could be the designed with a greater sequence specificity than 
GCN4 itself. 38 
 
1.5 Ferrocene Complexes as Electrochemical Sensors 
  Ferrocene complexes have been widely used in the electro-analytical sensors 
because of ferrocene’s attractive electrochemical properties, including a reversible 
oxidation and reduction and stability in aqueous conditions.55 In this section, 
ferrocene complexes designed as sensors to detect different analytes will be 
introduced. How the sensors interact with analytes in order to trigger an 
electrochemical response (modulation) in the solution phase, or immobilised on an 
electrode surface, as well as the sensors’ electrochemical signal loss for the 
detection of analyte, will be introduced. The basic principal behind an electrochemical 
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sensor, involves the change in the electrochemical output of a host molecule, which 
consists of a binding site for guest binding and a reporter group in close proximity, 
see Figure 13.56 This section focuses on sensors in which the reporter group is 
ferrocene. The two major approaches for surface immobilised ferrocene biosensor 
design, will be introduced. 
 
Figure 13 The binding of the guest species causes a change in the electrochemical output. 
 
 
  
1.5.1 Ferrocene complexes as cation and anion sensors 
  Plenio and Diodone studied more than twenty ferrocene nitrogen compounds with 
which a proton acts as a guest cation, and they reported a linear relationship 
between the anodic shift in potential and the distance between the proton and 
ferrocene, see Figure 14.57 The ferrocene compounds are more difficult to oxidise 
when protonated, resulting a higher potential of the ferrocene-ferrocenium redox 
couple. The through space electrostatic interaction between the ferrocene and the 
protonated nitrogen, causes the potential to shift linearly against the inverse distance. 
 
 
 
 
Chapter 1 Introduction and background 
21 
 
Figure 14 The anodic potential shifts plot as a function of inverse Fe-N distances. 
 
 
 
 
  Beer and co-workers demonstrated that the single redox active ferrocene receptor 
can also detect two different cations.58,59 They found that molecule 1 (Figure 15) 
containing two metal binding sites, can sense the presence of barium, magnesium or 
a mixture of the two. There are three different anodic potential shifts of 150, 395 and 
275 mV respectively for the three complexes: with 2Ba2+, 2Mg2+ and Ba2+∙Mg2+.58,59  
Figure 15 Structures of the small ferrocene complex sense ions. 
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  Plenio and Aberle prepared a ferrocene bridged cyclam 2 which display different 
large redox potential shifts, by the through space electrostatic interactions in the 
presence of different transition metal cations including Co2+, Ni2+, Cu2+, and Zn2+.60-63 
  Beer and co-workers prepared some redox responsive crown ether molecules. 
These are consisted of a crown ether unit and a conjugated linked ferrocene unit (3, 
4), as well as a saturated analogue (5).64 The addition of magnesium cations resulted 
in anodic shifts in the ferrocene oxidation wave of the three molecules in cyclic 
voltammetry. The addition of Mg2+ into the conjugated receptor systems in which the 
heteroatoms in the crown ether unit are linked to the redox center by a π-electron 
system, causes the anodic potential shifts of 100 and 110 mV for the ferrocene 
oxidation wave of 3 and 4 respectively. For the saturated analogue 5, the addition of 
Mg2+ only shifts the anodic peak potential less than 20 mV, suggesting that the 
electrochemical recognition mechanism in molecules 3 and 4 are majorly through the 
bond. 
  The conformational change induced by the guest binding may also provide a 
mechanism for changing the electrochemical behavior of the redox active center.65 
  The addition of K+ cations into the solution of the sulfur linked bis crown ferrocene 
(6) causes an unusual cathodic potential shift of 60 mV.66 This cathodic potential 
change is not due to the interactions through space or through bond interactions. It 
forms a 1:1 complex with K+ cations, sandwiching the cation between the two crown 
ether units. The complexation causes a reorientation of the sulfur lone pairs towards 
the iron center of the ferrocene, thereby increasing the electron density on the iron, 
resulting in a cathodic shift of the ferrocene redox potential.   
  A direct interaction between the ferrocene unit and a cation can also produce a 
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change in the redox property of the ferrocene unit. 7 can form the direct co-ordination 
with silver cations, to produce a ΔE1/2 of 282 mV larger than that observed with Ca
2+ 
cation, and this is against its smaller charge to size ratio of the silver cation.67 The 
shift in ΔE1/2 of ferrocene unit by Ag
+ is much larger than predicted due to its charge 
to size ratio. The x-ray crystal structures of the resulting Ag+ and Na+ complexes, 
indicate the Ag to Fe distance in the Ag+ complex is 3.37 Å and shorter than the 
distance of 4.39 Å between Na and Fe. UV-vis spectra reveal that it is because the 
ferrocene group acts as an electron donor to the Ag+ cation.67 
  Anionic species is challenging to be detected by electrochemical sensors. The 
binding of anions are more difficult with respect to cations because of their pH 
sensitivity and geometry range. Beer and co-workers prepared ferrocene containing 
molecule 8, and it can bind anions. The presence of H2PO4
- causes a cathodic shift 
of redox potential in ferrocene by the through space interactions for 125 mV and 70 
mV in DMSO and methanol-water solution respectively.68 
 
1.5.2 Ferrocene peptide derivatives as biomolecule sensors 
  There are two major approaches for the surface immobilised ferrocene peptide 
sensors. The first approach is the ‘signal off’ system in which the presence of the 
analyte will cause a drop in current. The second approach is the modulation system, 
in which complexation of the peptide with the biomolecule analyte in solution, 
produces an increase in the redox electrochemical response which is proportional to 
the analyte concentration, see Figure 16. 
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Figure 16 Two different approaches for the detection of a biological analytes using surface 
immobilised ferrocene peptides. A) ‘Signal off’ approach, in which the loss of the 
ferrocene tag cause a decrease in the current. B) Modulation approach, in which the 
complexation of the ferrocene peptide with the analyte causes an electrochemical 
response at a different potential. Darker line is the signal in the absence of analyte, and 
grey line is that in the presence of the analyte.
55 
 
 
  A ferrocene tag attached to the N-terminus of a Gly-Asp-Gly-Asp-Glu-Val-Asp-Gly-
Cys peptide sequence immobilised on a gold electrode surface can detect the 
caspase activity which occurs in apotosis.69 This system was therefore used to detect 
the presence of the caspase-3 enzyme.69 Incubation of the ferrocene peptide 
immobilised electrode in apoptotic cell lysates causes a significant decrease in the 
ferrocene redox current due to the recognition and cleavage of the N-terminal Asp-
Glu-Val-Asp peptide sequence by caspase-3. The loss of a ferrocene tag from the 
sensor results in a decrease in the current. 
  The ‘signal off’ approach has also been used for the detection of prostate specific 
antigen (PSA).70 PSA is a serine protease used in the early detection of prostate 
cancer.71,72 The ferrocene peptide sequence of Cys-His-Ser-Ser-Leu-Lys-Gln-Lys-
ferrocene, immobilised on a gold electrode surface, was used for the detection of 
PSA. PSA hydrolyses the Ser-Ser bond in the peptide sequence to cleave the 
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ferrocene tag and cause a decrease in the redox current. The decrease in current 
percentage is proportional to the concentration of PSA in the range of 0.5 to 40 ng 
mL-1.70 
  The modulation sensor approach has been used for the detection of HIV-1 protease 
(PR).73 The gold surface attached ferrocene conjugate of pepstatin (Val-Cal-Sta-Ala-
Sta) with two residues of 3S, 4S-4amino-3-hydroxy-6-methylheptanioc acid, was 
used because pepstatin can bind to the active sites of most aspartic proteases 
including HIV-1 PR.74 The interaction between the conjugate pepstatin and HIV-1 PR, 
was detected by cyclic voltammetry. An increasing concentration of HIV-1 PR 
increases the formal potential and decreases the current intensity of the ferrocene 
peptide conjugate immobilised on the surface, therefore the encapsulation of the 
ferrocene group by the protease makes the oxidation of the ferrocene group more 
difficult due to the shielding of counter ions access to the ferrocene group, see Figure 
17. A linear relationship between HIV-1 PR concentration (up 100 nM) and current, 
was reported.74 
Figure 17 Counter ions (red) in solution experience restricted access to the ferrocene 
group when the ferrocene peptide conjugate is encapsulated by HIV-1 PR (green).
55,73 
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1.5.3 Ferrocene peptide conjugates as ion sensors 
  The complexation of ferrocene peptide conjugates with metal ions generally 
involves the backbone coordination and N, O chelation, or interactions with amino 
acid side chains.55 For example, the ferrocene dipeptides incorporating sulfur side 
chains and the sulfur free analogues (9–16), were studied by electrochemistry in the 
presence and absence of various heavy metal ions in solution.75 Some of these 
ferrocene peptides incorporated protected Met or Cys amino acids. The sulfur-
containing amino acids are chelators of heavy metal ions, such as Hg2+.76 The 
titration of heavy metal ions into the ferrocene peptide solutions produced an anodic 
shifts of 30 to 70 mV in the redox potentials of 9 to 14. The addition of Hg2+ produced 
higher redox potential shifts than Cd2+, Pd2+, Zn2+ and Ag+. NMR studies revealed 
that the interaction with sulfur containing side chains is more important than with 
backbone amide groups.  Compound 15 is a sulfur free analogue, for which there is 
no significant electrochemical change on addition of Hg2+, supporting that sulfur-Hg 
coordination is required for a significant anodic potential shift. Compound 16 which 
contains a disulfide bond, is a known host for group II metal ions, however it does not 
undergo a similar electrochemical response on the addition of transition metal ions at 
the concentration of 0-60 ppm, and the reason is not clear.76 
Figure 18 Structures of the ferrocene peptide conjugate as ion sensor. 
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1.5.4 Ferrocene peptide nucleic acid (PNA) and ferrocene deoxyribonucleic 
acid DNA conjugates 
  Peptide nucleic acid (PNA) is an analogue of deoxyribonucleic acid DNA and it is 
composed of N-(2-aminoethyl) glycine units linked by peptide bonds with purine and 
pyrimidine nucleobases on side chains.77 The PNA/DNA hydrid is similar to double 
stranded DNA with a similar H-bonding network, but it does not experience the same 
interstrand electrostatic repulsion. A ferrocene PNA monomer immobilised on 
electrode surface for the detection of a complementary sequence strand of DNA has 
been developed by Metzler-Nolte. A PNA sequence was prepared with Cys on the N-
terminus, for surface immobilisation, and a ferrocene group at the C-terminus as a 
redox reporter.78 The ferrocene PNA experiences an anodic potential shift of 440 mV 
on hybridisation with complementary DNA, due to the distance dependent charge 
transfer rate of the sensor system, see Figure 19.79 The increasing distance between 
the ferrocene redox reporter and the surface causes an anodic shift of the peak 
potential and a decrease in the peak current of the ferrocene reporter.80 
 
Figure 19 The hybridisation of ferrocene PNA with complementary DNA increases the 
distance between the ferrocene group and the electrode surface and make the ferrocene 
group harder for electrochemical access. 
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  Kwak detected DNA hybridisation by the cleavage of S1 nuclease which only 
cleaves single strand DNA. Ferrocene DNA immobilised on a gold electrode 
hybridised with complementary and noncomplementary DNAs, and then the 
nonhybridised DNA was cleaved by S1 nuclease. CV and DPV of the dsDNA 
detected the differences between the three target hybridisation on the electrode.81 
  Hsing and co-workers provided a method to detect sequence specific DNA without 
immobilizing the probe molecule onto a solid support.82 In the method, ferrocene 
labelled PNA hybridised with a strand of complementary DNA directly in solution. The 
negatively charged hybrid and the neutrally charged ferrocene labelled PNA were 
studied by differential pulse voltammetry (DPV) with a negatively charged indium tin 
oxide electrode (ITO) and positive charged poly (allylamine hydrochloride) (PAH) 
layer coated ITO electrode. Due to the electrostatic repulsion between the hybrid and 
the ITO electrode, the hybrid has a smaller signal than the free ferrocene-PNA 
monomer as measured by DPV. Due to the electrostatic attraction between the 
hybrid and PAH-ITO electrode, the hybrid displays a stronger signal than the 
ferrocene-PNA probe by DPV, and the signal is proportional to the amount of 
complementary DNA with respect to the ferrocene-PNA. 
  Jenkins labelled a single strand oligonucleotide with ferrocene and characterised by 
DPV prior to and after the cleavage by a nuclease.83 The ferrocene-oligonucleotide 
displays a weaker signal in DPV prior to the cleavage in solution, as the 
oligonucleotide hinders the migration of ferrocene to the electrode.   
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1.6 Aims of the project 
  GCN4 is a bZip peptide that has been widely studied. The replacement of the 
leucine zipper domain by chemical linkage of the basic domains will retain its DNA 
binding ability. Ferrocene tagged small molecules have been widely studied for ion 
sensory applications, while ferrocene tagged biomolecules have been widely studied 
for ion and biomolecule sensory applications.  
  This project utilises the flexible ferrocene (due to free rotation of the Cp rings) as the 
dimerisation unit for two short GCN4 basic domains. The combination of the 
characteristic and attractive electrochemical properties of ferrocene and the DNA 
binding ability of the dimerised basic domains should provide an electrochemically 
active ferrocene peptide dimer, which would potentially bind to DNA.  
  Various DNA binding peptide dimers with various sequences based on native GCN4 
with artificial dimerisation linkers have been reported. The hinge domain maintains 
the spatial relationship between basic domain and leucine zipper for DNA binding. In 
this project, the GCN4 basic domains are dimerised with ferrocene, which has not 
been reported in the literature. The optimal conformation for correct alignment of the 
two α-helical basic domains for effective DNA target site binding, was studied by the 
ferrocene peptide dimers with various hinge sequences. This will also be used to 
investigate the shortest hinge domain to maintain the spatial relationship between the 
basic domain and the ferrocene unit for DNA binding.  
  The ferrocene peptides will be studied in solution rather than their being attached to 
an electrode surface, and thus neither the peptide chain nor the DNA will play a 
direct role in the electron transfer pathway. Therefore, if the ferrocene peptides bind 
to the DNA target site, the new environment experienced by the ferrocene group, 
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including the surrounding charges and steric hindrance, may play an important role in 
the electrochemical response. Changes to the ferrocene peptide, in the presence 
and absence of both non-specific and target DNA, will be investigated by 
electrochemical methods including cyclic voltammetry and differential pulse 
voltammetry. The various ferrocene peptide dimers, with different hinge sequences, 
will be compared and any differences in their electrochemical response will be 
discussed in terms of the DNA phosphate backbone-ferrocene distance established 
from the molecular dynamics simulation models. This is because the negatively 
charged DNA backbone may have a significant effect on the ferrocene by through 
space electrostatic forces. In contrast, how the ferrocene peptide dimers interact with 
non-specific DNA is unknown, and thus the electrochemical behavior of the ferrocene 
peptides in the presence of non-specific DNA will be studied and compared to that 
with non-specific DNA.  
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2.1 Introduction 
  In this chapter, the experimental techniques used in this project will be introduced. 
The preparation of side chain protected and side chain deprotected peptides inspired 
by the bacterial transcription factor GCN4, was carried out by microwave-assisted 
solid phase peptide synthesis (SPPS). The peptides were purified by preparative 
HPLC, characterised by MS and their purity is evaluated using analytical HPLC. All 
low molecular weight ferrocene complexes synthesised were characterised by 1H 
and 13C NMR, UV-visible, CV and MS. Ferrocene peptide dimers were subsequently 
synthesised and again characterised and purified by HPLC and MS and quantified by 
UV-visible spectroscopy. The GCN4 basic domain, the peptide adopted in this study, 
is unstructured in the absence of DNA containing a target site,33 and this therefore 
provides us with a method by which to study binding of ferrocene peptide dimers to 
various DNA sequences. The folding of peptides and ferrocene peptide dimers was 
therefore measured using circular dichroism (CD) spectroscopy. Ultimately all the 
ferrocene peptide dimers (44AA, 48AA, 50AA, 52AA and 56AA) were studied by 
cyclic voltammetry (CV) in order to study the redox character of the ferrocene group. 
Differential pulse voltammetry (DPV) has higher sensitivity than CV and so this 
technique was adopted to characterise the sample at lower concentrations. 
 
2.2 Fmoc solid-phase peptide synthesis (SPPS) 
  Solid-phase peptide synthesis (SPPS) was developed by Merrifield in 1963.84 SPPS 
involves the use of a support resin in peptide synthesis. The first amino acid is 
coupled to the resin. The majority of amino acid side chains are protected with 
temporary protecting groups, to prevent unwanted coupling and modifications to 
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these amino acid side chains. Protecting groups can be selected which are stable 
under the peptide synthesis conditions. However it is also possible to use alternative 
protecting groups which can be selectively removed, offering exciting opportunities in 
peptide synthesis. Similarly the N-terminus of the amino acid is protected with a 
fluorenylmethyloxycarbonyl (Fmoc) protecting group in order to prevent unwanted 
side reactions. Fmoc is an acid-stable protecting group used at the N-terminus and 
can tolerate, for example the TFA cocktail used for the cleavage of amino acid side 
chain protecting groups. It is stable to tertiary amines like N,N-diisopropylethylamine 
and pyridine. Therefore Fmoc is selectively removed by base induced β-elimination, 
see Scheme 1.  
 
Scheme 1 Mechanism of Fmoc cleavage using piperidine. R=peptide on resin 
 
 
  Having removed the Fmoc protecting group, peptide bonds are formed between the 
free amine (N-terminus) and the carboxylate (C-terminus) of a new Fmoc protected 
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amino acid using HBTU. Scheme 2 shows the mechanism of the activation of the 
carboxylate using HBTU. 
 
Scheme 2 Mechanism of peptide bond formation via HBTU activation. R = the peptide on resin, 
R2= the new amino acid. 
 
 
 
  The single amino acid loaded resin is washed and filtered, to remove any unreacted 
reagents and by-products. The Fmoc group located at the N-terminus of the amino 
acid is removed by piperidine and N,N-diisopropylethylamine in DMF solution 
(20/20/60), the resin again washed and filtered before coupling of the next amino 
acid. The amino acid cycles are repeated until the sequence is finished, thereby 
sequentially growing the peptide from the C- to the N- terminus. All the side chain 
protecting groups and the resin can be cleaved from the peptide by TFA/thioanisole/1, 
2-ethanedithiol (EDT)/anisole (90/5/3/2), which includes the cleavage agent TFA and 
the nucleophilic scavengers thioanisole, EDT and anisole, see Figure 1. Alternatively 
a resin such as 2-chlorotrityl chloride resin can be used which allows for the cleavage 
of the peptide from the resin under mildly acidic conditions such as 20% 2,2,2-
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trifluoroethanol (TFE), 20% acetic acid and 60% DCM, whilst retaining all the amino 
acid protection groups. 
 
Figure 1 Solid-phase peptide synthesis cycle. The first Fmoc group is deprotected from the 
resin bound amino acid, which subsequently couples with the HBTU activated second Fmoc 
amino acid building block, thereby extending the peptide sequence on resin. The Fmoc is 
again deprotected in preparation for the next synthesis cycle or for cleavage of the peptide 
from the resin. 
 
 
  Microwave assisted SPPS shortens the reaction times as the microwave energy 
activates molecules with a dipole moment and allows for rapid heating at the 
molecular level.85 The standard (25 Watt, 75°C, 300 seconds) coupling method was 
applied for most amino acid coupling. However coupling of Arg was carried out at 
room temperature, due to the formation of γ-lactam by the Fmoc-Arg(Pbf)-OH 
building block during carboxyl activation with microwave heating.86 The coupling of 
cysteine was performed at the lower temperature of 50°C,87 due to potential 
racemisation of the cysteine at the higher temperatures obtained during microwave 
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heating. This would also apply to histidine, however this residue was not present in 
our peptide sequences.87  
 
2.3 Ultraviolet-visible (UV-VIS) spectroscopy 
  Many organic molecules and functional groups are transparent in the ultraviolet (UV) 
and visible (VIS) regions of the electromagnetic spectrum, which spans between 190 
nm and 800 nm. The absorption of specific wavelengths of light causes gaps in the 
spectrum, resulting in what is called an absorption spectrum.  The absorption 
spectrum in this range can provide useful information about conjugated π-electron 
systems. The energy of the radiation absorbed is the same as the energy difference 
between the low and high energy states.88 The relationship between absorption, 
concentration, path length and the ability of a species to absorb light at a specific 
wavelength (molar absorptivity) is described by the Beer-Lambert Law.88 This 
formula is used widely for the quantification of the material. 
A = ε c l 
A = absorbance 
ε = molar absorptivity 
c = solute molar concentration 
I = sample cell length in cm 
 
2.3.1 The Ellman’s test 
  Though peptides absorb in the 190-230 nm region due to the peptide bond, 
chromophores are used to quantify peptide concentrations. Alternative 
chromophores include tryptophan (ε280nm= 5600 M
-1cm-1), tyrosine (ε275nm=1420 M
-
1cm-1) and phenylalanine (ε257nm=179 M
-1cm-1). The Ellman’s test is used for the 
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quantification of available thiols concentration in solution by UV-vis spectroscopy.89 
In the Ellman’s test, 5,5'-dithiobis-(2-nitrobenzoic acid) reacts with thiols to cleave the 
disulfide bond and results in the rapid formation of 2-nitro-5-thiobenzoate (NTB-), 
which ionises to the yellow coloured NTB2- dianion under neutral and basic aqueous 
conditions. The absorbance of NTB2- at 412 nm and its extinction coefficient of 
13,700 M-1 cm-1, is used to establish the concentration of available Cys in the sample 
and thereby the concentration of peptide.90 
 
Scheme 3 The reaction of a thiol with 5,5'-dithiobis-(2-nitrobenzoic acid) to yield NTB
2-
. 
 
 
 
2.4 Nuclear magnetic resonance (NMR) spectroscopy 
  NMR spectroscopy is an important technique with which to study the magnetic 
properties of various nuclei which can absorb and re-emit electromagnetic radiation 
when in a magnetic field. NMR spectra can provide information about the number of 
magnetically distinct environments for each atom being studied, as well as 
information about their environment.88 Hydrogen (1H) and carbon (13C) are the most 
common nuclei routinely studied in NMR, and they are also the ones used in this 
project. NMR experiments performed on the low molecular weight ferrocene 
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complexes were all recorded in either D2O or a deuterated organic solvent. All 
1H 
NMR spectra were recorded at 300 MHz on a Bucker AV III 300 NMR and all 13C 
NMR spectra were recorded at 100 MHz on a Bucker AV III 400 NMR spectrometer. 
1, 4-Dioxane was added in small quantities as an internal standard for 1H NMR 
recorded in D2O, whereas those collected in organic solvents were referenced to the 
solvent peak.91 DEPT (Distortionless Enhancement by Polarisation Transfer) NMR 
was used to determine the multiplicity of carbon atom substitution with hydrogen. The 
1H NMR spectra were reported as follows: δ (ppm), the number of nuclei in the 
particular chemical environment (based on integration), the multiplicity of the signals 
(s: singlet; d: doublet; t: triplet; q: quartet; m: multiplet; dd: doublet of doublet; dt: 
doublet of triplet), coupling constants in Hz, followed by the assignment of the H in 
the structure. The 13C NMR spectra were reported as follow: δ (ppm), the assignment 
of the C in the structure. 
 
2.5 Mass spectrometry 
  Electron impact (EI) mass spectrometry (MS) is one of the most common MS 
techniques, providing information about the mass to charge ratio of ions in three 
steps. First, it streams high energy electrons to the molecules for bombardment (this 
ionisation method is called electron impact), and the ionised molecules are 
subsequently accelerated in an electric field. Second, it separates the accelerated 
ions according to their mass to charge ratio by traversing in a magnetic field. Finally, 
a detector can count a number of ions with particular mass to charge ratio. The 
output is then amplified and sent to the recorder which provides the mass 
spectrum.33 Our samples were recorded by ESI or MALDI MS, which use different 
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ionisation techniques to EI-MS. The difference between the different techniques will 
be introduced in the following sub sections. 
 
2.5.1 Electrospray ionisation mass spectrometry (ESI-MS) 
  In an ESI mass spectrometer, the analyte solution is dispersed as an aerosol. ESI-
MS of peptides solutions results in the detection of multiple charged peptides. ESI-
MS were recorded on a Waters Micromass LCT with direct infusion of peptide 
solutions prepared either in water/acetonitrile (50 % to 50 % with 1 % formic acid) or 
methanol. The cone voltage is 15 V and the capillary voltage is 3200 V. The source 
temperature is 130°C and the desolvation temperature is 300°C. The scan range is 
200 to 2000 m/z and data is recorded in the positive ion mode. ESI-MS of the small 
molecular weight ferrocene complexes were recorded with direct infusion of 
methanol with the scan range between 200 to 1000 m/z and data is recorded in the 
positive ion mode. 
 
2.5.2 Matrix-assisted laser desorption ionisation mass spectrometry (MALDI-
MS) 
  In MALDI-MS, samples are prepared by mixing them with a matrix material and 
stabilizing them. Matrixes tend to be low molecular weight strongly absorbent 
compounds. In MALDI-MS, a laser ionises the matrix and causes the secondary 
ionisation of the sample. Sinapinic acid is typically used with our peptide samples; 
and gentisic acid for the low molecular weight ferrocene complexes. The reflectron 
grid reflects the ions towards the detector. All of our MALDI MS were recorded in 
positive mode on a Waters Micromass MALDI MX spectrometer. The laser 
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wavelength is at 337.1 nm with an average power of 3 mV at 10 Hz. All MALDI MS of 
peptide samples were recorded in linear mode with the range of 1000 to 10000 m/z. 
The MALDI MS of low molecular weight species were recorded in reflector mode with 
the range of 300 to 2000 m/z.  
 
2.6 Reversed phase high-performance liquid chromatography (HPLC) 
  HPLC is a column chromatographic technique which separates the components of 
a mixture depending on their affinity for a solid and mobile phase respectively. A 
liquid sample or the sample solution, are forced to pass over a solid adsorbent 
material packed in a column using the flow of liquid solvent under high pressure. The 
molecules exiting the column are monitored by UV-vis of the solution at a particular 
wavelength, selected based on the absorbance profile of the desired molecule in the 
case of peptides this is 222 nm due to absorbance of the peptide bond. In reversed 
phase HPLC, the solid adsorbent material is silica modified to be non-polar by 
attaching hydrocarbon chains to its surface, which in a C18 column corresponds to 
an eighteen carbon chain, and a polar solvent is used as the mobile phase. Thus as 
the mixture passes through the column, there will be a strong attraction between the 
polar solvent and polar molecules whilst the polar molecules will not experience a 
strong attraction and thereby association, with the hydrocarbon chains attached to 
the silica of the stationary phase. In contrast, the non-polar components in the 
mixture will be less soluble in the polar solvent and tend to adsorb on to the non-
polar stationary phase. Thus the polar molecules will pass through the column more 
quickly than the less polar molecules. A combination of the polarity of the molecules, 
the polarity of the mobile phase (which can be modified to include different solvents), 
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the nature of the stationary phase, contribute to the separation by HPLC. All our 
peptides are purified by preparative C12 column reverse phase HPLC as the peptide 
purity is evaluated by analytical C12 column reverse phase HPLC obtained using the 
same solvent gradient. 
 
2.7 Circular dichroism (CD) spectroscopy 
Circular dichroism (CD) is a spectroscopic technique, discovered by Aime Cotton and 
co-worker, which allows the study of differential absorption of left and right circular 
polarised light.92, 93 This occurs when the chromophore is optically active, which is 
the case for peptides due to the chirality of amino acids and the protein fold. CD is 
therefore routinely used for the study of protein secondary structure.94 
  The CD for all α-helical peptides has two negative bands at 222 nm and 208 nm, 
and a positive band at 190 nm, see Figure 2. The band at 222 nm is related to the 
n→ π* transition of the amide bond. The bands at 208 nm and 190 nm are a result of 
the exciton splitting of the π → π* transition of the amide bond. The CD of β-sheet 
peptides have a negative band at 210 – 220 nm due to the n→ π* transition of amide, 
and a positive band at 198 nm due to the π → π* transition of amide, see Figure 2.95 
 
Figure 2 CD spectra of an α-helical peptide, a β-sheet peptide and a random coiled peptide.
95
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 The observed ellipticity in millidegrees is converted into molar residual ellipticity θMRE 
and reported in units of mdeg cm2 dmol-1 residue-1. θMRE is calculated using 
ΘMRE = [Θ]/(10×c×d×n) 
Where: 
c = concentration  
d = cell path length in cm 
n = number of residues in the peptide 
 
  The extent to which the peptide is folded into an α-helix can be calculated from the 
molar ellipticity at 222 nm using the following equation which uses the mean residue 
ellipticity of polylysine for 100% α-helix θ222nm = -35,700 as a reference.
96 
 
Percentage folded as α-helix= [θ]222 ×100/-35700 
 
2.8 Electrochemistry 
  In voltammetry, the species of interest is analysed by the measurement of the 
current as a function of a potential which is varied. This provides a method for 
studying the redox potential of an electro-active system. The application of a 
potential can trigger a redox reaction, generating a current which can be measured. 
In our electrochemical studies, a three electrode cell is used which includes a 
working electrode, a reference electrode and a counter electrode, submerged in an 
electrolyte solution. The potentiostat connected to the three electrodes scan the 
potential at the working electrode. The potential is reported relative to that of the 
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Ag/AgCl reference electrode and the resulting current is monitored through the 
counter electrode, see Figure 3. 
 
 
Figure 3 A) The three electrode system, The potential is applied between the working and 
reference electrodes, and the current flow is monitored between the working and counter 
electrodes. The two different experiment set-up for electrochemistry; B): all three electrodes 
are emerged in the sample solution; C): only the working electrode is in sample solution in 
sample holder, reference and counter electrodes are in the buffer solution. The frit is at the 
bottom of sample holder. 
 
 
 
2.8.1 Cyclic voltammetry (CV) 
  Cyclic Voltammetry (CV) is a potential sweep technique where the potential of the 
working electrode is linearly changed with a constant scan rate from an initial value, 
Eintial, to a switching value, Eswitching, and then linearly reversed back to the original 
initial value, completing a full cycle (Figure 4).  
 
Figure 4 Diagram showing the potential change as a function of time for one CV cycle. 
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  The recorded current is plotted as a function of the potential, which for a reversible 
redox process results in a peak for the oxidation and reduction of the analyte in the 
forward scan and backward scan, respectively. The current versus potential diagram, 
contains a maximum ipa (anodic peak current) at Epa (anodic peak potential) in the 
anodic scan and a minimum current ipc (cathodic peak current) at Epc (cathodic peak 
potential) in the cathodic scan (Figure 5). 
 
Figure 5 An example of a cyclic voltammogram of a non-reversible system, with ΔEp more than 
59 mV and ipa/ipc > 1 
 
 
  
 The cyclic voltammogram can provide important information concerning the 
reversibility of the system. In a fully reversible system, the heights of the forward and 
reverse current peaks are the same, and are separated by 59 mV for a single 
electron process for each molecule. These features should be independent of the 
scan rate if electron transfer is fast.97 Slow electron transfer will cause a quasi-
reversible electron transfer, see Figure 5. 
  The anodic and cathodic peaks in the CV are asymmetrical due to the 
polarisation overpotential to make the electron transfer process happen. 
Overpotential is the potential difference between a half-reaction determined reduction 
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potential and the potential in redox event observed in the experiment. It is the extra 
energy added to the reaction in order to drive the reaction to proceed. The 
overpotential is described in the Butler-Volmer equation:89,99  
 
kET =  k
oe-αnFη/RT 
Where:  
kET = rate constant of the electron transfer process 
ko = rate constant for standard heterogeneous electron transfer 
α = transfer coefficient   
n = number of electrons transferred for each molecule 
R = universal gas constant 
T = temperature in K 
η = overpotential, and η= E-EO’ (EO’ = Epa+Epc/2 = formal potential) 
F = Faraday constant 
 
  The peak currents (ipa and ipc) are dependent on the scan rate, and are proportional 
to the square root of the scan rate, as described in the Cottrell equation.100 
 
i=nFAC(νD)1/2(π)-1/2 
 
Where: 
i = peak current (A) 
n = number of electrons transferred per molecule 
F = Faraday constant 
A = surface area of the electrode (cm) 
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C = bulk concentration (mol/cm3) 
D = diffusion coefficient of diffusion species (cm2/s) 
ν = scan rate (s-1) 
 
2.8.2 Differential pulse voltammetry (DPV) 
  Differential pulse voltammetry (DPV) involves varying the potential by applying a 
pulse method, in which successive potential steps (pulse) are applied to the working 
electrode, superimposing the pulse to a slow linear potential sweep, see Figure 6. In 
DPV, the baseline potential is held for a period of time before the application of the 
potential pulse, each potential pulse is fixed, and the current is recorded twice in 
each pulse period prior to the pulse and towards the end of the pulse. The selection 
of these two sampling points allows the decay of charging current to minimise its 
effect; thereby achieving high sensitivity.101 Differences between current 
measurements at these two points is plot as a function of potential, see Figure 7.  
DPV decreases the detection limit compared to CV, and thus provides a more 
sensitive method for the electrochemical study of dilute and valuable samples. 
 
Figure 6 Graph shows the potential change over time for DPV scan. The pulse is superimposed 
into the linear scan. 
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Figure 7 Typical DPV of 1,1’-s-ferrocenyldimethyl-L-glutathione at various concentrations 
between 11 to 84 µM. The linear sweep can only detect the ferrocene group. 
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3.1 Introduction 
  Due to ferrocene’s aqueous stability and its characteristic electrochemistry, 
ferrocene has become a popular molecule for electrochemical sensing and for 
biological studies. The latter is generally achieved by coupling a ferrocene unit with a 
biomolecule of interest, which has been extensively studied.102 Metzler-Nolte and 
Beckmann developed 1’-aminoferrocene-1-carboxylic acid (Figure 1) for use in solid-
phase peptide synthesis (SPPS), and subsequently used the N-terminus protected 
ferrocene building block in both tert-butoxycarbonyl (Boc) and 
fluorenylmethoxycarbonyl (Fmoc) SPPS methods.103,104 Peptides were coupled with 
1’-aminoferrocene-1-carboxylic acid, 1,1’-diamino ferrocene and 
ferrocenedicarboxylic acid, in an effort to prepare peptide conjugates with antiparallel 
or parallel alignment of the peptide substituents.103 
 
Figure 1 A) 1’-Aminoferrocene-1-carboxylic acid, B) ferrocene dicarboxylic acid and C) 1,1’-
diamino ferrocene. Their Fmoc and Boc protected derivatives were used in SPPS to integrate 
ferrocene into A) a peptide backbone or B)/C) for parallel alignment of two peptide strands.  
 
 
 
  The ‘click chemistry’ method for ferrocene peptide preparation was recently 
reported (Figure 2), and is an attractive approach as synthesis is performed under 
mild aqueous conditions, and with high chemoselectivity.55,105 However, one possible 
disadvantage involves the use on non-natural, and therefore more costly, amino 
acids. 
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Figure 2 ‘Click chemistry’ method for coupling ferrocene azide with an alkyne.
55 
 
 
  Sonogashira coupling is the cross coupling of an aryl halide and a terminal alkyne 
catalysed by Pd under an inert atmosphere, and it provides a method for the 
preparation of ferrocene peptide conjugates with low polarity covalent bonds.55 
Ferrocene can be tagged to either the C terminus or N terminus of peptides using 
this approach (see Figure 3).106,107 
 
Figure 3 A) and B) Sonogashira coupling of ferrocene with the C-terminus of a peptide. The 
ferrocene unit can either be tagged to the aryl halide or the terminal alkyne for the cross 
coupling. C) Sonogashira coupling of ferrocene with the N-terminus of a peptide, only the 
ferrocene tagged terminal alkyne was reported.
55,106,107
   
 
 
 
  The labelling of ferrocenylethyl maleimide and ferrocene iodoacetamide with the 
thiol group of cysteine in glutathione and a longer peptide sequence, has been 
reported.108-110 This approach provides a residue selective coupling strategy, without 
requiring any modification of the terminus of the peptide prepared by solid-phase 
peptide synthesis. Ferrocenyl N-substituted maleimide has been used to tag a 
hexapeptide in the literature.111 The advantage of coupling through the thiol side 
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chain of cysteine is that this amino acid has low natural abundance in proteins and is 
often involved in disulfide bonds. This allows for the selective coupling to unique 
cysteine sites which can be engineered into peptides and proteins, which has the 
advantage of being a natural amino acid.  
 
Figure 4 Coupling of the tripeptide glutathione with ferrocenylethyl maleimide through the thiol 
group on the cysteine. Both ferrocenylethyl maleimide and ferrocenylmethyl maleimide have 
been coupled with Cys in the literature. 
 
 
3.2 Strategy design 
3.2.1 Strategy A 
 Two strategies were proposed to dimerise our peptides with a ferrocene unit. In 
strategy A, the peptide couples with the ferrocene linker through the free C-terminus 
(required due to the location of the leucine zipper at the C-terminus of GCN4). This 
therefore required the preparation of a peptide with all side chains having protecting 
groups in place, in order to prevent side reactions, see Figure 5. 
  In order to cleave a peptide from the solid support, yet retain the side chain 
protecting groups, 2-chlorotrityl chloride resin was used. This is because a mild 
cleavage cocktail, 2,2,2-trifluoroethanol (TFE), acetic acid and DCM (2:2:6), is 
sufficient to cleave the peptide from the resin, whilst leaving all side chain protecting 
groups on. The resulting peptide could be coupled with the ferrocene linker molecule 
to give the ferrocene protected peptide dimer. A final TFA deprotection step would be 
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used to cleave all the side chain protecting groups from the peptide dimer, to yield 
the desired ferrocene peptide dimer product (see Figure 5). 
 
Figure 5 Synthetic strategy A; peptide cleaved from resin by a mild TFE mixture, and then 
coupled with the ferrocene linker through the C-terminus. This is followed by a TFA 
deprotection, which removes all the amino acid side chain protecting groups. 
 
 
 
  For strategy A, 1,1’-bis amino ferrocene and a 29 amino acid side chain protected 
peptide were synthesised, the latter manually in a microwave reactor. However 
cleavage of the peptide from the resin resulted in an insoluble peptide, and it was not 
possible to either purify or characterise it. In order to characterise the peptide, the 
insoluble protected peptide was subjected to strong cleavage conditions (95 % TFA, 
5% thioanisole, 3% EDT and 2% anisole), in order to remove all side chain protecting 
groups. Analytical HPLC and ESI-MS of the deprotected peptide, confirmed the 
presence of a major product which was the proposed 29 amino acid sequence. In 
order to evaluate if this strategy was worth pursuing, we attempted to couple our fully 
protected 29 amino acid peptide with a stilbene linker containing two amine groups 
which was commercially available, see Figure 6. Unfortunately this was unsuccessful 
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and only the mono-substituted ferrocene peptide was observed by MALDI MS, and 
thus the synthesis of the 1,1’-bis(aminoethyl)ferrocene linker molecule for strategy A 
was abandoned at the reduction of 1, 1’-bis nitrilemethylene ferrocene to 1,1’-
bis(aminoethyl)ferrocene, see Figure 7.  
 
Figure 6 Coupling of 4,4’-diaminostilbene with side chain protected 29 amino acid peptide. The 
protecting group was then removed by TFA cocktail for characterisation.  
 
 
 
Figure 7 Scheme for the synthesis of 1,1’-bis(aminoethyl)ferrocene (4) from ferrocene in four 
steps. The synthesis was abandoned at the last step due to the failure of strategy A. 
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3.2.2 Strategy B 
  The requirement for a fully deprotected peptide (due to the insolubility of the 
protected analogue) meant that the peptide could be synthesised by solid-phase 
peptide synthesis using rink amide MBHA resin. Strategy B is illustrated in Figure 8. 
It therefore proved necessary to develop a new strategy for the dimerisation of two 
peptide domains. Due to the unique nature and low natural occurrence of the amino 
acid cysteine, we proposed to take advantage of the thiol side chain for selective 
coupling to our peptide. Strategy B therefore involves dimerising two fully 
deprotected peptides through a single cysteine introduced in each sequence 
(towards the C-terminus) for this purpose. 
 
Figure 8 Strategy B: SPPS prepared peptide is cleaved and fully deprotected by TFA cocktail, 
and then the peptide coupled with a ferrocene linker molecule through its cysteine thiol side 
chain. 
 
 
  Initially we proposed to dimerise the peptide by coupling the cysteine side chain 
with a bromoacetic acid on 1,1’-bis bromoacetate methylene linker. 1,1’-bis 
bromoacetate methylene ferrocene was synthesised from ferrocene in four steps 
(see Figure 9), however it decomposed after column chromatography and HPLC. We 
therefore attempted to synthesise 1,1’-bis bromoacetate amino ferrocene, but only 
the mono substituted bromoacetate amino ferrocene was recovered in the product 
due to the rapid oxidation of the starting material 1,1’-bis-amino ferrocene to amino 
ferrocene in solution, see Figure 10.  
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Figure 9 Scheme for the synthesis of 1,1’-ferrocenyl bis (methylene 2- bromoacetate) (7) from 
ferrocene. The 1,1’-bis(hydroxymethylene)ferrocene (6) linker molecule was prepared in two 
steps and then reacted with bromoacetic acid to give the final linker molecule, 7. 
 
 
Figure 10 Scheme for the attempted synthesis of bis (2-bromo acetamide) ferrocene (12A) in 
five steps: lithiation of ferrocene, followed by bromination, two reactions for transformation 
into diamino ferrocene (Gabriel synthesis) and finally coupling with bromoacetic acid. However, 
only the mono substituted product 12B was formed. 
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  The final method involves the coupling of a peptide cysteine side chain with 1,1’-
bis(hydroxymethylene)ferrocene (6), synthesis in Figure 9, which can be synthesised 
from ferrocene in two steps. The ferrocene linker was first coupled with cysteine. In 
order to evaluate the reaction conditions required for efficient coupling, the resulting 
model complex was fully characterised in order to establish the influence of the Cys 
residue on the ferrocene chemistry. This work was subsequently expanded to longer 
peptides such as the Cys containing tripeptide glutathione (GSH). The resulting diGS 
model compound was compare to the diCys product, and represents a better model 
for ferrocene dimers of longer peptide sequences. 
 
3.3 Results and discussion 
3.3.1 Microwave assisted and full manual Solid-Phase Peptide Synthesis (SPPS) 
of protected peptide 
  In order to determine an effective method for the synthesis of a side chain protected 
peptide, 3 different synthesises were conducted to prepare a short 8 amino acid side 
chain protected peptide (Ac-LKACEEKG-COOH) on a 0.1 mmol scale, see table 1. 
The resulting products from the three methods were compared and the best method 
was subsequently used to prepare a 29 amino acid peptide based on GCN4. 
  In method 1, the deprotection and coupling was assisted by microwave heating to 
65℃; whereas in method 2, the deprotection and coupling was performed at room 
temperature and subsequently longer reaction times; in method 3, the deprotection 
and coupling was assisted by microwave heating to 50°C, but with longer reaction 
times than used in method 1 (Table 1).  
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Table 1 Synthesis of Ac-LKACEEKG-COOH on a 0.1 mmol scale. Methods 1 and 3 were carried 
out on a CEM microwave synthesiser. Method 2 was carried out manually at room temperature.  
HPLC purity was established using a C18 analytical column. 
 
 deprotection coupling crude product yield HPLC purity 
method 1 65 ℃ 20 W 3 min 65 ℃ 20 W 15 min 17% 97% 
method 2 RT 0 W 20 min RT 0 W 120 min 23% 97% 
method 3 50 ℃ 20 W 4.5 min 50 ℃ 20 W 18 min 25% 98% 
 
  For the synthesis of the protected peptide, 2-chlorotrityl chloride resin was chosen, 
as it can be cleaved from the resin using a mild TFE cocktail without removing the 
side chain protecting groups. The first amino acid Gly was loaded on to the resin 
manually. The loading rate of the first Gly was determined by monitoring the 
dibenzofulvene-piperidine adduct released on removal of the Fmoc group with 
piperidine, by UV visible spectroscopy based on a previously published procedure.112 
The loading rate of Fmoc-G-resin ranged from 0.65 mmol/g to 1.125 mmol/g in 
different tests for different samples. Better preparation of dry glass ware and the use 
of dry solvents, improved the reproducibility of loading rate measurements to 1.125 
mmol/g. For the two methods of microwave assisted SPPS, a CEM microwave 
reactor was employed. For the manual SPPS, the synthesis was carried out in a 
glass reaction vessel equipped with a filter funnel, and each coupling and 
deprotection was monitored by the Kaiser Test.113 In the commonly used Kaiser 
test,113 ninhydrin reacts with free amines (the N-terminus of the peptide) to yield an 
intense blue colour ninhydrin imino derivative, see Figure 11. 
 
 
 
 
 
 
 
 
 
 Chapter 3 Strategies for the dimerisation of peptide with ferrocene 
 
58 
 
Figure 11 The Kaiser test showing the reaction between the ninhydrin and the primary amine of 
an amino acid amine to produce a blue product. 
 
  
 
3.3.1.A Comparison of three SPPS method for protected peptide preparation 
  Method 1 was carried out on a CEM discovery microwave synthesiser at 65°C, The 
yield is calculated from the fully deprotected peptide as a result of the TFA 
deprotection and cleavage; this was due to the lack of availability of TFE at this time. 
The crude product percentage yield is 17% and the H+ and Na+ adducts of the 
peptide was observed in the MALDI MS.  Method 3 was also carried out on a CEM 
microwave synthesiser but at the lower temperature of 50°C.114 Four different K+ and 
Na+ adducts of the protected peptide, cleaved by 20% TFE, 20% acetic acid and 60% 
DCM, were observed in the MALDI MS. The protected peptide was then fully 
deprotected by TFA, in order to establish a yield which can be compared to method 1, 
and to characterise it further. Method 2 involved manual synthesis at room 
temperature, each coupling and deprotection was monitored by the Kaiser Test with 
ninhydrin and phenol. In the protected peptide’s MALDI MS generated by co-
crystallising with the matrix gentisic acid, five different Na and K adducts of the 
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peptide were found. Full deprotection of the peptides prepared by methods 2 and 3 
gave very similar percentage yields and high purities in HPLC (see table 1), however 
method 2 required longer reaction times with no additional benefit, and therefore 
method 3 was chosen for further synthesis of protected peptides. 
 
3.3.1.B Preparation of a 29 amino acid peptide based on GCN4 
  A 29 amino acid protected peptide sequence based on GCN4 with a C-terminus 
carboxylic acid (ALKRARNTEAARRSRARKLQRLKALEEKG-COOH) was designed 
to couple with a linker containing two amines. Microwave SPPS at 50 ℃ based on 
method 3 was applied after the manual loading of the first glycine (Gly G) residue. 1A, 
3K, 4R, 5A, 6R, 7N and 8T were double coupled because they are located towards 
the end of the synthesis which makes the coupling difficult. All the arginines (Arg, R) 
were coupled at room temperature because microwave heating accelerates the 
formation of lactams during the carboxy-activation of arginine, which competes with 
the amide bond formation. 23K to 28K were therefore coupled at room temperature 
for 120 minutes. Before an aliquot was cleaved and analysed by C18 analytical 
HPLC and MS to validate the successful synthesis of the peptide sequence at this 
stage, and HOBt was not included in the activator. The activator mix HOBT and 
HBTU in DMF, was used instead of HBTU in DMF, after 23K. 21R was coupled by 
microwave at 50 ℃ by mistake and 10 mg of the resin was cleaved using the TFE 
cleavage mixture after coupling of residue 20Q. Its MALD MS indicated the Na and K 
adduct of protected Fmoc-QRLKALEEKG-COOH and therefore the correct peptide 
sequence. Another 10 mg of resin was cleaved after the coupling of 9E, and its 
MALDI MS indicates the H adduct of the protected peptide.  The protected 29 amino 
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acid peptide has very poor solubility in organic solvents and water, and could not be 
detected by MALDI MS or purified by HPLC. Full deprotection by the TFA cleavage 
mixture resulted in a soluble peptide which could be analysed by MS. The H adduct 
of the peptide was found by MALDI MS, as well as a second peak at 1085 m/z which 
is also found in the MS after coupling 6E, and is consistent with the molecular weight 
of Ac-RLKALEEKG-COOH. The yield of crude 29 amino acid protected peptide is 
30 %, which is higher than that achieved in the synthesis of the 8 amino acid peptide 
using method 3; the use of HOBT and HBTU activator could have improved the yield. 
  We attempted to couple the crude protected peptide with 4,4’-diaminostilbene 
dihydrochloride, which is commercially available, using HOBT and PyBOP activator. 
When a suspension of 4 equivalents of the crude peptide was used, only mono 
substituted stilbene peptide adducts were detected in the MALDI MS after TFA 
deprotection (Figure 12). This coupling reaction could not be monitored directly by 
MS or HPLC due to the poor solubility of the protected 29 residue peptide. When 8 
equivalents of crude protected peptide was used for the coupling, neither the peptide 
dimer nor the mono substituted peptide was detected in MALDI MS following the TFA 
deprotection. 
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Figure 12. MALDI MS of the coupling reaction mixture (using 4 equivalents of crude protected 
peptide) after full deprotection using the TFA cleavage mixture. M is the mass of the mono-
substituted stilbene peptide molecule. Except for the peptide monomer, no other peaks were 
observed in the lower range of the MS. 
 
 
 
 
3.3.2 Synthesis of 1,1'-bis(cyanomethyl) ferrocene  
  We designed a synthesis of 1,1'-bis(aminomethyl) ferrocene from the reduction of 
the corresponding nitrile, which is prepared by the nitrile substitution of trimethyl 
ammonium, that is methylated from 1,1’-bis-dimethylaminomethyl ferrocene prepared 
from ferrocene (see Figure 7). Lithiation of ferrocene followed by electrophilic 
substitution of dimethyl methyleneammonium gave the bis substituted product in a 
24 % yield, which is lower than that reported in the literature.115 This is most likely 
due to a lack of a good nitrogen atmosphere and dry glassware preparation. N-
alkylation of 1,1’-bis dimethylaminomethyl ferrocene by iodomethane gave high 
yields of 88-95 % of the bis ammonium ferrocene product. Nucleophilic substitution 
of the ferrocene ammonium by cyanide was carried out under various different 
conditions including under microwave irradiation and using 18-crown-6, see Table 2. 
However none of these resulted in a high yield. 
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Table 2 Different reaction conditions used for the substitution of ferrocene ammonium by 
cyanide performed either under reflux or in a CEM microwave reactor. 
 Reagent reaction condition Yield 
Synthesis 1 KCN Heating under reflux in 
water for 2 hours 
none determined 
Synthesis 2 KCN Heating under reflux in 
water for 6 days 
17 % isolated by 
solvent extraction 
Synthesis 3 KCN, 18-crown-6 Heating under reflux in 
MeCN for 6 days 
9 % isolated by 
solvent extraction 
Synthesis 4 KCN Irradiation by microwave in 
water for 3 hours (100 ℃) 
none determined 
 
  A nucleophilic substitution of the ferrocene ammonium by cyanide for the mono 
substituted ferrocene has been reported to be successful under reflux in water for 2 
hours,116 however this did not work for the bis substituted ferrocene, so a longer 
reaction time was attempted. This resulted in a low yield of the ferrocene nitrile 
product which was characterised by ES MS and 1H NMR. In order to improve the 
yield, 18-crown-6 was used with KCN in acetonitrile as 18-crown-6 can complex the 
potassium in solution.
116
 However it did not improve the yield. 
  Microwave irradiation could accelerate the reaction, but no nitrile product was 
detected. We observed our 1,1’-bis cyanomethyl ferrocene product darkened and 
decomposed to dimethyl ferrocene as indicated by ES MS, after being stored in the 
freezer at -20 ℃ overnight. 
  Due to the solubility problems encountered at this time with our 29 amino acid side 
chain protected peptide, which cannot be purified and characterised before TFA 
deprotection and thus its coupling with linker molecule cannot be monitored, the 
preparation of this linker was abandoned at this last step. 
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3.3.3 Dimerisation with ferrocene linker through the cysteine side chain 
3.3.3.A Preparation of 1,1’-bis(hydroxymethylene)ferrocene and 1,1’-ferrocenyl 
bis (methylene 2- bromoacetate)  
  The ferrocene linker molecule 6 was prepared from ferrocene through 1,1'-
ferrocenedicarboxaldehyde (5) in two reactions based on Connell’s and Patwa’s 
method, see Figure 9.117,118 Recrystallisation gave 6 as brown crystals, which was 
later used as a linker for the coupling of peptides through the cysteine side chain 
(see below). 1,1’-Ferrocenyl bis (methylene 2- bromoacetate) (7) was synthesised by 
the esterification of 6 with three equivalents of bromoacetic acid catalysed by 4-
dimethylaminopyridine. However, the product decomposed to 1,1’-bis methyl 
ferrocene and characterised by 1H NMR spectrum and ES-MS after column 
chromatography and HPLC. The crude 7 which contains bromoacetic acid was 
characterised by 1H NMR.  
  An attempt to couple crude 7 which contains bromoacetic acid, with a crude 28 
amino acid peptide which contains a single Cys residue (13 equiv) in 50 % 
acetonitrile 50 % 100 mM phosphate buffer pH 7 solution for 20 hours, was 
unsuccessful as confirmed by the MALDI MS, in which only the 28 amino acid 
peptide starting material was found. 
 
3.3.3.B Preparation of 1,1’-diamino ferrocene and 1,1’-bis (2-bromo-acetamide) 
ferrocene 
  1,1’-Diamino ferrocene (11) was designed to couple with side chain protected 
peptide, and was also used for the preparation of 1,1’-bis (2-bromo-acetamide) 
ferrocene, see Figure 10. 
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  1,1’-Dibromo ferrocene (9) was synthesised by bromination of the crude 1,1’-
dilithiaferrocene (8) intermediate prepared from ferrocene. 11 was synthesised from 
9 by Gabriel synthesis. 11 was finally coupled with bromoacetic acid to make the 
linker molecule (see Figure 10).  
  The crude 9 was synthesised three times at 26 mmol, 69 mmol and 138 mmol 
scales, and the crude product was used for further synthesis directly as only a very 
small amount of ferrocene impurity was detected in the 1H NMR.  
  10 was synthesised at 1.3 and 2.9 mmol scale with 3.26 and 6.5 equivalents of 
phthalimide. 3.26 equivalents of phthalimide only gave the mono-substituted product. 
6.5 equivalents of phthalimide gave a mixture of mono and di-substituted product 
with the di-substituted product detected in the MALDI and ES-MS spectra. We 
attempted to purify the di-substituted product by column chromatography, but TLC 
indicated mono and di substituted products were in equilibrium. Synthesis on the 2.9 
mmol scale gave the mono substituted product in a higher percentage yield (24 %) 
than the 1.3 mmol scale (10 %). The crude product was used directly for further 
synthesis. The synthesis of 11 was carried out twice with all the procedures 
performed under a nitrogen atmosphere under Schlenk conditions. Despite this, the 
yellow product immediately darkens in the solution after work up. 1H NMR spectra 
were recorded while it was decomposing and amino ferrocene was detected. For the 
fresh yellow sample, 11 was found in the low voltage ES MS at 5 volt and by 1H NMR 
spectroscopy, at higher voltages (10 and 15 volt) fragmentation occurs, and only 
mono substituted amino ferrocene and ferrocene were observed. 
  In the second synthesis, the crude product was used for coupling with three 
equivalents of bromoacetic acid immediately after the synthesis. Only the mono 
 Chapter 3 Strategies for the dimerisation of peptide with ferrocene 
 
65 
 
substituted product, 2-bromo-ferrocenylacetamide, was observed in the ES-MS. This 
synthesis of this linker molecule was abandoned due to the instability of the 1,1’-
diamino ferrocene.  
 
3.3.3.C Synthesis of 1,1’-s-ferrocenyldimethyl-L-cysteine  and 1,1’-s-
ferrocenyldimethyl-L-glutathione  
  2.25 Equivalents of L-cysteine was coupled with 6 in water/acetone solution in the 
presence of 0.1 mL TFA. After 2 days of reaction the solvent was reduced in vacuo. 
The reaction progress was monitored by the Ellman’s test to determine the 
concentration of unreacted thiol groups (from unreacted cysteine side chain), see 
Figure 13. The product was precipitated by addition of cold diethyl ether into a 
reduced volume of the reaction solution, to yield pure 1,1’-s-ferrocenyldimethyl-L-
cysteine (13) as a yellow solid in a 23% yield. This was fully characterised by 1H 
NMR, 13C NMR, MALDI and ES mass spectrometry. 
Figure 13 Concentration of free thiol in the cysteine coupling reaction with 1,1’-bis 
(hydroxymethylene) ferrocene. It is calculated from the Ellman’s test of aliquots taken from the 
reaction solution at various time points. Plot showing the A) full reaction in 50 hours, and B) an 
expansion of the first 100 minutes of the reaction. 
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  Figure 13 shows the change in cysteine concentration in the whole experiment up 
to 50 hours, as well as an expansion of the first 100 minutes. The concentration of 
available thiol, and thereby free cysteine, decreased to 0.002 M from 0.03 M over 50 
hours. The reaction is quick at the beginning, in the first 17 minutes the concentration 
halved to ca. 0.014 M, and this is the reaction half-life. In the first 60 minutes, the 
cysteine concentration decreased 0.018 M. In the following 30 minutes, the 
concentration only decreased 0.007 M, and so the reaction has in effect reached 
equilibrium with no further significant change. 
  13 is not very soluble in either organic solvents or water. The addition of acid 
increases its solubility in water and so NMR spectra were recorded in the presence 
of acid, see Figures 14 and 15. The methylene hydrogens on the Cys side chain 
occur as AB systems in the 1H NMR spectra with a geminal coupling constant JAB of 
15 Hz due to the chirality of the L-cysteine. After 13 has been in acidic solution 
overnight, the solution turn from yellow to green, and the peaks of the Cp ring 
hydrogens and the hydrogens adjacent to the Cp ring, broadened. 
  13 has also been characterised by PENDANT 13C NMR spectrum, which 
determines the nature of primary, secondary, tertiary and quaternary carbon atoms, 
see Figure 15. 
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Figure 14 
1
H NMR spectrum of 1,1’-s-ferrocenyldimethyl-L-cysteine in MeOH-d4 –HCl (95-5) (A) 
and DMSO-d6-TFA (95-5) (B). 
                           A 
 
                       B 
 
Figure 15 PENDANT 
13
C NMR spectrum of 1,1’-s-ferrocenyldimethyl-L-cysteine in DMSO-d4–
TFA (95-5) 
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  13 was also characterised by MALDI and ESI-MS. 13 and its K and Na adducts 
were observed in MALDI MS. H, K and Na adducts of 13 were observed in the ES 
MS, see Figures 16 and 17. Its isotopic distribution pattern is in good agreement with 
the calculated isotopic distribution for [FeC16H22N2O4S2], see Figure 16. 
Figure 16 MALDI MS of 1,1’-s-ferrocenyldimethyl-L-cysteine recorded in the presence of 
gentisic acid matrix. The peptide dimer and its Na and K adducts were observed. The 
experimental and calculated isotopic distributions are in good agreement. 
 
 
 
 
Figure 17 ES-MS of 1,1’-s-ferrocenyldimethyl-L-cysteine, recorded in positive ion mode. H, Na 
and K adducts of the product were observed. 
 
 
 
  L-Glutathione was coupled to 6 using the same method as described for the Cys 
coupling reaction. The product was purified by precipitation, by the addition of 
ethanol into an aqueous solution of the crude product, to yield an orange product. 
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MALDI MS of 1,1’-s-ferrocenyldimethyl-L-glutathione (14) contained the desired 
product as the major species, as well as a small amount of a larger species which 
could be consistent with a disubstituted peptide coupled to a mono substituted 
peptide, see Figure 18. However, this species was not detected in the 1H NMR and 
13C NMR spectra, and therefore could be an artefact formed in the gas-phase. 
Figure 18 MALDI MS of 1, 1’-s-ferrocenyldimethyl-L-glutathione; hydrogen and Na adducts of 
the peptide were observed, 1342 is consistent with a disubstituted peptide coupled to a mono 
substituted peptide. The theoretical and experimental isotopic distribution patterns of the 
product are in good agreement. 
 
 
 
  1,1’-s-Ferrocenyldimethyl-L-glutathione contains 6 amino acids, including polar 
residues, and displays significantly better solubility that the smaller 1,1’-s-
ferrocenyldimethyl-L-cysteine analogue. Its NMR spectra were all recorded without 
acid in the solution, see Figure 19. However it did precipitate out of water when 
stored at room temperature overnight.  In the 1H NMR of 1,1’-s-ferrocenyldimethyl-L-
glutathione, again the methylene hydrogens on the Cys side chain occur as AB 
systems in the 1H NMR spectra with a geminal coupling constant JAB of 15 Hz due to 
the chirality of the L-cysteine., see Figure 19. 
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Figure 19 NMR spectra of 1,1’-s-ferrocenyldimethyl-L-glutathione. 
1
H NMR was recorded in D2O 
and 
13
C NMR was recorded in DMSO-d6. The peptide dimer has lower solubility in water. 
 
 
 
3.3.4 Stability test of 1,1’-s-ferrocenyldimethyl-L-glutathione by 1H NMR 
spectroscopy 
  As the 1,1’-s-Ferrocenyldimethyl-L-glutathione precipitates out from water solution, 
and this water solution is required for many further experiments, acid was added to 
improve its longer term solubility. Diglutathione substituted ferrocene was dissolved 
in a water-TFA (95-5) solution, and this solution stored for 6 days without the 
appearance of any precipitation. A stability test in a MeCN-d3:D2O:TFA 50:50:0.05 
solution, monitored by 1H NMR, indicates that the Fe2+ to Fe3+ oxidation process is 
occurring in the ferrocene over these 6 days, as the peaks assigned to the 
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hydrogens on the Cp ring and those next to the Cp ring, become broader (see Figure 
20), which imply the formation of the paramagnetic ferrocenium. Acetonitrile was 
used in the solution mixture for the stability test because this solvent is adopted in 
HPLC purification of peptides, and in addition the acetonitrile can provide a peak for 
calibration of 1H NMR spectra. 
Figure 20 
1
H NMR spectra of 1,1’-s-ferrocenyldimethyl-L-glutathione in a MeCN-d3:D2O:TFA 
50:50:0.05 solution, recorded over 6 days. Peaks assigned to the Cp hydrogens and hydrogens 
next to Cp ring, broaden over time. 
 
 
 
 
 
 
 
 
3.3.5 UV of 1,1’-s-ferrocenyldimethyl-L-glutathione and 1,1’-s-
ferrocenyldimethyl-L-cysteine 
  Ferrocene peptide dimers have a peak centered around 255 nm in their UV-visible 
spectra (Figure 21). UV-visible spectra of the dimers at various concentrations allow 
us to determine the extinction coefficient of ferrocene which is used in subsequent 
chapters for concentration determination of the longer ferrocene peptide dimers. 
Therefore, solutions of both 13 and 14 were prepared at different concentrations and 
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their UV-visible spectra recorded. Experiments were repeated in triplicate in order to 
validate that data and their average absorbance values at 255 nm were plot as a 
function of concentration, from the slope of which their extinction coefficients could 
be determined (see Figure 21).  
Figure 21 A) The average absorbance of the dimers at 255 nm is plotted against the 
concentration, the error bars correspond to standard deviations generated from three repeated 
experiments. UV-vis spectra of C) 1,1’-s-ferrocenyldimethyl-L-glutathione and B) 1,1’-s-
ferrocenyldimethyl-L-cysteine in water-TFA (97-3) at three different concentrations at room 
temperature.  
 
 
  Both dimers have similar extinction coefficients of 10884 and 10717 M−1 cm−1 as 
expected. The average value was therefore used for experiments with the longer 
ferrocene peptide dimers, see Chapters 4 and 5. 
 
3.3.6 CV titration of 1,1’-bis(hydroxymethylene)ferrocene  
  1,1’-Bis(hydroxymethylene)ferrocene (6) stock solution was titrated into a 100 mM 
phosphate buffer pH 7 solution, and the CV recorded between 0 and 0.7 V using gold 
and carbon electrodes, see Figure 22. 
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Figure 22 CV of 1,1’-bis(hydroxymethylene)ferrocene at 10, 20, 30 and 40 µM using a gold 
working electrode. 
 
 
  The ferrocene peptide dimer solutions at concentrations lower than 40 µM do not 
display proportional ipa or ipc to their concentration, because they are lower than the 
minimum detectable concentration of the experimental kit. 40 µM 6 solution gave a 
strong signal in the CV, the oxidation and reduction peaks of which are easily defined, 
and ipa/ipc (peak anodic current and peak cathodic current) is equal to 1, so 6  is 
considered to be chemically reversible. The ΔEp (difference between oxidation 
potential and reduction potential) is equal to 57 mV, which indicates a single electron 
redox process, as an ideal one electron process should yield a ΔEp of 59 mV if it is 
electrochemically reversible.119 
 
3.3.7 CV of 1,1’-s-ferrocenyldimethyl-L-glutathione (diGSCH2 Fc) solutions 
  A titration of 1,1’-s-ferrocenyldimethyl-L-glutathione (14) was used to check the 
experimental kit with a low-volume sample holder, in which the counter and reference 
electrodes are not in the sample holder, but in the bulk electrolyte solution, coupled 
to the sample through a glass frit (see Chapter 2 for full experimental details). The 
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experiment was conducted using a gold and carbon working electrode, respectively, 
see Figure 23. 
 
Figure 23 CV titration of 1,1’-s-ferrocenyldimethyl-L-glutathione using a carbon and gold 
working electrode, and a small volume fritted sample holder. 
 
 
 
  In both the CV recorded with either a gold or carbon working electrode, the ipa and 
ipc are both proportional to the concentration. However, the ipa is always larger than 
ipc, which indicates it is not chemically reversible in this experimental kit. The ΔEp is 
around 100 mV, which is much larger than the ideal value of 59 mV, which indicates 
it is not electrochemically reversible. Alternatively this could be because there is a 
problem with the conductivity at the frit of the sample holder where the electron 
transfer happens between the sample solution in the holder and the buffer solution in 
the larger vial. We continued the comparison of these two electrochemistry 
experimental kit set-ups using our longer ferrocene peptide dimers, and these 
findings are reported in Chapter 4. 
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3.3.8 DPV titration of 1,1’-S-ferrocenyldimethyl-L-glutathione 
  A DPV titration was performed in addition to the CV experiments, as DPV is more 
sensitive and can therefore be recorded on solutions of lower concentrations 
(important when working with biomolecules). The titration was performed twice at 
various concentrations, and the resulting peak currents plotted as a function of 
concentration (see Figure 24). Both DPV titrations of 1,1’-S-ferrocenyldimethyl-L-
glutathione share the same gradient.  When the concentration is 5.67 µM and 7.14 
mM, it did not give valid peak currents on the plot, but the plot did suggested that a 
concentration range of between 11.5 to 178 µM should yield valid data in the DPV 
experiment.   
Figure 24 Peak currents from two DPV titrations are plotted as a function of the concentration 
of 1,1’-S-ferrocenyldimethyl-L-glutathione. Both plots share very similar gradients with R
2
 
greater than 0.99. 
 
 
 
3.4 Conclusions 
  We have developed an efficient method for the SPPS of side chain protected 
peptides by the synthesis of a short peptide using three methods at room 
temperature or with microwave irradiation. A side chain protected 29 amino acid 
peptide design based on GCN4 was prepared by this method for strategy A; it has 
low solubility in water and organic solvents and cannot be purified and characterised 
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without full deprotection of amino acid side chains. We attempted to couple this 
peptide with a commercially available stilbene linker, but only the mono substituted 
peptide was found in MS after deprotection. Due to the low solubility of peptide with 
fully protected side chains, strategy A was abandoned. However an unstable linker, 
1,1’-diamino ferrocene, was synthesised for strategy A. The synthesis of 1,1’-bis 
aminoethyl ferrocene was abandoned at the last step, due to the required change in 
strategy. Strategy B was to couple a ferrocene linker with a single cysteine 
introduced into a peptide sequence for this purpose. 1,1’-Ferrocenyl bis (methylene 
2-bromoacetate) was synthesised for strategy B, but it decomposed to 1,1’-ferrocenyl 
bis methylium after HPLC and column chromatography. We attempted to couple the 
crude 1,1’-ferrocenylbis(methylene-2-bromoacetate) with peptide, but no peptide 
dimer was observed in MS. We attempted to couple diamino ferrocene with 
bromoacetic acid, but only mono substituted product was found in ES MS due to the 
decomposition of diamino ferrocene immediately in solution. 1,1’-
Bis(hydroxymethylene)ferrocene was coupled with cysteine and glutathione and the 
products have been fully characterised. Both the cysteine and glutathione coupled 
product have an absorbance at 255 nm in their UV-visible spectra, from which an 
extinction coefficient was determined. CV experiments of 1,1’-s-ferrocenyldimethyl-L-
glutathione and 1,1’-bis (hydroxymethylene)ferrocene were performed using two 
different experimental set-ups in order to check the use of a small volume sample 
holder. 1,1’-Bis(hydroxymethylene)ferrocene was found to be electrochemically 
reversible in CV by the kit set-up with all three electrodes emerged in the sample 
solution. The two electrochemistry experimental set-up will be further compared for 
the longer ferrocene peptide dimers, described in Chapter 4. 
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4.1 Introduction 
  GCN4 binds specific DNA target sites, as a helical homodimer with the binding 
affinity being highly dependent on dimerisation. GCN4 is dimerised through a C-
terminal leucine zipper domain. However, the monomeric GCN4 basic region (which 
lacks a leucine zipper domain) can also recognise and bind to the target DNA site, 
but with a lower affinity.120 Stabilisation of the GCN4 helical content and enhanced 
dimerisation, significantly improves the basic domain’s affinity for the DNA target site. 
Which is why monomeric GCN4 has a much weaker DNA binding affinity than the 
bZIP domain of natural GCN4.121,122  
  An important study by Kim and co-workers involved replacing the leucine zipper 
domain with a disulfide bridge. They found that this dimer displayed similar DNA 
binding to those with the leucine zipper, whereas the monomer displays only weak 
DNA binding. This work therefore demonstrated that dimerisation was important for 
strong and selective DNA binding, and the role of leucine zipper was to function as a 
dimerisation domain.35  
  As dimerisation is the only function of the leucine zipper component of GCN4, 
peptides designed based on GCN4 and which have been coupled with non-natural 
linkers, have been reported in the literature.35,36,38 These peptide dimers display 
similar DNA binding as native GCN4. 
  Mascarenas and co-worker synthesised a DNA binding peptide dimer based on 
basic region of GCN4 with a light-modulated azobenzene linker.36 In their design, the 
peptide is dimerised with the azobenzene linker molecule through the Cys side chain 
of a Gly-Gly-Cys sequence, introduced at the C-terminus of the basic domain of 
GCN4. The azobenzene adopts a trans conformation, however an irradiation of 365 
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nm wavelength light, this converts to the cis conformation.  The cis isomer binds to 
DNA containing the CREB recognition site, with 60-70 times more efficiency than the 
trans isomer, due to the more appropriate distance between the two DNA binding 
basic regions. 
  Schepartz and co-worker prepared a series of DNA binding peptide dimers which 
are composed of two identical 29 amino acid peptides contain the basic region and 
hinge of GCN4 and a Gly-Gly-Cys C-terminal cap linked by disulfide bonds to 2 
different positions of a bis(terpyridine) iron (II) complex. The resulting complexes 
position the two DNA binding basic regions at different distances. These dimers were 
shown to display different binding affinities for the DNA containing GCN4 target 
site.38 
  The electrochemistry of ferrocene has been well studied, and a number of excellent 
reviews have recently been reported on it.38,123,124 It has been used to tag large 
biomolecule for sensor purposes. The two Cp (cyclopentadienyl) rings of ferrocene 
can freely rotate due to the low energy barrier, which could provide important 
flexibility to allow peptide domains to be appropriately aligned for strong DNA binding. 
Ferrocene is stable to high temperature and unaffected by water.125 From the crystal 
structure of ferrocene, the distance between the two Cp rings is 3.3 Å,126 which is 
shorter than the distance between the side chains on the two Cys which replace the 
first residue in the leucine zipper domain in the crystal structure of GCN4-CRE DNA 
complex (Figure 1), and thus a flexible new spacer is required between the ferrocene 
and the peptides. 28AA peptide (Table 1) was therefore prepared which contained 
the full basic domain and hinge region of GCN4 terminating with a flexible Gly-Gly-
Cys-Gly towards the C-terminus. A shorter 26AA peptide was also prepared which 
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differed from the 28AA peptide in that it lacked the two flexible Gly residues between 
the hinge and Cys for subsequent dimerisation with ferrocene. A 25AA peptide was 
prepared with one fewer Gly at the C-terminus, adjacent to the Cys residue, than the 
26AA peptide. This offered the opportunity to study how the C-terminal Gly affects 
the dimer’s DNA binding. Finally shorter 22AA and 24AA peptides were prepared, 
each of which contained fewer residues from the hinge region of GCN4 (LQRMKQ). 
The C-terminal Gly between the hinge region and the Cys residue, was introduced to 
make DNA alignment of the folded basic regions (α-helical recognition units) more 
flexible in the presence of target DNA. The 22AA and 24AA were compared so as to 
establish the shortest hinge sequence required to maintain the spatial relationship 
between the basic domain and the dimerisation unit, for effective DNA binding. 
Figure 1 Distance measured between the side chains of Cys residues which replace the first 
residue in leucine zipper domain of GCN4-DNA complex crystal structure (PDB code: 2DGC).
29 
 
 
Table 1 Peptide sequences designed as DNA binding dimers based on GCN4. 
 
 N-terminus basic domain hinge C-terminus 
wild type GCN4 MIVPESSDPAAL KRARNTEAARRSRARK LQRMKQ EDKV[…]ER 
Disulfide bridge
4 
PESSDPAAL KRARNTEAARRSRARK LQRMKQ GGC 
azobenzene linker
5 
DPAAL KRARNTEAARRSRARK LQ GGC 
Iron complex linker
6 
SAAL KRARNTEAARRSRARK LQRMKQ GGC 
MBR-CC DEGRADO
11 
AL RRARNREAAARSRARR AEKLKA  LEEK[…]LG 
22AA AL KRARNTEAARRSRARK L GCG 
24AA AL KRARNTEAARRSRARK LQR GCG 
25AA AL KRARNTEAARRSRARK LQRMKQ C 
26AA AL KRARNTEAARRSRARK LQRMKQ CG 
28AA AL KRARNTEAARRSRARK LQRMKQ GGCG 
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4.2 Peptide sequence design based on GCN4 
  We compared peptide sequences used in the artificial miniature DNA binding 
peptides based on GCN4 which has previous been reported in the literature. 29,35,36,38 
DeGrado and co-workers reported a MBR-CC, in which an artificial basic region only 
contained those residues which were conserved in the basic regions of eight different 
DNA binding bZIP proteins which bind to either the TRE or CRE sites in DNA.29 In 
MBR-CC, only two residues on the C-terminus were retained to cap the basic region; 
and this has also been applied in our sequence design.  
  In the azobenzene linker GCN4 dimer, Mascarenas and co-workers carried out 
modeling by reference to Richmond’s GCN4-CRE complex crystal structures to 
predict the right position to insert azobenzene linker so as for the cis and trans 
isomers to bind differently to DNA CRE site.36,126 
 
4.3 Results and discussions 
4.3.1 Molecular dynamic (MD) simulations of the peptide dimers 
  The MD simulations were performed based on the modified crystal structure of 
complex including GCN4 and CRE DNA.126 The excess residues on the GCN4 
peptide model were removed, N-terminal groups and C-terminal Cp ring tagged 
cysteine were put into the correspond position on the peptide. Parameter of the 
ferrocene-cysteine unit was imported to define the ferrocene group structure. The 
solvent box TIP3PBOX 15 and Na+ were employed to the center of peptide-DNA 
complex to model the water solvent. The simulations were all performed with an 
energy minimisation followed by MD simulation. All the simulation stages were 
carried out with the all atom force field. In the initial 0.5 ns MD simulation, the 
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simulation temperature was set up to 298 K from 0K and then continued for the rest 
of the simulations up to 10 ns. Each complex simulation was performed in triplicate to 
validate the result and the average model was calculated as a final result. The 44AA, 
48AA, 52AA and 56AA complex with CRE DNA were used for MD simulations. 
  In the MD simulation model of the 44AA-CRE complex after 10 ns, the C-terminus 
of the two peptide strands were unfolded up to the Lys residue at position 18, the 
only residue in the hinge domain, and the remainder of the peptide sequence (the 
basic domain) was α-helical and bound to the major groove of the DNA target site 
(Figure 2A). The single amino acid in the hinge sequence is too short for the dimeric 
DNA binding of peptide. In the MD simulation model of the 48AA-CRE complex after 
10 ns, the C-terminus of one peptide strand is unfolded up to the Arg residue at 
position 21, three residues into the basic region (Figure 2B). 48AA forms a better 
complex with CRE DNA compared to 44AA, due to the longer hinge sequence. In the 
52AA-CRE DNA complex after 10 ns, both strands are fully α-helical resulting in a 
well folded peptide-DNA complex. However, one peptide strand appears to have 
been pushed away from the DNA backbone in the 56AA-CRE DNA complex. 
Therefore I conclude that the sequence in 52AA can provide the optimal 
conformation for formation of a well folded peptide-DNA complex while the sequence 
in 56AA is too long for it to be reasonably accommodated, see Figure 2. 
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Figure 2 MD simulation models of peptide-CRE DNA complexes at 10 ns; A) 44AA, B) 48AA, C) 
52AA and D) 56AA. 
 
 
 
 
4.3.2 Method development for peptide synthesis on the Liberty-1 microwave 
automated peptide synthesiser 
  We attempted to synthesise the 26AA using a single amino acid coupling method as 
well as a method which included a single amino acid coupling followed by capping for 
each amino acid, however, both of these methods resulted in a very impure mixture 
in which the target peptide was not the major species. Instead various shorter 
peptide sequences were detected due to incomplete peptide synthesis. Therefore, 
we adopted the double coupling method for each amino acid of 26AA and the longer 
28AA which yielded the target peptide as the major product, which was 28-32% pure 
as determined by preparative HPLC after cleavage from the resin, see Figure 3. 
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Figure 3 Preparative C12 HPLC of the crude A) 26AA and B) 28AA peptides, using a gradient 
increasing 0% acetonitrile (0.05 %TFA) in water (0.05 %TFA) to 20% over 20 minutes followed 
by a 20 minute wash of 20 % acetonitrile (0.05 %TFA) monitored at 222nm.  
 
 
  The initial attempt to cleave the 26AA from the resin using the TFA cleavage cocktail 
for a period of 2 hours led to the presence of an impurity. This was confirmed by 
MALDI MS (Figures 4 and 5) to be the 26AA with a Cys which still contained the 
triphenylmethyl protecting group. The peptide was then subjected to fresh cleavage 
TFA cocktail for a further 2 hours. This resulted in fully deprotected 26AA as the 
major product as confirmed by both HPLC and MALDI MS (Figure 4 and 5). 
Figure 4 Analytical C12 HPLC of the 26AA after 2 hours and 4 hours cleavage respectively 
using a gradient increasing 0% acetonitrile (0.05 %TFA) in water (0.05 %TFA) to 20% over 20 
minutes followed by a 20 minute wash of 20 % acetonitrile (0.05 %TFA) monitored at 222nm. 
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Figure 5 MALDI MS of the two crude major fractions from the analytical C12 HPLC of the 26AA 
after TFA cleavage. A) the peak at 18
th
 minute, the side chain fully deprotected 26AA; B) the 
peak at 25.7
th
 minute, 26AA with Cys triphenylmethyl protecting group. 
 
 
 
 
  For the purification of the peptide, the C12 column was used instead of the C18 
column due to an improved separation of the peptide using the same gradient. 
Isolated fractions, having been identified by ESI-MS were combined and lyophilised 
to yield the pure peptide product as a white powder. This was subsequently dissolved 
in water and analysed using the Ellman’s test to determine the concentration of 
available thiols in solution, which in this case was equivalent to the peptide 
concentration to calculate the synthesis yield (Table 2). 
 
 Table 2 Experimental peptide synthesis yields 
 
 Percentage of Yield 
22AA 39% 
24AA 41% 
25AA 1% 
26AA 26% 
28AA 26% 
   
  22AA and 24AA were obtained in higher yield than the longer 26AA and 28AA 
peptides. Whereas the low 1 % yield for the 25AA is due to it being an isolated by-
product of a faulty synthesis of 26AA, in which the 1st Gly did not couple to the resin. 
 Chapter 4 Design, synthesis and electrochemical evaluation of ferrocene peptide dimers based on GCN4 
86 
 
4.3.3 Characterisation of peptides 
  Except for the 25AA peptide which was characterised by a very poor quality MALDI 
MS, and which could not be characterised by ESI-MS due to its low concentration 
and high salt content, all other peptides were characterised by ESI MS recorded in 
the positive mode, and studied by C12 analytical HPLC in order to establish purity 
(Figures 6 and 7). 
 
Figure 6 Analytical C12 HPLC of purified peptides eluted by increasing the gradient from 100% 
water (0.05% TFA) to 20% acetonitrile (0.05 % TFA) over 20 minutes followed by a 20 minute 
wash of 20% acetonitrile (0.05 % TFA). A:22AA, B: 24AA, C: 25AA, D: 26AA, E:28AA. The peak 
eluting at the second minute in 22AA HPLC is consistent with acetic acid which is used to 
dissolve the peptide. 
 
 
 
  Figure 7 shows the analytical C12 HPLC of the purified peptides by the same 
gradient. As expected the longer peptides display longer retention times. The 25AA 
and 26AA peptides share very similar retention times, consistent with their similarity 
differing only a single Gly located towards C-terminus in the sequence.  
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Figure 7 ES-MS of 22AA, 24AA, 26AA and 28AA recorded in positive mode. 
 
 
 
 
4.3.4 Disulfide bond formation 
  Before the successful coupling of designed peptides with 1,1’-bis 
(hydroxymethylene) ferrocene was developed, the coupling of 28AA was carried out 
in a glass vial without the protection of a nitrogen atmosphere. Oxidised peptide 
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dimer formed under these reaction conditions and this was characterised by ES-MS 
(Figure 8) which depicts the ESI-MS of the fraction collected between 28AA and 
peptide ferrocene dimer in HPLC. This fraction contains unreacted 28AA peptide 
monomer, the target dimer and the oxidised dimer. As the oxidised dimer has the 
molecular weight twice that of 28AA peptide monomer, it can be challenging to 
assign peaks in the ESI-MS. The oxidised peptide dimer was characterised by the 
isotopic distributions which confirm the charge state of odd numbers. The addition of 
dithiothreitol (DTT) reduces the oxidised dimer to peptide monomer and this process 
was monitored by analytical C12 HPLC (Figure 9). The oxidised peptide dimer peak 
disappeared 10 minutes after the addition of DTT. 
Figure 8 ES-MS of the oxidised peptide dimer recorded 24 hours of the reaction time. +12, +11, 
+10 and +9 adducts of the peptide dimer were detected; +5 adduct of 28AA was detected; +8, 
+9 and +11 adducts of oxidised dimer peptide were detected. 
 
 
Figure 9 4 analytical C12 HPLC of purified peptides eluted by increasing the gradient from 
100% water (0.05% TFA) to 20% acetonitrile (0.05 % TFA) over 20 minutes followed by a 20 
minute wash of 20% acetonitrile (0.05 % TFA). The peak corresponding to oxidised dimer 
disappeared 10 minutes after the addition of DTT.  
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4.3.5 Dimerisation of peptides with 1, 1’-bis (hydroxymethylene) ferrocene 
  Having successfully synthesised and purified the different peptides based on GCN4, 
with a single Cys for dimerisation located towards the C-terminus and having studied 
the dimerisation through Cys with 1,1’-bis(hydroxymethylene) ferrocene (see Chapter 
3), we were ready to monitor the coupling reaction between 1,1’-
bis(hydroxymethylene) ferrocene and the 28AA peptide.  
  Three equivalents of 28AA were coupled with the ferrocene linker based on the 
reaction conditions developed in Chapter 3. The progress of the reaction was 
monitored by both HPLC and ESI-MS. The sample was analysed by ESI-MS after 24 
hours, 48 hours and 4 days after the addition of TFA, which is required to catalyse 
the reaction, see Figure 10. 
Figure 10 Positive mode ES MS of 28AA coupling reaction with 1,1’-bis(hydroxymethylene) 
ferrocene solution monitored after 24 hours, 48 hours and 4 days. +4, +5 and +6 adduct of 
28AA were found after 24 hours. S=28 amino acid peptide starting material; P=56 amino acid 
disubstituted ferrocene peptide dimer. 
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  The ESI-MS of the reaction mixture after 24 hours contains peaks which could be 
assigned to both the 28AA starting material and the desired product 56AA Fc. After 
48 hours both were again detected, though a slightly larger proportion of product. 
However these two MS spectra can only be interpreted in a qualitative rather than a 
quantitative fashion. In contrast HPLC can be used to quantitatively monitor progress 
of the reaction. This required an appropriate HPLC profile to be established that 
could separate peptide monomer, product dimer and oxidised peptide dimer (an 
expected side product). The final profile consists of increasing the gradient from 
100% water (0.05% TFA) to 20% acetonitrile (0.05 % TFA) over 20 minutes on a C12 
column. After the C12 HPLC gradient had been developed to separate 28AA and 
56AA Fc, the reaction between the 28AA peptide monomer and 1, 1’-bis 
(hydroxymethylene) ferrocene was monitored by C12 analytical HPLC (see Figure 
11). 
Figure 11 Analytical C12 HPLC monitoring the dimerisation reaction of 28AA with 1,1-
bis(hydroxymethylene) ferrocene. Shown are HPLC profiles of a 28AA monomer control and 
aliquots taken from the reaction at various reaction time. The gradient increases from 100% 
water (0.05% TFA) to 20% acetonitrile (0.05 % TFA) over 20 minutes followed by a 20 minute 
wash of 20% acetonitrile (0.05 % TFA) was used and eluting peaks monitored at 222 nm, No 
peptide species was detected in the ES-MS of fraction E and F. 
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  In Figure 11, the peak confirmed by ESI-MS assigned to the desired product 28AA 
Fc dimer steadily increased over 190 minutes in comparison to that assigned to the 
28AA peptide monomer. There is no significant change between 190 and 350 
minutes reaction time, however the amount of impurity (shoulder after 56AA Fc and 
labeled D in Figure 9) increased over this time making the dimer more difficult to 
purify. We were unable to identify the nature of species D by ESI-MS, which 
contained many m/z peaks including various salt adducts of the product peptide. The 
small peak between the unreacted 28AA peptide monomer and the desired 56AA Fc 
product corresponds to the oxidised dimer, confirmed by ESI-MS.  
  The reaction was also monitored by the Ellman’s test which measures the 
concentration of unreacted Cys thiols from the side chain concentration in the 
reaction solution (Figure 12). 
Figure 12 Concentration of available thiol concentration, equivalent to the concentration of 
unreacted 28AA peptide, as calculated from the Ellman’s test. 
 
 
A plot of the thiol concentration as measured using the Ellman’s test monitored as a 
function of reaction time (see Figure 12) shows the concentration of the 28AA 
starting material decrease over time as the reaction progresses. The two points at 0 
min are the concentration of 28AA based on an aliquot from the reaction mixture prior 
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and post the reaction initiation by addition of TFA. After the first 100 minutes, the 
concentration of 28AA monomer does not appear to decrease much and thus the 
reaction has reached equilibrium. The reduction in thiol concentration would be 
consistent with both product formation (56AA Fc peptide dimer) and the formation of 
the oxidised peptide dimer as an undesired side product. 
  The analogous coupling reaction between the 26AA peptide and 1,1’-bis 
(hydroxymethylene)ferrocene was also monitored by analytical C12 HPLC using the 
same gradient as developed earlier for the 28AA peptide (Figure 13). The reaction 
was initially set up with 3 equivalents of the 26AA peptide monomer with respect to 
ferrocene molecule. However an additional 1/6 equivalent of 1,1’-bis 
(hydroxymethylene)ferrocene was added into the reaction mixture after 210 minutes 
of reaction time. A similar change of reaction mixture to that of the 28AA coupling 
reaction was observed. 
Figure 13 Analytical C12 HPLC for monitor the dimerisation reaction of 26AA with 1, 1’-bis 
(hydroxymethylene) ferrocene. Shown are HPLC profiles of aliquots taken from prior the 
addition of TFA, the reaction at 50
th
, 110
th
, 160
th
 225
th
 and 280
th
 minute. A gradient increases 
from 100% water (0.05% TFA) to 20% acetonitrile (0.05 % TFA) over 20 minutes followed by a 20 
minute wash of 20% acetonitrile (0.05 % TFA) was used and eluting peaks monitored at 222 nm, 
26AA and product peptide were characterised by ESI-MS. No peptide species was detected in 
the ES-MS of fraction at 3.5
th
 and 9
th
 minute. 
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  For the coupling of the three remaining peptides 22AA, 24AA and 25AA, three 
equivalents of peptide monomer was coupled with 1, 1’-bis (hydroxymethylene) 
ferrocene over 120 minutes, as the reaction mixture appeared to reach equilibrium 
within 100 minutes and longer reaction times yielded more impurity, resulting in more 
difficult separation (more peak overlap) of the target peptide dimer products. All the 
purified ferrocene peptide dimers were characterised by ESI MS and C12 analytical 
HPLC (Figure 14 and Figure 15). 
 
Figure 14 Analytical C12 HPLC of purified ferrocene peptide dimers eluted by increasing the 
gradient from 100% water (0.05% TFA) to 20% acetonitrile (0.05 % TFA) over 20 minutes 
followed by a 20 minute wash of 20% acetonitrile (0.05 % TFA). A: 44AA, B: 48AA, C: 50AA, D: 
52AA, and E: 56AA. 
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Figure 15 ESI-MS of the 44AA, 48AA, 52AA and 56AA ferrocene peptide dimers recorded in 
positive mode.  
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4.3.6 Quantification of ferrocene peptide dimers 
  The ferrocene peptide dimers were quantified by their UV absorbance at 255 nm 
and their extinction coefficient was calculated from the sum of the ferrocene 
extinction coefficient as 255 nm as determined in the previous chapter (Chapter 3) 
and two equivalents of the peptide extinction coefficient at 255 nm determined here. 
There is a peak for both 1, 1’-S-ferrocenyldimethyl-L-glutathione and 1, 1’-S-
ferrocenyldimethyl-L-cysteine at 255 nm in their UV spectra. These two small 
ferrocene peptide molecules share the same extinction coefficient at 255 nm. The 
average value of 10800 L mol−1 cm−1 was used as the extinction coefficient of our 
ferrocene linker domain. This peak was also found in all the UV-visible spectra 
recorded of all the ferrocene peptide dimers recorded under similar conditions. In 
order to calculate the extinction coefficient of the peptide, the UV visible spectra of 
the 24AA, 26AA and 28AA peptides were recorded at various concentrations. These 
experiments were repeated in triplicate in order to validate the data (Figure 16). 
 
Figure 16 Extinction coefficient calculations of A) 24AA, B) 26AA and C) 28AA peptide 
monomers at 255 nm. The average absorbances at 255 nm are plot as a function of peptide 
concentrations. The error bars shown corespond to the standard deviation of the data 
recorded in triplicate. 
 
 
 
  Extinction coefficient determination for peptide contribution was performed in 
triplicate. The average absorbance at 255 nm was plot as a function of peptide 
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concentration. Standard deviation was used as the error bar. These three peptides 
share similar extinction coefficients at 255 nm, and so the average value of 216 
Lmol−1cm−1 was used for subsequent calculation for ferrocene peptide dimers, in 
which an extinction coefficient of 11232 Lmol−1cm−1. 
 
4.3.7 Circular dichroism (CD) of peptide monomers and ferrocene peptide 
dimers with CRE and non-specific DNA 
  The GCN4 basic domain is unstructured in the absence of DNA containing a target 
site, and this therefore provides us with a method by which to test the peptide dimers’ 
binding to different DNA sequences by monitoring their folding.127 In order to 
compare the structures of the peptide monomer and ferrocene peptide dimers in the 
absence and presence of CRE and non-specific DNA, circular dichroism (CD) was 
carried out on solutions containing either 10 µM peptide monomer or 5 µM peptide 
dimer in the absence and presence of 5 µM DNA. 
  As described, we designed peptide sequences with different hinge domains and 
subsequently different distances between the DNA binding basic domain and the 
dimerisation unit (ferrocene). This will allow us to study the spatial relationship 
between the two domains and the influence this will have on their DNA binding 
affinity, see Table 3. In the shorter sequences, the 22AA and 24AA peptides only 
have one or three residues, respectively, in the hinge domain, which should allow us 
to evaluate what is the shortest hinge required for DNA binding. There is one Gly 
located at the C-terminus of 26AA which is not present in 25AA. This should allow us 
to evaluate if sequences extending beyond the C-terminus play an important role. 
Both 26AA and 28AA sequences contain the whole hinge, differing only in two Gly 
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residues as a spacer between the peptide basic domain and the dimerisation unit. 
These two sequences were designed to study if a flexible spacer between the 
peptide and the ferrocene dimerisation unit, affects their DNA binding affinity. 
 
Table 3 Peptide sequences used in these studies 
 
Peptide N-terminus Basic domain Hinge C-terminus 
22AA AL KRARNTEAARRSRARK L GCG 
24AA AL KRARNTEAARRSRARK LQR GCG 
25AA AL KRARNTEAARRSRARK LQRMKQ C 
26AA AL KRARNTEAARRSRARK LQRMKQ CG 
28AA AL KRARNTEAARRSRARK LQRMKQ GGCG 
 
 
4.3.7.A CD of peptide monomers with CRE and non-specific DNA 
  All five peptide monomers were studied by CD to establish folding. Solutions of 10 
µM peptide monomer in the presence and absence of 5 µM duplex DNA, and in the 
presence of 100 mM NaCl and 10 mM phosphate buffer pH 7, chosen to mimic 
physiologically relevant conditions, were studied by CD (see Figure 17). 
  A very noisy signal was obtained for the CD of 22AA peptide using 10 scans and so 
the scan number was increased to 16. This gave a reasonably smooth CD spectrum. 
The CD spectra of the peptide monomers could be consistent with a 310 helix, and 
thus they are either in random coil or 310 helical in the absence of target DNA,
128-130 
but form α-helixes in the presence of CRE-DNA. The residual molar ellipticity,RME, 
of the peptides was calculated from the CD, and the residual molar ellipticity at 222 
nm was used to calculate the percentage of α-helical folding, which was found to be 
16% for 22AA peptide in the absence of DNA, see Table 4.131,132 Addition of DNA 
containing either the CRE target site or a NS strand, showed no significant change in 
the folding. 
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Figure 17 CD spectra of 10 µM peptide monomers in the absence and presence of 5µM CRE 
and NS DNA. Independent experiments were performed in triplicate. CD of A), B) and C) 22AA; 
D), E), and F) 24AA, G), H) and I) 25AA, J) K) and L) 26AA, M), N) and O) 28AA in 100 mM 
phosphate pH 7 and 10 mM NaCl. A) is the CD of 22AA by 10 scans, and it is not used for the 
evaluation of data. NS DNA sequence: 5’-TGGAGTATGCGTCGATTCGT-3’ 
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Table 4 The average percentage of α-helical content of peptide monomers in the absence and 
presence of CRE and non-specific (NS) DNA, based on []222 from CD. The CD of 22AA was 
only repeated in twice, and thus no standard deviation has been calculated. 
 
peptide monomer Alone with CRE DNA with NS DNA 
22AA 16 20 17 
24AA 19±3 70±2 21±3 
25AA 22±4 78±3 34±5 
26AA 30±3 90±2 42±2 
28AA 33±2 82±4 38±2 
  
  A trend can be observed between increasing the peptide length and greater folding, 
see Table 4. All peptide monomers, except the shortest 22AA peptide, display intense 
negative minima at 208 and 222 nm in the CD spectra recorded in the presence of 
DNA containing the CRE target site. However analogous experiments recorded in the 
presence of non-specific (NS) DNA resulted in a significantly smaller change to the 
CD spectra, see Figure 17. The minima at 208 and 222 nm are consistent with 
formation of an α-helix, and therefore sequence-specific DNA binding. Notably the 
26AA peptide is the most folded in the presence of DNA, suggesting there is no 
advantage in the two additional Gly residues in the 28AA peptide. 
  Following these experiments in the presence of CRE DNA, the solutions were 
investigated by ESI-MS. All peptides were detected as monomers, confirming that 
they did not dimerise through formation of a disulfide bond through the Cys located 
towards their C-terminus. Therefore changes in the CD are truly due to binding of 
peptide monomers to the DNA target site. The binding of GCN4 peptide monomers 
with DNA, has previously been reported in the literature.120-122 Peptide monomers 
based on GCN4, which lack a dimerisation unit, have also been reported to 
recognise the DNA CRE target site. Lai and co-workers designed a peptide based on 
GCN4, and this sequence contains the whole hinge domain and the basic region.122 
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Lai’s peptide monomer is 10 % and 70 % folded respectively in the absence and 
presence of CRE DNA, which is similar to that reported for peptide dimers in which 
the GCN4 basic domains are dimerised by a disulfide bond.133 Lai’s peptide 
sequence is similar to our 25AA and 26AA sequence except for the Cys and Cys-Gly 
cap located at our C-terminus. However, all our peptide monomers are more folded 
both in the absence and presence of CRE DNA. This suggests that the Cys or the 
Cys-Gly cap at the C-terminus stabilises the formation of the α-helix in the presence 
and absence of CRE DNA. The stabilisation of peptide α-helixes by a terminal Cys 
has previously been reported in the literature.134,135 In the presence and absence of 
DNA, the 26AA monomer is more helical than the analogous 25AA and has the 
highest helicity of all our peptides. The 26AA peptide has a C-terminal Cys-Gly while 
the 25AA peptide has only a single Cys at the C-terminus. It has been reported that 
the preference for N-terminal Gly in the α-helix, while C-terminal Gly cannot stabilise 
the α-helix, but does frequently occur in α-helical motifs.133,136 This has not previously 
been investigated.136 The 28AA peptide has a lower helicity than the 26AA peptide 
which suggests that the two Gly spacers between the hinge and the C-terminal Cys-
Gly may interfere with any Cys stabilisation.  
 
4.3.7.B CD of ferrocene peptide dimers with CRE and non-specific DNA 
  As we now have evidence that these peptide monomers are able to display 
sequence-specific DNA binding, it remained for us to evaluate the ferrocene peptide 
dimers, in order to establish if the ferrocene dimerisation domain would be tolerated 
and if sequence specific DNA binding could be retained. 
  All CD experiments with ferrocene peptide dimers were performed at 5 µM, in the 
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absence and presence of 5 µM DNA by recording and averaging 16 CD scans. 
Experiments were repeated in triplicate in order to validate the data, see Figure 18. 
The molar ellipticity and the percentage folding were calculated by the method 
mentioned in the previous section, see Table 5.131 Again the percentage folding 
trends to increase as the number of residues increases, except for the 56AA dimer, 
which suggests that two Gly spacers introduced between the hinge and the Cys may 
interfere with any peptide stabilisation by Cys, similar to that observed for the peptide 
monomers. 
 
Table 5 The average folding percentage of ferrocene peptide dimers in the presence and 
absence of DNAs, based on []222 from CD. 
 
Peptide dimers alone/% Peptide with NS DNA/% Peptide with CRE DNA/% 
44AA 14±2 19±2 24±2 
48AA 24±1 22±2 92±3 
50AA 32±1 42±2 115±2 
52AA 29±2 38±1 113±3 
56AA 18±1 22±1 55±2 
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Figure 18 CD spectra of peptide dimers in the absence and presence of CRE and NS DNA. 
Experiments were repeated in triplicate. CD of A), B) and C) 44AA; D), E), and F) 48AA, G), H) 
and I) 50AA, J) K) and L) 52AA, M), N) and O) of 56AA in 100 mM phosphate pH=7 and 10 mM 
NaCl. 
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  There is only a small increase in the helicity for the 44AA ferrocene peptide dimer in 
the presence of DNA, which indicates that it cannot bind to DNA efficiently. 
Presumably this is because the single residue hinge domain is unable to provide the 
minimum length required between the basic domain and the ferrocene dimerisation 
domain, in order to bind DNA as a helical dimer.  These findings are supported by our 
molecular dynamics (MD) simulations up to 10 ns (see Figure 19). The MD model of 
44AA-CRE complex clearly shows that one of the peptide strands is unwinding. The 
44AA ferrocene peptide dimer is therefore unable to bind to the CRE DNA target 
sites with the basic domains folded into α-helixes, which is important for strong and 
selective DNA binding. 
 
Figure 19 The MD simulation model of the complex between the 44AA and CRE DNA at 10 ns. 
The box in the figure shows the unwinding of one of the peptide strands. The simulation 
starting model was modified from the 2DGC PDB file a GCN4bZIP-CRE DNA complex.
29 
 
 
 
  The 48AA, 50AA, 52AA and 56AA ferrocene peptide dimers display higher helicity in 
the presence of CRE DNA than their monomer analogues. All these dimers bind to 
DNA sequence selectively. This is due to dimerisation by the ferrocene unit which 
provides the necessary “free” rotation of the two peptide strands required in order to 
correctly orientate the basic region and therefore stabilise the resulting ferrocene 
peptide dimer-CRE DNA complex. It is in good agreement with the reported 
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literature, in which the dimerised peptide based on GCN4 can bind to the DNA target 
site while the isolated peptide monomer fails to do so with a high affinity.35 
  The 48AA ferrocene peptide dimer is less folded and appears to have less binding 
affinity than either 50AA or 52AA with CRE DNA. This is supported by the MD 
simulations in which one strand of 48AA is beginning to unwind and both strands are 
pushed away to maintain the 48AA ferrocene peptide dimer-CRE DNA complex 
model. Thus the short hinge of the 48AA peptide sequence is not long enough for the 
optimal spatial relationship between basic domain and ferrocene dimerisation unit for 
CRE DNA binding (see Figure 20). 
 
Figure 20 The overlay of the MD simulation models of the ferrocene peptide dimer-DNA 
complex after 10 ns. 52AA-DNA complex in blue (the ferrocene unit is not shown); 48AA-DNA 
complex in green. One 48AA peptide strand unwinds in box A while both strands are pushed 
away for the CRE DNA (in box A and B). The simulation starting model was modified from the 
2DGC PDB file of a GCN4-bZip CRE DNA complex.
29
 
 
 
 
  CD of the 56AA ferrocene peptide dimer is consistent with selective DNA binding, 
however it is less helical than the 28AA peptide monomer, with apparently reduced 
binding affinity to CRE DNA than 28AA. In Figure 21, the simulation model of the 
56AA ferrocene dimer-CRE DNA complex is overlaid with that for the 52AA ferrocene 
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dimer-CRE DNA complex which has the highest DNA binding affinity as determined 
by CD in the four simulated ferrocene peptide dimers. One of the peptide strands of 
the 56AA ferrocene peptide dimer is pushed away from the CRE DNA compared to 
the model with the shorter 52AA ferrocene peptide dimer, and thus the two C-
terminal Gly spacer appears to hinder the formation of optimal conformation for 
correct alignment of the two α-helices of the 56AA ferrocene peptide dimer, for 
effective binding to the CRE DNA target site.    
 
Figure 21 The overlay of the MD simulation models of the ferrocene peptide dimer-DNA 
complex after 10 ns. 52AA ferrocene dimer-CRE DNA complex in yellow (the ferrocene unit is 
not shown); 56AA ferrocene dimer-CRE DNA complex in green. One 56AA peptide strand is 
pushed away for the CRE DNA in box. The simulation starting model was modified from the 
2DGC PDB file of a GCN4-bZip CRE DNA complex.
29
 
 
 
 
  The only difference between the peptides sequences in 50AA ferrocene peptide 
dimer and 52AA ferrocene peptide dimer is the single Gly located beyond the Cys for 
dimerisation towards the C-terminus. They behave similarly in the CD experiments, 
which indicates that they bind to DNA selectively and have the highest DNA binding 
affinity of the various dimers investigated. In the MD simulation of 52AA-CRE DNA 
complex, the two peptide strands are not unwound or pushed away from the CRE 
DNA binding site and are more folded than for the 44AA, 48AA and 56AA ferrocene 
peptide dimers, supporting its higher DNA binding affinity, see Figures 19-21. 
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However, the 50AA and 52AA ferrocene peptide dimers are both calculated as being 
more than 100 % folded in the presence of CRE DNA based on CD ellipticity at 222 
nm. This change must be due to the change of peptide helicity, as well as another 
conformational change on formation of the peptide-CRE DNA complex. In the CD 
spectra of the 48AA, 50AA, 52AA and 56AA ferrocene peptide dimers with CRE 
DNA, a positive induced CD signal appears at 275 nm, which can be assigned to a 
protein-induced DNA bending of B-type DNA.136-138 For wild type GCN4, it must bend 
and distort the CRE site to maintain the important basic region-phosphate 
interactions, and the critical Thr236-phosphate backbone contact.29,139 Mascarenas’ 
azobenzene linked peptide dimer based on GCN4 also bends the DNA when it binds 
to CRE DNA in the cis conformation.36 We compared the CRE model from GCN4 
bZip-CRE DNA complex crystal structure in the literature with our simulation model of 
the 52AA ferrocene dimer-CRE DNA complex, and can observe a bending towards 
the peptide dimerisation unit, see Figure 22.  
 
Figure 22 The overlay of CRE DNA in the crystal structure of the complex formed with native 
GCN4 (green) and the CRE from the MD simulation model of the 52AA ferrocene dimer-CRE 
DNA complex at 10ns (blue).
 
Bending of the latter towards the ferrocene dimerisation domain 
can be observed.
 
The simulation starting model was modified from the 2DGC PDB file of a 
GCN4-bZip CRE DNA complex.
29
 
 
  In our peptide design for the 50AA and 52AA ferrocene peptide dimers, we have 
included both the basic and hinge domains of native GCN4, and thus the stronger 
50AA and 52AA ferrocene dimer DNA bending than native GCN4, must be due to the 
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ferrocene dimerisation unit and the short Gly-Cys located at the C-terminus. We 
measured the distance between the two sulphur atoms of Cys side chains in the 
52AA ferrocene dimer-CRE DNA MD model to be 4.5 Å (see Figure 23), which is 
much shorter than the 8 Å distance between the side chains on the two Cys 
residues, which replace the first residue in the leucine zipper domain in the crystal 
structure of the GCN4-CRE DNA complex (see Figure 2). Therefore, the ferrocene 
dimerisation domain holds the two peptide strands closer together than in the native 
GCN4 bZip complex, subsequently bending the CRE DNA more. 
Figure 23 Distance measured between the sulphur atoms of the two Cys residues in the 52AA 
ferrocene dimer-GCN4 DNA MD model. The simulation starting model was modified from the 
2DGC PDB file of a GCN4-bZip CRE DNA complex.
29 
 
 
 
4.3.8 Electrochemical characterisation of ferrocene peptide dimers 
   In the previous chapter, we reported the electrochemistry of our precursor linker 
molecule, 1,1’-bis (hydroxymethylene)ferrocene and the product of two short 
peptides (GSH) dimerised through their Cys side chain, 1,1’-s-ferrocenyldimethyl-L-
glutathione (diGSFc). 1,1’-Bis (hydroxymethylene)ferrocene displayed fully reversible 
electrochemistry consistent with a single electron transfer process by the 
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experimental set up with all three electrodes emerged in the sample solution, while 
diGSFc did not display completely reversible electrochemistry by experimental set up 
with working electrode in a sample holder. 
  We therefore aimed to evaluate if the attractive electrochemical properties of 
ferrocene were retained on linking to larger peptide units based on GCN4. The 
electrochemical characterisation was carried out in two experimental kits. In kit A, the 
ferrocene peptide dimer was in a narrow-bottom conical glass vial with a stirrer bar to 
raise the liquid level for adequate immersion of electrodes, and all the electrodes are 
emerged in the sample solution. In kit B, the ferrocene peptide dimer was in a 200 µL 
sample holder with working electrode, the sample holder was submerged in a 20 mL 
sample vial with reference and counter electrodes held in a 0.1 mM phosphate buffer 
pH=7 and 0.1 M NaCl solution, see Chapter 2 Figure 6. 
 
4.3.8.1 Differential Pulse Voltammetry titration of 52AA Fc by Set A 
  Differential pulse voltammetry (DPV) is more sensitive than cyclic voltammetry, so it 
can detect ferrocene peptide dimers at lower and more biological relevant 
concentrations. 52AA was first characterised by DPV to test the experimental kit as it 
required significantly less sample. 
 
Table 6 DPV titration of 52AA Fc 
 
Concentration (µM) Potential/ V Current/ A 
40 0.314 2.34×10
-8
 
31.1 0.313 1.90×10
-8
 
22.7 0.313 1.37×10
-8
 
17.0 0.313 1.10×10
-8
 
12.9 0.313 8.31×10
-9
 
   
  The titration of increasing concentration of the 52AA ferrocene dimer, the peak 
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potential remains the same (table 6) and the peak current is proportional to the 
concentration of peptide dimers (Figure 24), and thus this experimental set up gave 
valid data for DPV.  
  The ferrocene peptide dimer can stick to the gold electrode surface. The DPV of 
used electrode after 52AA DPV in blank buffer solution still display a peak at 0.313 V, 
and this peak disappeared after the electrode was polished and cleaned. 
 
Figure 24 DPV titration of 52AA peptide dimer, the peak currents are plotted against the 
concentration of ferrocene peptide dimer in 0.1 M NaCl and 0.01 M phosphate buffer pH=7. 
 
 
4.3.8.2 Cyclic voltammetry of 52AA Fc by Set A 
  The previous section demonstrated a valid DPV of 52AA ferrocene peptide dimer. 
We now moved on to the cyclic voltammetry (CV) study of the ferrocene peptide 
dimer. CV can provide us more information about the electrochemical properties of 
the ferrocene peptide dimers as CV includes a reversed scan in which both the 
oxidation and reduction of the ferrocene peptide can be studied while only an 
oxidation process was recorded in DPV.  
  The cyclic voltammetry (CV) experiment of 52AA Fc by set A was conducted using 
both a carbon and a gold working electrode. 0.1 mM 52AA Fc was scanned by CV at 
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various different scan rates to check the reliability of the experimental data obtained 
using set A. These experiments were performed in triplicate. In the CV recorded 
using a carbon working electrode, the reduction peak is too weak to be processed 
out (Figure 25). 
 
Figure 25 CV of 0.1 mM 52AA Fc by carbon eletrode at 200 mV/s using carbon working 
electrode. 
 
 
  Under these conditions, the ΔEp values are all much larger than 59 mV, which is not 
consistent with a one electron redox process. This could due to the resistance of the 
sample holder frit where the electron transfer occurs between the sample solution in 
the holder and the buffer solution in the vial. In the CV of diGSFc by the same 
experimental kit, they all displayed a ΔEp around than 100 mV which cannot indicate 
the one electron process in CV, so it may be due to the frit of sample holder. 
  In Cottrell equation, ipa and ipc are proportional to the square root of the scan rate (t
-
1/2). The average ipa was plot as a function of the square root of the scan rate. (Figure 
26) The error bar shown correspond to the standard deviation of the data recorded in 
triplicate. Except for the ipa at 5 mV/s, the trend line fully within the error bar of all 
average ipa, therefore 5 mV/s is too slow to provide validate CV data for the 52AA 
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peptide. 
 
Figure 26 CV of 52AA Fc by carbon electrode, the average ipa was plotted against the square 
root of the scan rate. The error bar shown corespond to the standard deviation of the data 
recorded in triplicate. 
 
 
 
  0.1 mM 52AA was scanned by CV using gold working electrode at variant scan 
rates to check its reliability by plotting ipa and ipc against the square root of scan rate. 
This experiment was repeated in triplicate to validate the data. 
 
Figure 27 CV of 0.1 mM 52AA by gold electrode, average ipa and ipc was plotted as a function 
of the square root of scan rate. The error bar shown corespond to the standard deviation of the 
data recorded in triplicate. 
 
 
 
  In Figure 27, the trend lines of ipa and ipc are outside most of the error bar of 
average value, and thus the gold electrode CV of 52AA by kit A is not reliable. 
 
 Chapter 4 Design, synthesis and electrochemical evaluation of ferrocene peptide dimers based on GCN4 
112 
 
4.3.8.3 Cyclic voltammetry of ferrocene peptide dimers by Set B 
  As the CV of 52AA peptide by kit A cannot yield reliable data, we continued the CV 
experiments using kit B in which all the electrodes are emerged in the sample 
solution, so the sample holder frit cannot interfere the electron transfer process. 
  We recorded the CV of all the ferrocene peptide dimers at 100 mM concentration 
and with a scan rate 20 mV/s. Each CV experiment was performed in triplicate using 
fresh sample stock solutions. 
  The 44AA peptide dimer has the shortest peptide strand and larger ipa and ipc than 
other dimers, see Figure 28. Its ferrocene redox center is more exposed to the 
solution for electron transfer. This implies that electrochemical activity of the redox 
center can be affected by the steric hindrance from the presence of molecule linked 
to the redox center by preventing charge transfer to and from the electrode. Except 
for 48AA, the ferrocene peptide dimers with longer peptide sequences have lower ipa 
and ipc values due to the steric hindrance of the peptide’s random conformation. 
Similar observation have previously been reported by Jenkins and co-workers.83 In 
their study, the presence of a DNA strand attached to a ferrocene shields the 
ferrocene resulting in a less intense current in the DPV.83 
Figure 28 CV of the ferrocene peptide dimers (100mM) recorded at 20 mV/s using gold working 
electrode in experimental kit B. 
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  In the CV of the peptide dimers, their ΔEp are all around 59 mV which indicate a one 
electron redox process under these conditions; except for 56AA, their │ipa/ipc│ are 
all 1.01 or 1.02 which indicates that 44AA, 48AA, 50AA and 52AA peptides all display 
fully reversible for an oxidation of the ferrocene group to the ferrocenium cation. 
56AA has the lowest ipa, ipc and a │ipa/ipc│ of 1.08 and therefore gives the least 
electrochemistry. This could be because of its longer peptide in random conformation 
without DNA which can shield the ferrocene redox center from the access of the 
counter ions. 50AA, 52AA and 56AA share similar Epa and Epc, because they have 
similar sequences except for the C-terminal Gly spacer. 44AA and 48AA are more 
cathodic and easier to be oxidised than the longer ferrocene peptides dimers. A 
possible explain is that they do not have the entire hinge and both have one less Lys 
residue which is positively charged (see Table 7). 
 
Table 7 The average analytical data of the ferrocene peptide dimers. ΔEp= Epa- Epc; E1/2= (Epa+ 
Epc)/2. All the peptide dimers’ │ipa/ipc│ are around 1 and all the peptide dimers’ ΔEp are 
around 59 mV 
 
 
  ipa/A ipc/A Epa/mV Epc/mV │ipa/ipc│ ΔEp/mV E1/2/mV 
44AA 8.70E-08±3.48E-09 -8.59E-08±-4.30E-09 329±8 271±7 1.01 58 300 
48AA 1.74E-08±7.48E-09 -1.73E-08±-6.40E-09 320±5 262±6 1.01 58 291 
50AA 1.97E-08±8.47E-09 -1.95E-08±-6.65E-10 358±6 301±4 1.01 57 330 
52AA 1.90E-08±9.69E-10 -1.87E-08±-3.93E-10 357±8 297±6 1.02 60 327 
56AA 1.29E-08±3.74E-10 -1.20E-08±-1.74E-10 357±9 300±4 1.08 57 329 
 
 
4.4 Conclusions 
  Five different peptide sequences based on GCN4 were designed, synthesised, 
characterised and purified. The longer peptide displayed a longer retention time in 
HPLC. These peptides were coupled to 1,1’-bis (hydroxymethylene)ferrocene to yield 
the desired ferrocene peptide dimers. The coupling reaction was monitored by the 
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Ellman’s test and analytical HPLC, and required much less time than the coupling of 
the short peptide glutathione with 1, 1’-bis (hydroxymethylene) ferrocene. The lack of 
a nitrogen atmosphere for the coupling reaction resulted in the formation of oxidised 
peptide dimer, which could be reversibly reduced by the addition of excess DTT. The 
ferrocene peptide dimers were quantified through their absorbance at 255 nm in their 
UV visible spectra, and the extinction coefficient was calculated by the sum of the 
small ferrocene molecules’ extinction coefficient and two equivalents of the extinction 
coefficient of the peptide all at 255 nm.  
   The peptide monomers and ferrocene peptide dimers have been studied by CD. All 
the peptide monomers display sequence specific binding to DNA based on CD 
spectroscopy, except for the 22AA peptide monomer which is too short for the 
recognition of target DNA, presumably as it does not retain sufficient conserved 
residues from native GCN4. 
  The ferrocene peptide dimers bind to DNA, based on CD studies, except for the 
short 44AA ferrocene peptide dimer, the sequence of which is again too short for 
recognition of target DNA while its hinge domain sequence is too short to maintain 
the spatial relationship between the DNA binding basic domain and the ferrocene 
dimerisation unit. These findings are supported by MD simulations. The peptide 
monomers are less helical in the presence of CRE DNA, consistent with reports that 
their binding is weaker. It is because of dimerisation, achieved by a leucine zipper in 
native GCN4 and by the ferrocene unit described here. The ferrocene unit provides 
the necessary flexible “free” rotation of the two peptide strands required in order to 
correctly orientate the basic region, with respect to the major groove of DNA, and 
therefore stabilise the resulting ferrocene peptide dimer-DNA complex. 
 Chapter 4 Design, synthesis and electrochemical evaluation of ferrocene peptide dimers based on GCN4 
115 
 
  The 48AA ferrocene dimer has been determined as the minimum sequence 
required to bind DNA specifically. 50AA and 52AA have extremely similar sequences 
except the latter has a Gly residue beyond the Cys, the site of dimerisation, located 
at the C-terminus. They are the most helical ferrocene peptide dimers in the 
presence of CRE DNA as determined by CD, which is again supported by MD 
simulations performed on model complexes with CRE DNA. However they are over 
100 % folded based on our CD calculations. This is due to a protein-induced DNA 
bending of the CRE DNA, which has been observed in the CD spectra, and which 
must also contribute to the signal at 222 nm used to calculate the percentage folded.  
  The electrochemistry of the ferrocene in peptide the dimers was studied using two 
different sets of experimental setup. In the set with a small volume sample holder, the 
DPV titration of 52AA Fc yielded the peak currents which were proportional to 
peptide concentration; however the DPV cannot provide much information about the 
electrochemistry of the ferrocene in peptide dimers. Whereas CV includes two 
reversible scans and thus provide more information than the DPV. Using the 
experimental set-up with all electrodes in the sample solution in a small volume cell, 
all the ferrocene peptide dimers were studied by CV which shows it is a one electron 
redox process. The electrochemistry of the peptide dimers is fully reversible under 
these conditions in the CV.  
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5.1 Introduction 
  In view of the attractive electrochemical properties, the ability to substitute both Cp 
rings to generate a symmetrical dimerisation unit, and the effectively (low energy 
barrier) free rotation of the two Cp rings providing the basic domains with no 
constraints in order to position themselves for effective DNA binding. We aimed to 
dimerise GCN4 using ferrocene. Though we are interested in using this as an 
artificial dimerisation domain in other biological systems, the well-studied GCN4 
transcription factor will allow us to evaluate its effectiveness. Studies reported here 
investigate DNA binding and sequence selectively. How the electrochemistry of the 
ferrocene probe changes on binding to target and non-specific DNA is investigated 
and reported here. 
 
 
5.2 Gel electrophoresis of ferrocene peptide dimers with CRE and NS DNA 
  In collaboration with Dr Aimee Gamble, gel electrophoresis experiments were 
conducted on 50 nM CRE and NS DNA at room temperature with increasing 
concentrations of ferrocene peptide dimers. Though the experiments were conducted 
by Dr Gamble in the School of Bioscience, the results will be compared with the CD 
results presented in the previous section. 
  In the gel electrophoresis experiment with the 44AA ferrocene dimer, the peptide 
does not form a new complex with NS DNA. A small amount of 44AA appears to 
form a new complex with CRE when at least 1 equivalent is added. This is observed 
as a faint band towards the top of the gel which migrates more slowly due to complex 
formation, see Figure 1. However this complex does not cause an increase in helicity 
 Chapter 5 DNA binding of Ferrocene peptide dimers 
118 
 
in CD study, so 44AA may interaction with CRE in a non-specific manner which does 
not involve an α-helical recognition domain. 
 
Figure 1 Gel mobility shift assay of CRE and NS DNA in the presence of increasing equivalents 
of the 44AA ferrocene dimer. 
 
 
 
 
  A similar gel electrophoresis study of the 48AA ferrocene dimer, shows the 
formation of a complex with the CRE DNA to a greater extent than with the 44AA 
ferrocene dimer. A small amount of the 48AA ferrocene dimer forms a complex with 
the NS DNA, however this requires significantly more 48AA ferrocene dimer than 
with the CRE DNA, see Figure 2. Therefore, though same non-specific DNA binding 
is detected at higher equivalence, the 48AA ferrocene dimer binds sequence 
selectively at lower equivalents. Furthermore, the formation of a 48AA ferrocene 
dimer-NS DNA complex is not observed in the CD of the 48AA ferrocene dimer with 
NS DNA, suggests that the dimer interaction with NS-DNA is non-specific and does 
not involve the formation of an α-helical recognition domain.  
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Figure 2 Gel mobility shift assay of CRE and NS DNA in the presence of increasing equivalents 
of the 48AA ferrocene dimer. 
 
 
 
  In the gel electrophoresis experiments conducted with the 52AA and 56AA 
ferrocene dimers and CRE DNA and NS DNA, the results were similar to those 
obtained for the 48AA ferrocene dimer, consistent with their similar behaviour by CD, 
see Figure 3. 
 
Figure 3  Gel mobility shift assay of CRE and NS DNA in the presence of increasing 
equivalents of  A) the 52AA ferrocene dimer; B) the 56AA ferrocene dimer. 
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5.3 Cyclic Voltammetry (CV) of ferrocene peptide dimers with DNA 
  Having established that some of the ferrocene peptide dimers are able to sequence 
specifically bind to DNA containing the CRE site with a defined peptide fold, it 
remained for us to evaluate if the electrochemistry of the ferrocene dimerisation 
domain was sensitive to these binding events. Therefore, cyclic voltammetry (CV) 
experiments were conducted in the absence and presence of DNA containing either 
the CRE or NS sequence. 
  These experiments were carried out in experimental setup with all working, counter 
and reference electrodes submerged directly in the sample solution rather than the 
low volume setup describe in Chapter 3, as this kit has been proved to give valid 
data for small ferrocene dimer molecules, see Chapter 4. All these CV experiments 
were independently repeated for 100 µM ferrocene peptide dimers in the presence 
and absence of one equivalent NS or CRE DNA in triplicate in order to validate the 
data. 
  Our ferrocene peptide dimers are studied in solution for DNA detection, and thus 
the electron transfer occurs through the electrolyte. The basic domains of the peptide, 
which interact with the CRE DNA site, as well as the CRE DNA, are not expected to 
play a direct role in the electron transfer. Our hypothesis is that the DNA will cause a 
change in the ferrocene group redox behaviour, as a result of through space 
electrostatic interactions. Also the conformational changes of ferrocene peptide 
dimers on complexation with CRE DNA will cause a conformational change of the 
ferrocene which may alter its redox behaviours, and would change the solution 
diffusion behaviour of the redox probe. 
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  Except for 50AA, all the CV of all the ferrocene peptide dimers experiences some 
similar change in the presence of CRE and NS DNA. In the presence of CRE and NS 
DNA, all the peptide dimers have a │ipa/ipc│>1 and ΔEp of less than 59 mV, which 
indicates that none of these ferrocene peptide dimers, have a fully reversible redox 
couple in the presence of DNA, see Table 1 and Figure 4.  In the presence of either 
CRE or NS DNA, there is cathodic shift in Epa and E1/2 as well as an increase in ipa for 
all the ferrocene peptide dimers (see Table 1 and Figure 4), due to the through space 
electrostatic interactions between the ferrocene group and the negatively charged 
DNA, as well these electrostatic interactions making it easier to oxidise. We 
measured the distance between the nearest DNA phosphate backbone and the 
ferrocene groups in the simulation models of the ferrocene peptide dimers-CRE DNA 
complex at 10 ns, see table 2. The ferrocene peptide dimer with a shorter distance 
from the DNA phosphate backbone has a smaller redox potential (E1/2) and thus it is 
easier to be oxidised. 
  For the CVs of the 50AA ferrocene dimer in the presence of CRE DNA, the 
│ipa/ipc│=1.1 while ΔEp is 59 mV, so 50AA is reversible in the presence of CRE. 
However no MD simulations were performed for the 50AA ferrocene dimer-CRE DNA 
complex, and therefore the reversible redox behavior of the 50AA ferrocene dimer-
CRE DNA complex is unclear. 
  The CV of 50AA and 52AA in the presence of either CRE or NS DNA, are very 
different, and the only difference in their structure is the Gly located beyond C-
terminus outside the dimerisation unit. The unstructured terminal Gly may hinder the 
ferrocene in the 52AA-DNA complex, possibly making the complex more difficult to 
be oxidised and resulting in a more positive Epa. This has also been found for the 
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56AA ferrocene dimer which contains Gly residues towards the C-terminus, and 
there is only a 9 to 14 mV decrease in the redox potential of the ferrocene group in 
the 56AA ferrocene dimer complexed with CRE or NS DNA. 
 
Figure 4 Cyclic voltammetry of 100 µM ferrocene peptide dimers recorded in the absence and 
presence 100 µM CRE and NS DNA at 20 mV/s, A) 44AA, B) 48AA, C)50AA, D)52AA, E)56AA.  
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Table 1 The data from the CV of ferrocene peptide dimers in the absence and presence of CRE and NS DNA related to Ag/AgCl. ΔEp= Epa- Epc, 
E1/2= (Epa- Epc)/2 
 
 
 
 
 
 ipa/A ipc/A Epa/mV Epc/mV │ipa/ipc│ ΔEp/mV E1/2/mV 
44AA 8.70×10-8±3.48×10-9 -8.59×10-8±4.30×10-9 329±8 271±7 1.01 58 300 
NS+44AA 9.97×10-8±4.49×10-9 -5.40×10-8±-1.62×10-9 300±6 270±6 1.85 30 285 
CRE+44AA 1.05×10-7±3.14×10-9 -7.80×10-8±-2.73×10-9 307±5 252±5 1.34 55 280 
48AA 1.74×10-8±7.48×10-9 -1.73×10-8±-6.40×10-9 320±5 262±6 1.01 58 291 
NS+48AA 2.49×10-8±8.47×10-9 -2.26×10-8±-7.46×10-10 306±6 279±5 1.1 27 292 
CRE+48AA 3.56×10-8±1.14×10-9 -3.25×10-8±-1.04×10-9 310±4 257±5 1.1 53 284 
50AA 1.97×10-8±8.47×10-9 -1.95×10-8±-6.65×10-10 358±6 301±4 1.01 57 330 
NS+50AA 3.32×10-8±1.36×10-8 -2.20×10-8±-7.59×10-10 306±4 272±4 1.51 34 289 
CRE+50AA 2.16×10-8±7.99×10-9 -1.90×10-8±-7.81×10-10 315±5 256±5 1.137 59 286 
52AA 1.90×10-8±9.69×10-10 -1.87×10-8±-3.93×10-10 357±8 297±6 1.02 60 327 
NS+52AA 2.55×10-8±1.10×10-9 -2.28×10-8±-7.32×10-10 320±9 274±4 1.12 46 297 
CRE+52AA 3.96×10-8±1.27×10-9 -2.79×10-8±-6.44×10-10 341±9 290±5 1.42 51 316 
56AA 1.29×10-8±3.74×10-10 -1.20×10-8±-1.74×10-10 357±9 300±4 1.08 57 329 
NS+56AA 2.53×10-8±5.82×10-10 -1.56×10-8±-5.79×10-10 328±6 300±5 1.62 28 314 
CRE+56AA 2.93×10-8±1.32×10-9 -1.46×10-8±-6.29×10-10 345±8 293±7 2.01 52 319 
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Table 2 The distance between ferrocene in each ferrocene peptide dimer and the nearest 
phosphate backbones on each CRE DNA in MD simulation models, and the redox potential of 
the ferrocene peptide dimer in the presence of CRE DNA. 
 
 
MD model distance to phosphate backbones/Å E1/2/mV 
44AA+CRE 8.8 279.5 
48AA+CRE 10.5 283.5 
52AA+CRE 12.3 315.5 
56AA+CRE 16.3 319 
 
 
5.4 Differential Pulse Voltammetry (DPV) of ferrocene peptide dimers with DNA 
  The differential pulse voltammetry (DPV) experiments of ferrocene peptide dimers 
in the absence and presence of CRE and NS DNA were all conducted in the same 
experimental setup with the working, counter and reference electrode submerged in 
the sample solution as in the CV experiments. All the DPV experiments were carried 
out at the lower concentration of 40 µM, and the ferrocene peptide dimers were 
added to the DNA solutions to avoid precipitation rather than the reverse. The 
potential was scanned from -0.05 V to 0.7 V in the DPV, so only the oxidation 
character of the ferrocene peptide dimers in the absence and presence of DNA was 
studied, see Table 3 and Figure 5. In the DPV of the ferrocene peptide dimers in the 
absence of DNA, the dimers with longer peptide strands have smaller peak currents, 
which is in agreement with the CV. This is because of the steric hindrance introduced 
by the peptide strands, and similar observation have previously been reported by 
Jenkins and co-workers.
140
 In their study, the presence of a DNA strand attached to a 
ferrocene shields the ferrocene resulting in a less intense current in the DPV 
spectrum.140 
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Table 3 The data from the DPV of ferrocene peptide dimers in the absence and 
presence of CRE and NS DNA related to Ag/AgCl 
 
 
Sample Ep/mV Ip/A 
44AA 313 1.60×10-7 
44AA+NS 304 3.31×10-7 
44AA+CRE 305 1.55×10-7 
48AA 310 1.25×10-7 
48AA+NS 301 3.04×10-7 
48AA+CRE 293 1.95×10-7 
50AA 307 1.12×10-7 
50AA+NS 302 2.95×10-7 
50AA+CRE 291 1.91×10-7 
52AA 304 9.60×10-8 
52AA+NS 300 2.82×10-7 
52AA+CRE 303 1.71×10-7 
56AA 304 7.29×10
-8
 
56AA+NS 296 1.37×10
-7
 
56AA+CRE 303 8.70×10-8 
 
Figure 5 The DPV of ferrocene peptide dimers in the presence and absence of CRE 
and NS DNA. A): 44AA ferrocene dimer, B): 48AA ferrocene dimer, C): 50AA ferrocene 
dimer, D): 52AA ferrocene dimer, E): 56AA ferrocene dimer. 
 
 
 
 
 
 
 
 
 
 
 
 
 Chapter 5 DNA binding of Ferrocene peptide dimers 
126 
 
  In the DPV study of the 44AA ferrocene peptide dimer, the presence of CRE and 
NS DNA reduces peak potential, whilst the presence of NS DNA increases the peak 
current but the presence of CRE DNA does not change the current significantly. The 
gel electrophoresis study did not indicate the formation of a 44AA ferrocene dimer-
CRE DNA complex, while the CD proves that no helix is formed in this complex. Thus 
the 44AA ferrocene dimer is not structured in the presence of either CRE and NS 
DNA and binding is non-specific, and in this conformation, the ferrocene is easier to 
oxidise. In this conformation, the 44AA ferrocene peptide dimer forms random 
structure on NS DNA, the ferrocene group can get close to the negative charged 
DNA and thus cause a change in the electrochemical behaviour of the ferrocene 
group, see Figure 6. The ferrocene group is more exposed to the counter ions in this 
conformation than its random structure in the absence of DNA. 
 
Figure 6 Cartoon representation of proposed binding mode between our designed ferrocene 
peptide dimer and NS DNA in a random or non-specific fashion. 
 
 
 
 
  In the DPV of the 48AA, 50AA, 52AA and 56AA ferrocene dimers in the presence of 
NS DNA, the peak current increases. However the CD studies indicated no formation 
of an α-helix and therefore no binding to NS DNA. These findings were supported by 
the gel electrophoresis studies. However these did suggest an element of non-
specific binding to NS DNA as indicated by same smearing of the DNA, see Figure 6. 
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 Thus the non-helical conformation of the ferrocene peptide dimers on NS DNA 
expose the ferrocene unit more to the electrolyte than peptide dimers’ random 
structure in the absence of DNA and the dimeric α-helical conformation of peptide 
dimers in the presence of CRE DNA. The MD simulations of the ferrocene peptide 
dimers indicates that the ferrocene unit is held between the two peptide strands and 
is not in full contact with CRE DNA, see Figure 2 in Chapter 4.  
  The presence of CRE DNA increases the peak currents and decreases the peak 
potentials of the 48AA, 50AA 52AA and 56AA ferrocene dimer in DPV to make the 
ferrocene unit easier to be oxidised due to the conformation of ferrocene peptide 
dimer-CRE DNA exposes the ferrocene unit more to the electrolyte than the 
ferrocene peptide random conformation in the absence of DNA.  
 
 
 
5.5 Conclusions 
  The ferrocene peptide dimers have been investigated by CD, gel electrophoresis, 
CV and DPV in the presence of CRE and NS DNA. 
  The ferrocene peptide dimers similarly display sequence specific binding to DNA, 
this time based on both CD and gel electrophoresis studies, except for the short 
44AA ferrocene peptide dimer, the sequence of which is again too short for 
recognition of target DNA while its hinge domain sequence is too short to maintain 
the spatial relationship between the DNA binding basic domain and the ferrocene 
dimerisation unit. These findings are supported by MD simulation.  
  The ferrocene linker domains, have been well tolerated, and still allow the peptides 
to take the advantage of the sequence specific DNA recognition of the native GCN4. 
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  All the ferrocene peptide dimers display fully reversible redox electrochemistry in 
the absence of DNA based on CV, and thus the peptide does not seem to interfere 
with the redox advantage of the ferrocene probe. In the presence of CRE or NS DNA, 
E1/2 decreases due to the through space electrostatic interactions between the 
ferrocene group and the negatively charged DNA. This is also in agreement with the 
DPV experiments. In the presence of NS DNA, the ferrocene group can get much 
closer to the DNA due to non-specific binding in a random conformation, and leads to 
a more significant change in the electrochemistry of the ferrocene group. There may 
be a relationship between the ferrocene group E1/2 and the distance between the 
ferrocene reporter group and DNA phosphate backbone.  
  The current for the ferrocene peptide dimer increases in the presence of DNA in 
DPV, and is always higher in the presence of NS DNA. The random conformation of 
the ferrocene dimer bound to NS DNA may expose the ferrocene unit more to the 
counter ions for electron transfer than its random structure in the absence of DNA, or 
its well folded dimeric binding conformation in the ferrocene dimer-CRE DNA 
complex, which is supported by the MD models of ferrocene dimer-CRE DNA 
complex. 
  For the first time we have designed an electrochemical probe combining the 
sequence specific DNA binding of GCN4 bZip, and the reversible redox 
electrochemical behaviour of ferrocene. Though DNA binding is sequence specific, 
the electrochemical output is not fully understood and cannot be used to identify the 
nature of the DNA present.  
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6.1 Conclusions 
  A strategy was developed for the dimerisation of two peptides based on GCN4 with 
a ferrocene linker. This involves: the preparation of a small molecule ferrocene linker; 
its coupling with the single amino acid, Cys, and the tripeptide glutathione (GSH); 
synthesis of five peptides based on GCN4 (22AA, 24AA, 25AA, 26AA and 28AA) and 
their dimerisation with ferrocene. Molecular dynamic simulations were performed on 
models of four of these ferrocene peptide dimers complexed to target DNA to aid in 
the design process. Circular dichroism experiments of the ferrocene peptide dimers 
and peptide monomers in the presence and absence of CRE target site containing 
DNA and non-specific DNA, were performed in order to evaluate sequence specific 
DNA binding. Electrochemical studies of the ferrocene peptide dimers in the 
presence and absence of CRE and non-specific DNA were performed by cyclic 
voltammetry (CV) and differential pulse voltammetry (DPV). 
  We attempted to dimerise peptides with a ferrocene linker molecule using two 
different strategies. Strategy A involved the formation of a peptide bond between the 
carboxylic acid, located at the C-terminus of an amino acid side chain protected 
peptide, and an amine of the ferrocene linker molecule. An efficient method for the 
solid-phase peptide synthesis (SPPS) of a fully side chain protected peptide was 
developed by the synthesis of a short octapeptide using three different methods. A 
side chain protected 29 amino acid peptide, designed based on GCN4, was prepared 
using the best method. However, the product displayed very poor solubility in water 
and organic solvents, and could not be purified or characterised without fully 
deprotecting all of the amino acid side chains. Attempts were made to couple this 
peptide using a commercially available stilbene linker through amine groups. 
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However, only small amounts of the mono substituted peptide could be detected by 
MALDI MS. Due to the low solubility of the amino acid side chain protected peptide, 
this strategy was abandoned. However an unstable 1,1’-diamino ferrocene linker was 
being prepared for strategy A prior its being abandoned. In strategy B, coupling to 
the peptide was proposed to occur between the thiol group of a single Cys in the 
sequence, and a ferrocene linker. A number of ferrocene linkers were initially 
proposed and synthesised for strategy B, but finally 1,1’-bis (hydroxymethylene) 
ferrocene was prepared from ferrocene through two reactions. It was first coupled 
with cysteine and a tripeptide glutathione, and the products fully characterised. 
These ferrocene peptide dimer model compounds share an absorbance at 255 nm 
with the same extinction coefficient in their UV-visible spectra which was 
subsequently used for the quantification of the ferrocene peptide dimers in solution. 
CV experiments of 1,1’-S-ferrocenyldimethyl-L-glutathione and 1,1’-
bis(hydroxymethylene)ferrocene were performed using two different experimental 
set-ups in order to trial the use of a small volume sample holder, important when 
working with small quantities of product as was the case here. Unfortunately 1,1’-S-
ferrocenyldimethyl-L-glutathione was not found to be electrochemically reversible in 
the CV experiment using the small sample holder, but instead, the experimental set-
up with all three electrodes submerged directly in the sample solution had to be 
employed in further studies. 
  We designed five peptides based on the basic and hinge domain of GCN4. Different 
length peptides, with varying number of conserved residues from native GCN4, were 
investigated for binding to DNA as monomers. These peptides generally contain the 
basic region residues, the complete hinge area and an additional short spacing 
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sequence with a Cys for coupling to the ferrocene linker molecule. All five peptides 
were coupled to 1,1’-bis (hydroxymethylene) ferrocene to yield the corresponding 
ferrocene peptide dimers.  
  The ferrocene peptide dimers were evaluated electrochemically using the two 
different experimental set-ups described earlier. A DPV titration of the 52AA 
ferrocene peptide dimer was successfully performed with the small sample holder; 
however, DPV cannot provide information about the reversibility of the redox 
chemistry of the ferrocene group. CV experiments of the ferrocene peptide dimers at 
various scan rates demonstrated that the experimental set up without the small 
volume sample holder is required. All the ferrocene peptide dimers were studied by 
CV which shows they undergo a one electron redox process and are fully reversible.  
The GCN4 basic domain is unstructured in the absence of DNA containing a target 
site, and this therefore provides us with a method by which to test the peptide dimers’ 
binding to different DNA sequences by monitoring their folding. Except for the 
shortest 22AA, all the peptide monomers bind sequence selectively to CRE DNA. 
The same can be said for the peptide dimers. The shortest 44AA does not bind to 
DNA while all the longer ferrocene peptide dimers are more helical in the presence of 
CRE DNA, but are largely unchanged in the presence of NS DNA. The 52AA and 
50AA ferrocene peptide dimers have the highest α-helicity in the presence of CRE 
DNA of all the dimers. However, this is consistent with over 100% folded, and thus 
there must be another conformation in the complex contributing to the CD signal. 
Bending of CRE DNA has also been reported in the literature for other DNA binding 
peptide dimers based on GCN4 and was indicated by the MD simulations of the 
ferrocene peptide dimer-CRE DNA complexes.  
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  The gel electrophoresis studies investigating binding between the ferrocene peptide 
dimers and CRE or NS DNA are in agreement with the results obtained from the CD 
experiments. The shortest 44AA ferrocene peptide dimer does not form a stable 
complex with CRE DNA, but the remaining ferrocene peptide dimers do form stable 
complexes with CRE DNA, and these are capable of sequence specific DNA binding. 
  CV experiments were carried out for all the ferrocene peptide dimers in the 
presence of one equivalent of CRE or NS DNA, in an effort to study the ferrocene 
group’s redox behavior in the peptide-DNA complex. Only the 50AA ferrocene 
peptide dimer is electrochemically reversible in the presence of CRE DNA, all the 
remaining ferrocene peptide dimers are not. All the dimers’ Epa and E1/2 shift towards 
negative potential, while there is no trend for the change of Epc, accompanied by an 
increase in ipa, indicating that the ferrocene groups are easier to oxidise in the 
presence of DNA due to their proximity to the negatively charged DNA. However, no 
notable distinction could be made between CRE and NS DNA. There may be a 
relationship between the ferrocene group E1/2 and the distance between the 
ferrocene group and the DNA phosphate backbone, which is supported by the MD 
simulations of models of the ferrocene peptide dimer-CRE DNA complex. 
  In the DPV of the 44AA, 48AA, 50AA, 52AA and 56AA ferrocene peptide dimers 
recorded in the presence of NS DNA, the peak current increased more than in the 
presence of CRE DNA. Presumably the ferrocene unit is more exposed to the 
electrolyte in the presence of NS DNA than in either the peptide dimers’ random 
structure in the absence of DNA, or the α-helical conformation of ferrocene peptide 
dimer bound to CRE DNA. The latter can be explained by the MD simulations of the 
ferrocene peptide dimer-CRE DNA complexes, which indicates that the ferrocene 
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unit is held between two peptide strands and is not fully exposed to the solvent and 
electrolyte. Though no simulations have been performed on the peptide dimer bound 
to NS DNA, clearly there is non-specific binding occurring, which is resulting in an 
increase in the DPV current.  The ferrocene peptide dimers display a bigger increase 
in DPV current in the presence of NS DNA rather than DNA containing the target site, 
and thus what we have developed is more like a ‘negative’ electrochemical sensor. 
 
6.2 Future work 
6.2.1 Surface bound ferrocene tagged peptide dimer 
  All the ferrocene peptide dimers reported here were studied in solution in an effort 
to sense the DNA in our electrochemistry studies, and thus electron transfer occurs 
through the counter ions in the electrolyte to the ferrocene group attached to the 
peptide. The peptide sequence (primarily basic domain) and the DNA do not play a 
direct role in the electron transfer process. In order to involve the peptide strand and 
the DNA in the electron transfer process, the redox active ferrocene unit can be 
attached to the N-terminus of the DNA binding peptide dimer, which is attached to an 
electrode surface, see Figure 1. 
 
Figure 1 Diagram illustrate the conformational change of the electrode surface bound 
ferrocene peptide dimers; arrows shows the electron transfer occurrence. 
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  In the absence of DNA, the peptide strands will be random coils in solution, and the 
redox ferrocene probe will be able to be located in close proximity to the electrode 
surface for electron transfer. The rate of electron transfer decay across a hydrogen 
bond is equal to that across two covalent bonds.141 Therefore, the hydrogen-bonded 
network may act as a molecular ‘shortcut’ for electron transfer. When peptide 
ferrocene dimers bind to the target DNA major groove site, the peptide strand will 
become helical and produce both an intra and inter hydrogen bonding network with 
the target DNA, see Figure 1. Therefore the redox active ferrocene group is still 
accessible for electron transfer, but located further away from the electrode and with 
more electron transfer decay than that in the absence of DNA. This design may 
provide an approach for DNA sensing. 
 
6.2.2 Ferrocene dimerised c-Fos/c-Jun heterodimer 
  The transcription factor c-Fos and c-Jun heterodimer bZip can bind to DNA AP-1 
sites. Jun can form a homodimer and a heterodimer with Fos, while Fos cannot form 
homodimer. The c-Fos and c-Jun heterodimer binds to the AP-1 DNA site 25 times 
more efficiently than the c-Jun homodimer.142 The Fos-Jun heterodimer bends DNA 
towards the major groove, whereas the Jun homodimer bends DNA towards the 
minor groove to give a distinct DNA-protein complex in topology.143 The Fos-Jun 
dimer basic domain consists of  residues 139 to 165 of c-Fos, and 254 to 280 of c-
Jun, which interacts directly with target DNA.144 The C-terminal regions form an 
asymmetric coiled-coil as the dimerisation domain, see Figure 2. Ferrocene 
dimerisation of the c-Fos and c-Jun basic domains may provide DNA binding 
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ferrocene peptide dimers similar to our peptide dimers based on GCN4, but would 
importantly expand the scope to non-symmetrical biomolecular recognition. 
 
Figure 2 X-ray crystal structure of c-Fos and c-Jun heterodimer bound to DNA (PDB 
code:1A02).
145 
 
 
 
6.2.3 Ferrocene dimerised helix-loop-helix basic domains 
  Morii and co-workers prepared four constrained peptide dimers, the sequences of 
which were based on a helix-loop-helix basic domain of a DNA binding protein MyoD, 
see Figure 3.146 The basic domains of MyoD were dimerised with a derivative of 9, 
10-dihydrophenanthrene- 9, 10-diol (DHP), (R,R)-DHP and (S,S)-DHP, with different 
orientations (N-terminus to N-terminus and C-terminus to C-terminus arrangements).  
One of the dimers with right handed and C-terminus to C-terminus arrangement, 
binds specifically to the native MyoD binding site, Figure 11B in Chapter 1.146 
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Figure 3 X-ray crystal structure of MyoD basic helix loop helix domain bound to DNA. (PDB 
code 1MDY)
147
 
 
 
 
  The ferrocene replacement for the constrained linker may give a peptide dimer with 
effectively free rotation of the two Cp rings, providing the basic domains with no 
constraints in order to position themselves for effective DNA binding. Again this work 
would expand the scope of these ferrocene peptide dimerisation domains to a 
different class of DNA binding proteins. 
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7.1 Materials  
  Ferrocene, aluminium chloride and n-butyllithium were purchased from Acros 
Organics, acetyl chloride, sodium hypochlorite, 4-dimethylaminopyridine, copper(I) 
chloride, sodium azide, TFE, anisole, thioanisole, EDT, phenol and acetic anhydride 
were purchased from Fisher scientific. Bromoacetic acid and phthalimide were 
purchased from Alfa Aesar. Dimethylmethylene ammonium iodide, 
tetramethylethylenediamine, 1,1,2,2-tetrabromoethane, copper (I) oxide, ninhydrin  
and sodium bromohydride were purchased from Sigma Aldrich. Pd 10% WT on 
active carbon was purchased from Aldrich, TFA, DIPEA, dimethylformamide, HBTU, 
HOBt, PyBOP, glutathione, resins and all Fmoc protected L-amino acids were 
purchased from AGTC bioproducts. All the reagents were used as received unless 
stated otherwise. 
 
7.2.1 Solid-Phase Peptide Synthesis (SPPS) of protected peptide 
  In manual SPPS, synthesis is performed either at room temperature or sometimes 
using a microwave CEM discovery unit. The 2-chlorotrityl chloride resin was swollen 
in DMF 30 min prior the synthesis. Synthesis was performed in the following 
sequence; wash with DMF (10 mL), add deprotect (10 mL of 20% piperidine in DMF), 
five washes of 7 mL DMF, add fmoc-protected amino acid (2M in DMF, 5 
equivalents), add activator (0.5M HBTU in DMF, 5 equivalents), add activator base 
(2M DIEA in NMP, 10 equivalents), followed by coupling for 18 minutes. The only 
exception was Arginine which was double coupled at room temperature for 80 
minutes. Following the deprotection of the last amino acid the peptide was capped 
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with an acetyl (Ac) group by treatment of the resin bound peptide with 20 % acetic 
anhydride and 20 % DIEA in DMF for 30 minutes at room temperature. The resin 
was washed three times with DMF (10 mL), followed by three further washings with 
DCM (10 mL), and finally three washes with diethyl ether (10 mL), before being left to 
dry overnight. The protected peptide was cleaved by treatment with 20% TFE and 20% 
acetic acid in DCM, for 4.5 minutes. The cleavage solution after filtration was 
reduced to a small volume. Addition of cold diethyl ether (-20 °C) results in 
precipitation of the peptide.  MS and analytical HPLC were recorded for short side-
chain-protected peptides. However the 29 amino acid side-chain-protected peptide 
could not be characterised due to solubility issues. In the end the protected peptide 
was deprotected by TFA/thioanisole/EDT/anisole 90/5/3/2 (10 mL) for 
characterisation.  
 
7.2.2 Solid-Phase Peptide synthesis by CEM Liberty 1 peptide synthesiser 
  Peptides (22-28 amino acids) were synthesised using a microwave reactor CEM 
liberty One automated Peptide Synthesiser on a 0.25 mmol scale with rink amide 
MBHA resin following standard Fmoc solid-phase peptide synthesis (SPSS) 
protocols. The synthesis was carried out in a fritted polymer reaction vessel. The 
resin bubbled by nitrogen gas in DMF (15 mL) 30 min prior to the synthesis. 
Synthesis was performed in the following sequence; wash with DMF (10 mL, top), 
add deprotect (10 mL of 20% piperidine in DMF with 0.1M HOBT, 35W, 75°C, 180s), 
four washes of 10 mL DMF (top, bottom, top, top), add amino acid (2M in DMF, 5 
mL), add activator (2 mL, 0.5M HBTU in DMF), add activator base (1 mL, 2M N,N-
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diisopropylethylamine in N-methyl-2-pyrrolidone), followed by running the coupling 
program (25W, 75°C, 300s). For the synthesis of the 25AA, 26AA and 28AA peptide, 
(25W, 75°C, 300s) except for Cys (0W, 50°C, 120s followed by 25W, 50°C, 240s) 
and Arg (0W, room temperature, 2400s), all the couplings were performed as 
standard double programs, in which the amino acid, activator and activator base 
were added and coupled, drained, and the resin washed before addition of a second 
portion of amino acid, activator and activator base and coupling (25W, 75°C, 300s). 
In the synthesis of the remaining peptides (22AA, 24AA), all the coupling were 
standard single programs, except for Cys (0W, 50°C, 120s followed by 25W, 50°C, 
240s) and Arg (0W, room temperature, 2400s). Following the deprotection of the last 
amino acid the peptide was capped with an acetyl (Ac) group by treatment of the 
peptide with, 20 % acetic anhydride, 20 % N,N-diisopropylethylamine in DMF for 30 
minutes at room temperature. The resin was washed three times with DMF (10 mL), 
followed by three further washings with DCM (10 mL), and finally three washes with 
diethyl ether (10 mL), before being left in a desiccator to dry overnight.  
  The resin bound peptide was stirred with TFA(90%)/thioanisole(5%)/1,2-
ethanedithiol(3%)/anisole(2%) (10 mL) for 4 hours under nitrogen gas. This 
simultaneously cleaves the peptide from the resin and removes the amino acid side 
chain protecting groups to yield the C-terminal amide (due to choice of resin). The 
peptides were separated from the resin by filtration and the volume of the TFA 
peptide filtrate reduced to about 5 mL. To this was added cold diethyl ether (-20 °C) 
which resulted in the formation of a white precipitate. This suspension was stored at -
20 °C overnight, so as to ensure maximum recovery of product. The precipitate was 
collected by filtration and dried in a desiccator overnight. 
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  The crude peptide was dissolve in 25 mL 10% acetic acid in water, and then 
purified by preparative reversed-phase C12-HPLC by increasing the gradient from 
100% water (0.05% TFA) to 20%  acetonitrile (0.05 % TFA) over 20 minutes. This 
was followed by the continuous wash with 20% acetonitrile (0.05% TFA) for a further 
20 minutes. The collected fractions were characterised by ESI-MS, those that 
contained the product were combined and lyophilised to yield the purified peptide as 
a white solid. 
  The peptides were characterised by ESI-MS and purity established by analytical 
C12 HPLC with the same gradient as used earlier. Peptide concentrations were 
determined by the Ellman’s test. 
22AA ESI-MS: expected: M=2440.9, m/z observed: [M+3H]3+=814.4, [M+4H]4+=611.1, 
[M+5H]5+=489.1, [M+6H]6+=407.7, consistent with a deconvoluted M=2440.3. 
24AA ESI-MS: expected: M=2767.2, m/z observed: [M+3H]3+=923.2, [M+4H]4+=692.6, 
[M+5H]5+=554.3, [M+6H]6+=462.1, [M+7H]7+=396.2, consistent with a deconvoluted 
M=2766.5. 
25AA MALDI-MS: expected: M=3040.6, m/z observed: [M+H]+=3041.5. 
26AA ESI-MS: expected: M=3097.6, m/z observed: [M+3H]3+=1033.3, 
[M+4H]4+=775.2, [M+5H]5+=620.4, [M+6H]6+=517.3, [M+7H]7+=443.4, consistent with 
a deconvoluted M=3097.0. 
28AA ESI-MS: expected: M=3211.8, m/z observed: [M+4H]4+=803.8, [M+5H]5+=643.2, 
[M+6H]6+=536.2, consistent with a deconvoluted M=3211.1. 
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7.2.3 Kaiser test 
  Potassium cyanide in distilled water solution (0.253 mmol, 1 mL) was diluted with 
pyridine (49 mL) to make solution A; ninhydrin (1 g) was dissolved in n-butanol (20 
mL) to make solution B; phenol (40 g) was dissolved in n-butanol (20 mL) to make 
solution C. A few beads of resin were put into a glass sample vial; 2-3 drops of 
solution A, B and C were added to the resin. The mixture was heated at 110 °C for 5 
minutes. The resin with free amine turned blue after 5 minutes, while the resin 
without free amine remained the same colour. This therefore allows for the 
determination of whether a coupling or deprotection has successfully occurred. 
 
7.2.4 Ellman’s Test of peptide 
  For the Ellman’s test of the peptide solution, a blank solution of 3 mL TRIS buffer 
pH 8 with 0.1 mL 5,5'-dithiobis-(2-nitrobenzoic acid) solution (30 mM) was used as 
the control blank. This was followed by the addition of 0.01 mL of the peptide stock to 
the  blank solution, and after 15 minutes equilibration the UV-visible spectrum was 
recorded between 360 nm and 600 nm. The test was repeated in triplicate and the 
average absorbance at 412 nm was used to calculate the concentration based on the 
extinction coefficient of 13,600 M-1cm-1 for the 2-nitro-5-thiobenzoate product. This 
allows for the concentrations of readily available thiol groups to be determined.  
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7.3 Preparation of the low molecular weight disubstituted ferrocene molecules 
7.3.1 1,1-Bis(N,N-dimethylaminomethy)ferrocene 
  1,1-Bis(N,N-dimethylaminomethy)ferrocene preparation was based on the method 
reported by Glidewell115 with some modification. 
Scheme 1 Reaction scheme for the synthesis of 1,1-bis(N,N-dimethylaminomethy)ferrocene 
from ferrocene in 2 steps. 
 
 
 
  n-Butyllithium (34 mL, 54 mmol) was added dropwise to a stirred solution of 
ferrocene (4.84 g, 26 mmol) and tetramethylethylenediamine (6.28 g, 54 mmol) in 
hexane (250 mL) under nitrogen gas for 18 hours, and then diluted with diethyl ether 
(200 mL). Dimethylmethylidene ammonium iodide (10 g, 54 mmol) was added and 
the reaction mixture stirred under nitrogen gas for a further 24 hours. Water (50 mL) 
was added and the reaction mixture was stirred for 20 min. A second portion of water 
(100 mL) was added. The aqueous layer was washed with diethyl ether (150 mL) 
twice, the organic layer dried over MgSO4, which was removed by filtration and the 
solvent removed in vacuo to yield the crude product. 1, 1’-Bis (dimethylamino methyl) 
ferrocene was isolated by flash column chromatography (30 % DCM- 10 % 
triethylamine -60 % hexane) as a brown solid (1.89 g, 24 %).  
δH (300 MHz, CDCl3): 2.18 (12H, s, H5), 3.27 (4H, s, H4), 4.07 (4H, t, J 2 Hz, H1), 4.10 
(4H, t, J 2 Hz, H2).
 
ESI-MS+: expected M[C16H24FeN2]=300.1, m/z observed [M+H]
 + = 301.1. 
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7.3.2 1, 1’-Bis(trimethylammonium iodide methyl) ferrocene 
Scheme 2 Reaction scheme for the synthesis of 1, 1’-bis(trimethylammonium iodide methyl) 
ferrocene 
 
 
  The preparation of 1, 1’-bis(trimethylammonium iodide methyl) ferrocene was 
modified slightly from Forgie’s method.148 
Iodomethane (0.73 g, 0.005 mol) was added dropwise into a stirred solution of 1,1-
diacetyl ferrocene (0.5 g, 0.0017 mol) in methanol (5 mL). The mixture was stirred 
under reflux for 10 min.  Precipitation with diethyl ether (150 mL) gave 1, 1’-
bis(trimethylammonium iodide methyl) ferrocene as a brown solid (0.95 g, 95 %). 
δH (300 MHz, D2O): 2.88 (18H, s, H5), 4.30 (4H, s, H4), 4.40 (4H, t, J 2 Hz, H1), 4.90 
(4H, t, J 2 Hz, H2).  
δc(75 MHz, D2O, DEPT): 52.0 (C3), 66.2 (C4), 71.8 (C1), 73.2 (C2). 
ESI-MS+: expected M[C18H30FeN2I2]= 584.0, m/z observed [M-I]
 + = 457.0.  
 
7.3.3 1, 1’-Bis nitrilemethylene ferrocene 
  1, 1’-Bis nitrilemethylene ferrocene was prepared according to the preparation of 
cyanomethyl ferrocene by Daniel, but with modified reaction times.149 
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Scheme 3 Synthesis of 1,1'-bis(cyanomethyl) ferrocene by nitrile substitution under reflux.
 
 
 
  A mixture of potassium cyanide (1.27 g, 0.0195 mol) and 1, 1’-
bis(trimethylammonium iodide methyl) ferrocene (0.95 g, 0.0016 mol) in water (8 mL) 
was stirred under reflux (120 ℃) for 34 hours. Solvent extraction with diethyl ether, 
drying over MgSO4, filtration and solvent removal in vacuo yielded 1, 1’-bis 
nitrilemethylene ferrocene (43 mg, 10 %) as a yellow solid, (19 mg, 5%). Half of the 
residues was dissolved in water (8 mL) and stirred under reflux (120 ℃) for a further 
3 days. An additional 1, 1’-bis nitrilemethylene ferrocene was isolated as yellow solid 
by solvent extraction (diethyl ether), (41 mg 12%). Overall yield (60 mg, 17 %) 
δH (300 MHz, CDCl3): 4.10 (4H, t, J 2 Hz, H2), 4.14 (4H, t, J 2 Hz, H1), 4.33 (4H, s, 
H4). 
ESI-MS+: expected M[C14H12FeN2]=264.0, m/z observed [M+H+MeOH]
 += 297.1.  
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7.3.4 1,1'-Ferrocenedicarboxaldehyde 
  This synthesis is modified version of Connell’s report.117 
Scheme 4 Synthesis of 1,1'-ferrocenedicarboxaldehyde 
 
 
 
  Tetramethylethylenediamine (8 mL, 0.53 mmol) was added to a stirred solution of 
ferrocene (5 g, 26 mmol) in dry diethyl ether (60 mL) in one portion under nitrogen 
gas. The solution was stirred at room temperature for 10 minutes and then cooled to 
0°C. n-Butyl lithium (35 mL, 1.6 M, 56 mmol) was added dropwise at 0°C, and the 
orange solution stirred for 21 hours at room temperature. Anhydrous 
dimethylformamide (7 mL, 91 mmol) was added dropwise to the mixture at -78°C and 
the mixture stirred for 2 hours under a nitrogen gas atmosphere. The mixture was 
opened to the air, water (50 mL) added and stirred for a further 30 minutes. The 
aqueous layer was extracted four times with hot ethyl acetate (100 mL), and the 
combined organic layers were dried over MgSO4. Evaporation to dryness gave the 
crude product as a dark red solid. Recrystalisation from boiling ethyl acetate gave 
1,1’-ferrocenedicarboxaldehyde as red needles(0.9 g, 14 %). 
1H NMR (300 MHz, CDCl3): δ= 9.95 (2H, s, H5), 4.88 (4H, t, J 1.5 Hz, H2), 4.67 (4H, t, 
J 1.5 Hz, H1). 
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13C NMR (148 MHz, CDCl3): δ= 193.12 (C4), 80.67 (C3), 74.52 (C2), 71.22 (C1). 
ES-MS+: expected M[C12H10FeO2]= 242.0, m/z observed [M+Na]
+= 265.0. 
Melting point: 155-157 °C; literature melting point: 156 °C.150 
 
7.3.5 1,1’-Bis(hydroxymethylene)ferrocene 
This synthesis is modified from Patwa’s method.118 
Scheme 5 synthesis of 1,1’-bis(hydroxymethylene)ferrocene 
 
 
 
  A solution of 1,1'-ferrocene dicarboxaldehyde (0.31 g, 1.28 mmol) in dry methanol 
(5 mL) was stirred at 0 °C under nitrogen gas for 15 minutes. NaBH4 (0.11 g, 2.82 
mmol) was added into the solution in one portion, the mixture was stirred for 2.5 
hours under a nitrogen gas atmosphere at room temperature. The reaction mixture 
was evaporated to dryness, and extracted three times with ethyl acetate (15 mL), the 
combined organic phases was filtered and evaporated to dryness to yield the crude 
product as an orange solid. This was purified by flash column chromatography 
(hexane: diethyl ether=1:1) and precipitation from boiling ethyl acetate on addition of 
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cold petrol to yield 1,1’-bis(hydroxymethylene) ferrocene as brown needles (0.24 g, 
76 %). 
1H NMR (300 MHz, CDCl3): δ= 4.40 (s, 4H, H4), 4.21 (t, 4H, J 1.5 Hz, H2), 4.17 (t, 4H, 
J 1.5 Hz, H1), 3.21 (s, 2H, H5). 
13C NMR (148 MHz, CDCl3): δ= 89.73 (C3), 68.47 (C2), 67.50 (C1), 60.75 (C4). 
ES MS+: expected M[C12H14FeO2]=246.0, m/z observed [M]
+= 246.0 , [M+Na]+= 
269.0. 
Melting point: 108-110 °C; literature melting point= 106-108 °C.118 
 
7.3.6 1,1’-Ferrocenyl bis (methylene 2-bromoacetate) 
 
Scheme 6 Synthesis of 1,1’-ferrocenyl bis (methylene 2- bromoacetate) 
 
 
 
  A solution of 4-dimethylaminopyridine (0.5 mg, 0.0041 mmol) in DCM (0.1 mL) was 
added into a stirred solution of bromoacetic acid (0.17 g, 1.22 mmol) and 1,1’-
bis(hydroxymethylene) ferrocene (0.1 g, 0.406 mmol) in DCM (10 mL) solution. The 
reaction mixture was stirred under reflux (48 °C) and protected from the light for 48 
hours, and then the reaction mixture was evaporated to dryness to yield the crude 
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product as a brown sticky solid. This was characterised by 1H NMR which indicated 
bromoacetic acid was present as an impurity. Column chromatography and HPLC 
were subsequently attempted for the purification of 1,1’-ferrocenyl bis (methylene 2- 
bromoacetate), however it was found to decomposed after column chromatography 
and HPLC. 
1H NMR (300 MHz, CDCl3): δ= 3.83 (4H, s, H5), 4.22-4.23 (4H, t, J 2 Hz, H2), 4.29-
4.30 (4H, t, J 2 Hz, H1), 4.98 (4H, s, H4). 
 
7.3.7 1,1’-Dibromo ferrocene 
Scheme 7 Synthesis of 1,1’-dibromo ferrocene 
 
 
  The preparation of 1,1’-dibromo ferrocene is based on Shafir’s method 24 and the 
preparation of the intermediate 1,1’-dilithiaferrocene is based on Bishop’s method 25. 
  n-Butyllithium (1.6M in hexane, 34 mL, 54 mmol) was added dropwise into the 
stirred solution of ferrocene (4.84 g, 26 mmol) and TMEDA (6.28 g, 54 mmol) in 
degased hexane (200 mL). The mixture was stirred for 20 hours, resulting in the 
formation of an orange precipitate. Tetrabromoethane (6.65 mL, 19.7 g, 57 mmol) 
was added dropwise to the fresh dilithium ferrocene in hexane mixture which was 
stirred in an acetone/dry ice cooling bath (-78 °C) for 3 hours followed by 14 hours 
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stirring at room temperature. Precipitation twice gave 1,1’-dibromoferrocene  as an 
orange powder (2.13 g, 24 %). 
δH (300 MHz, CDCl3): 4.16-4.30 (4H, m, H1), 4.49 (4H, s, H2).  
δc(75 MHz, CDCl3, DEPT): 69.9 (C1), 72.7 (C2), 78.4 (C3). 
ESI-MS+: expected M[C10H8Br2Fe]= 343.8, m/z  observed [M]
+ = 343.8. 
 
7.3.8 1-Bromo-1’-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-ferrocene151 
Scheme 8 Synthesis of 1-bromo-1’-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-ferrocene 
 
 
 
  A mixture of 1,1’-dibromo ferrocene (0.45 g, 1.3 mmol), phthalimide (0.625 g, 4.2 
mmol) and copper(I) oxide (0.19 g, 1.3 mmol) in degased pyridine (5 mL), was under 
nitrogen atmosphere and refluxed (120 °C) for 48 hours. The mixture was 
evaporated to dryness, triturated with hexane and filtered through a short column of 
Al2O3. The column was washed with hexane (400 mL) until the wash became 
colourless before the addition of reaction mixture, and then washed with diethyl ether 
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and the orange ether was evaporated to give the crude product as dark red needle 
crystals. The crude product was dissolved with hot diethyl ether (5 mL), and 
recrystallised in an ice bath to give 1-bromo-1’-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-
yl)-ferrocene as yellow needle crystals (34 mg, 6.4 %). 
δH (300 MHz, CDCl3): 4.15-4.46 (6H, m, H1, H2, H1’), 5.08-5.21 (2H, m, H2’), 7.74-7.77 
(2H, m, H7, H8).  
δc(75 MHz, CDCl3): 63.20 (C3), 63.30 (C2), 66.92 (C1), 67.45 (C1’), 69.25 (C3’), 70.49 
(C2’), 122.37 (C8), 131.06 (C6), 133.33 (C7). 165.90 (C5). 
ES MS+: expected M[C18H12FeBrNO2]=408.9, m/z observed [M+Na-Br]
+=354.0, 
[M+Na+MeOH-Br]+=386.0, [M+Na]+=432.0, [M+Na+MeOH]+= 464.0. 
 
7.3.9 1,1'-Bis(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-ferrocene
152 
Scheme 9 Synthesis of 1,1'-Bis(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-ferrocene 
 
  A mixture of 1,1’-dibromo ferrocene (1 g, 2.9 mmol), phthalimide (2.78 g, 19 mmol), 
and Cu2O (0.42 g, 5.8 mmol) in degased pyridine (7 mL) was under a nitrogen 
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atmosphere and refluxed (120 °C) for 26 hours. The mixture was evaporated to 
dryness, and then redissolved in DCM, filtered through a hexane washed celite pad 
and washed with DCM until the wash became colourless. The evaporated filtrate was 
dissolved in chloroform, washed by water, dried by MgSO4 and evaporated to 
dryness to give crude 1,1'-bis(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-ferrocene as 
brown solid (0.773 g, 56 %) and this is used for future synthesis as phthalimide and 
cannot be remove by purification.  
δH (300 MHz, CDCl3): 4.23-4.30 (4H, m, H1), 5.79-5.39 (4H, m, H2), 7.58-7.61 (8H, m, 
H3 and H4). 
ES MS+: expected M[C27H16FeN2O4]=476.3, m/z observed [M+Na]
+= 499.0. 
MALDI MS+: expected M[C27H16FeN2O4]=476.3, m/z observed [M+H]
+= 477.3.  
 
7.3.10 1,1’-Diamino ferrocene and amino ferrocene 
Scheme 10 Synthesis of 1,1’-diamino ferrocene and amino ferrocene 
 
 
 
  A mixture of hydrazine hydrate (8 mL), 1,1'-bis(1,3-dihydro-1,3-dioxo-2H-isoindol-2-
yl)-ferrocene (770 mg, 1.6 mmol) in degased ethanol (20 mL) was refluxed for 3 
hours under nitrogen gas. The mixture was cooled to room temperature, water (20 
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mL) was added, extracted with diethyl ether (2×20 mL), dried over MgSO4, which 
was removed by filtration, solvent removed in vacuo to give the crude product as a 
yellow powder. The crude product is used for future synthesis directly, because it is 
unstable and decomposes under nitrogen gas.   
ES-MS+: expected M[C10H12FeN2]=216.0, m/z observed [M]+=216.0, [M-NH2]=201.0. 
 
7.3.11 1,1’-s-Ferrocenyldimethyl-L-cysteine  
Scheme 11 Synthesis of 1,1’-s-ferrocenyldimethyl-L-cysteine  
 
 
  To a solution of 1,1’-bis(hydroxymethylene)ferrocene (0.2 g, 0.9 mmol) in degased 
acetone (4.4 mL) was added a solution of L-cysteine (0.222 g, 1.8 mmol) in degassed 
water (3.7 mL), followed by the cautious addition of TFA (0.1 mL). The reaction 
mixture was stirred under a nitrogen atmosphere for 48 hours. The solution was 
concentrated under reduced pressure, and the product precipitated by addition of 
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diethyl-ether. The pale yellow solid was recovered by filtration and washed with 
diethyl ether and air dried. Yield 95 mg (23%). 
1H NMR (300 MHz, DMSO-d6, 5% TFA): δ= 8.34 (s, 4H, NH2), 4.11-4.20 (m, 8H, 
CpH), 4.14-4.12 (m, 2H, H3), 3.60 (s, 4H, H1), 2.93 (dd, J 5, 15 Hz, 2H, H2B), 2.85 
(dd, J 7, 15 Hz, 2H, H2A). 
1H NMR (300 MHz, MeOH-d4, 5% HCl): δ= 4.32-4.24 (m, 8H, CpH), 4.11 (t, J 4 Hz, 
2H, H3), 3.62 (s, 4H, H1), 3.14 (dd, J 3, 15 Hz, 2H, H2B), 2.95 (dd, J 8, 15 Hz, H2A). 
13C NMR (148 MHz, DMSO-d6, 5% TFA): δ= 169 (C=O), 84 (CpC-CH2), 69, 68 (CpC-
H), 51 (C3), 31, 30 (C1, C2). 
ES MS: expected M[C18H24FeN2O4]=452.3, m/z observed [M]
+= 452.3, [M-Cys]+= 
332.0. 
MALDI MS: expected M[C18H24FeN2O4]=452.3, m/z observed 452.3 [M]
+
, 475.2 
[M+Na]+, 491.0 [M+K]+, 332.0 [M-Cys]+. 
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7.3.12 1,1’-s-ferrocenyldimethyl-L-glutathione  
Scheme 12 Synthesis of 1,1’-s-ferrocenyldimethyl-L-glutathione 
 
  To a solution of glutathione (0.56 g, 1.8 mmol) in degassed water (4.2 mL) was 
added a solution of 1,1’-bis(hydroxymethylene)ferrocene (0.2 g, 0.8 mmol) in 
degased water-acetone (43%/57% 5 mL) followed by the cautious addition of TFA 
(0.1 mL). The reaction mixture was stirred for 49.5 hours at room temperature and 
the solvent removed in vacuo, followed by the addition of ethanol (3×8 mL) and its 
subsequent removal under vacuo. The residue was redissolved in 3 mL water, 
precipitated on addition of ethanol (6 mL) and storage at -20 °C. A yellow sticky solid 
(0.3 g) was recovered by filtration and lyophilisation overnight yielded a yellow 
powder. Yield (0. 25 g, 38%). 
1H NMR (300 MHz, D2O): δ= 4.47-4.44 (dd, J 3, 8 Hz, 2H, 2×H7), 4.28-4.24 (m, 8H, 
8×Cp-H), 3.93 (s, 4H, 4×H8), 3.78 (t, 2H, J 6Hz, 2×H4), 3.49 (s, 4H, 4×H2), 3.02-
2.96 (dd, J 5, 14 Hz, 2H, 4×H3), 2.81-2.77 (dd, J 5, 14 Hz, 2H, 4×H3), 2.49-2.44 (td, 
J 3, 8 Hz, 4H, 4×H5), 2.13-2.05 (q, J 7 Hz, 4H, 4×H6). 
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13C NMR (148 MHz, DMSO-d6): δ= 171.6, 170.9, 170.8, and 170.7 (C=O), 85.2 (C1), 
69.3, 69.2, 68.3 and 68.2 (CpC), 52.9 (C7), 52.3 (C4), 41.1(C8), 33.5 (C3), 31.5 (C2), 
30.8 (C5), 26.9 (C6). 
ES MS: expected M[C32H44FeN6O12S2]=824.2, m/z observed [M+H]
+= 825.1, 
[M+Na]+= 847.0, [M+2Na-H]
+= 869.0. 
 
7.4.1 Coupling of the peptide with 1,1’-bis (hydroxymethylene)ferrocene 
  The synthesis of di substituted ferrocene peptide dimers was performed at 0.9 µmol 
scale in water (2 mL) with 0.3 µmole 1, 1’-bis (hydroxymethylene) ferrocene in 
acetone (1 mL). All the solvents were degased by nitrogen gas bubbling for 30 
minutes. TFA (0.1 mL) was added into the mixed solution, the reaction vessel is 
protected from the light and under nitrogen atmosphere, mixture solution stirred for 
120 minutes. After this the solvent was removed in vacuo, the product re-dissolved in 
1.5 mL water and purified by semi preparative C12 HPLC by increasing the gradient 
from 100% water (0.05% TFA) to 20%  acetonitrile (0.05 % TFA) over 20 minutes. 
This was followed by the continuous wash with 20% acetonitrile (0.05% TFA) for a 
further 20 minutes. The fractions containing product were combined and lyophilised 
to yield the purified peptide as a white solid. The peptide was characterised by ES-
MS and analytical C12 HPLC. 
44AA ESI-MS: expected: M=5091.7, m/z observed: [M+6H]6+=849.5, [M+7H]7+=728.4, 
[M+8H]8+=637.4, [M+9H]9+=566.7, [M+10H]10+=510.1, [M+11H]11+=463.9, consistent 
with a deconvoluted M=5091.4. 
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48AA ESI-MS: expected: M=5744.4, m/z observed: [M+6H]6+=958.3, [M+7H]7+=821.6, 
[M+8H]8+=719.0, [M+9H]9+=639.2, [M+10H]10+=575.4, consistent with a deconvoluted 
M=5744.0. 
50AA ESI-MS: expected: M=6291.2, m/z observed: [M+5H]5+=1259.6, 
[M+6H]6+=1049.6, [M+7]7+=899.9 [M+8H]8+=787.5, [M+9H]9+=700.1, 
[M+10H]10+=630.2, [M+11H]11+=573.0, [M+12H]12+=525.4, consistent with a 
deconvoluted M=6292.2. 
52AA ESI-MS: expected: M=6405.3, m/z observed: [M+7H]7+=915.7, [M+8H]8+=801.5, 
[M+9H]9+=712.8, [M+10H]10+=641.6, [M+11H]11+=583.3, [M+12H]12+=534.7, 
[M+13H]13+=493.6,  consistent with a deconvoluted M=6404.7. 
56AA ESI-MS: expected: M=6633.5, m/z observed: [M+6H]6+=1106.7, 
[M+7H]7+=948.88, [M+8H]8+=830.39, [M+9H]9+=738.12, [M+10H]10+=664.51,  
consistent with a deconvoluted M=6634.7. 
 
7.4.2 Monitor the coupling reaction of cysteine using the Ellman’s test 
  The coupling of cysteine with 1,1’-bis(hydroxymethylene) ferrocene was monitored 
by the Ellman’s test.89 Aliquots of the reaction mixture were monitored prior to the 
addition of TFA into the mixture solution, and 17 min, 30 min, 60 min, 75 min, 90 min, 
24 hour and 50 hour of the reaction time, were monitored by the Ellman’s test (see 
section 7.2.4).  
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7.4.3 Monitor the coupling reaction of 28AA and 26AA by HPLC and Ellman’s 
test  
  The Ellman’s test of the 28AA reaction mixtures were recorded at prior to and after 
the addition of TFA after 10 min, 63 min, 75 min, 103 min, 215 min, 310 min and 480 
min of the reaction, were monitored by the Ellman’s test (see section 7.2.4).  
  The reaction was also monitored by analytical reversed-phase C12-HPLC by 
increasing the gradient from 100% water (0.05% TFA) to 20% acetonitrile (0.05 % 
TFA) over 20 minutes. This was followed by the continuous wash with 20% 
acetonitrile (0.05% TFA) for a further 20 minutes. The 26AA coupling solution was 
monitored by analytical HPLC before the addition of TFA, 50 min, 110 min, 160 min 
of reaction time, after 225 min, when a further 1/6 equivalent 1,1’-
bis(hydroxymethylene) ferrocene was added, and finally after 280 minutes. 
 
7.4.4 Extinction coefficient determination of Ferrocene 
  The extinction coefficient of ferrocene was determined by recording the UV-visible 
spectra of 1,1’-s-ferrocenyldimethyl-L-cysteine and 1,1’-s-ferrocenyldimethyl-L-
glutathione at various concentrations. A stock solution of 1,1’-s-ferrocenyldimethyl-L-
cysteine was diluted to 1.84×10-2 mM, 3.69×10-2 mM, 5.53×10-2 mM and 7.37×10-2 
mM in water and their UV-visible spectra recorded between 200 nm and 300 nm. A 
stock solution of 1,1’-s-ferrocenyldimethyl-L-glutathione was diluted to 4.05×10-2 mM, 
6.08×10-2 mM and 8.09 ×10-2 mM in water and their UV spectra were recorded 
between 200 nm and 300 nm. The experiments were carried out in triplicate to 
validate the data. Spectra of both complexes display a peak centered around 255 nm. 
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The average absorbance values at 255 nm were plot as a function of concentration, 
from the slope of which their extinction coefficients was determined. 
 
7.4.5 Extinction coefficient determination of ferrocene peptide dimer 
  For the UV of 26AA, two 2.6 mM and one 2.4 mM in water stock solutions were 
prepared and quantified by the Ellman’s test. Solutions of 1.7 mM, 1.3 mM and 0.97 
mM 26AA were prepared by dilution of the stock solution and their UV spectra were 
recorded between 200 nm and 300 nm. The experiment was carried out in triplicate 
to validate the data. 
  For the UV of 28AA and 24AA, a 3.55 mM, a 3.6 mM and a 3.75 mM in water stock 
solution were prepared and quantified by the Ellman’s test. 0.22, 0.42, 0.63 and 0.75 
mM 28AA solutions were diluted from the stock solutions and their UV spectra were 
recorded between 200 nm and 300 nm. The experiments were carried out in triplicate 
to validate the data. 
 
7.5.1 Electrochemical study of 1,1’-bis(hydroxymethylene)ferrocene and 1,1’-s-
ferrocenyldimethyl-L-glutathione 
  The bis-substituted molecules’ electrochemistry was studied by cyclic voltammetry 
and differential pulse voltammetry. 
  All the glassware and vial lids were cleaned using the following procedures: soaking 
in 20% H2SO4 aqueous solution overnight; rinsed with ultra-pure water (× 10); 
soaking in ammonia-hydrogen peroxide (1:1) solution overnight, rinsed with ultra-
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pure water (× 10), soaking in ultra-pure water overnight, rinsed with water (× 10) and 
then dried in a clean oven exclusively used for electrochemistry glassware. 
  Before each scan of sample, the Ag/AgCl reference electrode was rinsed with water; 
the palladium counter electrode was burned with a Bunsen burner, the working 
electrode was polished by 1, 0.3 and 0.05 micron alumina powder for 8 minutes 
respectively followed by 10 ultra-pure water rinses and sonications, a blank buffer 
solution was scanned in 12 segments (6 CV scans) to confirm the experimental set 
up is clean.  
  The cyclic voltammetry (CV) was recorded on a CH Instruments Electrochemical 
Analyser with the Initial and low E of 0 V, High E of 0.7 V, 0.1 V/s scan rate and the 
sensitivity of 5e-7 A/V. 
  The differential pulse voltammetry (DPV) was recorded on an Autolab from -0.05 V 
to 0.7 V at the scan rate of 3 mV/s. 
 
7.5.2 CV titration of 1,1’-bis(hydroxymethylene)ferrocene and ,1’-s-
ferrocenyldimethyl-L-glutathione solutions 
  A 600 µL solution of water, 100 mM NaCl and 100 mM phosphate buffer pH 7 (60 
µL) was prepared and degased by nitrogen gas for 30 minutes in a narrow-bottom 
conical glass vial within a stirrer bar to raise the liquid level for adequate immersion of 
electrodes. The experimental set up was kept in a CN Instruments Picoamp Booster 
& Faraday Cage. A gold working electrode was used in the experiment. 
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  A stock solution of 1,1’-bis(hydroxymethylene)ferrocene (1.6 mg) in water (1 mL) 
was titrated into the buffer solution, 1 µL at a time until it gave a sufficiently strong CV 
signal to be analysed. After each addition the solution was degased for 30 minutes 
before recording a CV.  
  The solution of water (8 mL), 1M NaCl (1 mL) and 0.1M phosphate buffer pH 7 (1 
mL) was prepared and degased by nitrogen gas for 30 minutes in a 22 mL glass vial. 
1, 1’-s-Ferrocenyldimethyl-L-glutathione (1 mg) was dissolved in 0.1M phosphate 
buffer pH 7 (1.2 mL) to prepare 1 mM stock solution. The 1, 1’-s-ferrocenyldimethyl-
L-glutathione dilutions of 1, 0.5, 0.25, 0.125, 0.0625 mM were added into the 200 µL 
sample holder held in the solution in a glass vial, and degased for 20 minutes before 
recording the CV with either a gold or carbon working electrodes.  
 
7.5.3 DPV of 1,1’-s-ferrocenyldimethyl-L-glutathione solutions 
  The DPV of a 1,1’-s-ferrocenyldimethyl-L-glutathione solution were recorded twice 
for 2 different stock solutions with a gold working electrode, and a low volume 200 µL 
sample holder kept in a vial within buffer solution (15 mL, 0.1 M phosphate buffer pH 
7, 0.1 M NaCl). 
  A stock solution (7.14 mM) was prepared by dissolving 1,1’-s-ferrocenyldimethyl-L-
glutathione (1 mg) in 0.1 M phosphate buffer pH 7 (170 µL). All dilutions were 
degased for 30 minutes prior to recording the DPV scan. In experiment 1, the DPV 
was recorded for the 7140, 178, 35.7 and 17.9 µM dilutions. In experiment 2, the 
DPV was recorded for the 84, 47, 23, 11.5 and 5.7 µM dilutions.  
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7.5.4 CV and DPV of ferrocene peptide dimers by carbon and gold electrode 
  All the glassware was cleaned as is described in section 7.5.1. Before each scan of 
sample, the Ag/AgCl reference electrode was rinsed by water; the palladium counter 
electrode was burnt by Bunsen burner, the working electrode was polished by 1, 0.3 
and 0.05 micron alumina powder for 8 minutes respectively followed by water rinse 
and sonication. A blank buffer solution was scanned in 12 segments to confirm the kit 
is clean.  
  The peptide solution was degased by nitrogen gas for 30 minutes before each 
sample scan. 
  In set A (SVC-3), the working electrode was placed into a sample holder which 
contained the ferrocene peptide dimers in 170 µL 0.01 M phosphate buffer pH 7 and 
0.1 M NaCl in pure water; the sample holder, reference and counter electrodes were 
put into the sample vial with 10 mL 0.01 M phosphate buffer pH 7 and 0.1 M NaCl in 
pure water solution. 
  In the CV of 52AA Fc by set A, initial E is 0 V, high E is 0.7 V and low E is 0 V;  0.1 
mM dimers were scanned at 5, 10, 20, 50, 100, 200 and 500 mV/s by gold and 
carbon electrode. The experiment was repeated in triplicate to validate the data. 
  The DPV titration of 52AA Fc was carried in set A kit by gold electrode. A stock 
solution of 52AA Fc was titrated into a 170 µL solution of 0.1 M NaCl and 0.01 M 
phosphate buffer pH 7 to make 12.85, 17, 22.7, 31 and 40 µM dilutions. The DPV 
was scanned from -0.05 V to 0.7 V at 3mV/s 
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  In the CV of 52AA Fc by set B, the solution of water (480 µL), 1M NaCl (60 µL) and 
0.1M phosphate buffer pH 7 (60 µL) was prepared and degased by nitrogen gas for 
30 minutes in a narrow-bottom conical glass vial within a stirrer bar to rise the liquid 
level for  the electrodes. The experiment kit was kept in a CN Instruments Picoamp 
Booster & Faraday Cage. Gold working electrode was used in the experiment. 
Peptide dimers (44AA Fc, 48AA Fc, 50AA Fc, 52AA Fc and 56AA Fc) were added to 
the vial to dilute to 100 µM for CV (initial E is 0 V, high E is 0.7 V and low E is 0 V) at 
20 mV/s.  
 
7.5.5 CV of ferrocene peptide dimers with CRE and NS DNA 
  All the glassware was cleaned as is described in section 7.5.1. All the CV 
experiments were conducted on a CH instruments Electrochemical Analyser with a 
three electrode system consisting of a gold working electrode, a Ag/AgCl reference 
electrode and a platinum counter electrode. 
    Before each scan of sample, the Ag/AgCl reference electrode was rinsed by water; 
the palladium counter electrode was burned by Bunsen burner, the working electrode 
was polished by 1, 0.3 and 0.05 micron alumina powder for 8 minutes respectively 
followed by 10 times ultra-pure water rinse and sonication, a blank buffer solution 
was scanned in 12 segments (6 CV scans) to confirm the experimental set up is 
clean. 
  In the CV of ferrocene peptide dimers in the presence of DNA, the solution of water 
(360 µL), 1M NaCl (60 µL), 500 µM double stranded DNA (120 µL) and 0.1M 
phosphate buffer pH 7 (60 µL) was prepared and degased by nitrogen gas for 30 
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minutes in a narrow-bottom conical glass vial with a stirrer bar to raise the liquid level 
in order to submerge the electrodes. The experiment setup was kept in a CH 
Instruments Picoamp Booster & Faraday Cage. Ferrocene peptide dimers (44AA, 
48AA, 50AA, 52AA and 56AA) were added to the sample so that the final 
concentration was 100 µM for CV (initial potential is 0 V, high potential is 0.7 V and 
low potential is 0 V) at 20 mV/s. All the CV experiments were independently repeated 
in triplicate to validate the data. 
 
7.5.6 DPV of ferrocene peptide dimers with CRE and NS DNA 
  All the DPV experiments were conducted on an Autolab potentiostat with a three 
electrode system consisting of a gold working electrode, a Ag/AgCl reference 
electrode and a platinum counter electrode. All the glassware was cleaned as is 
described in section 7.5.1. 
  In the DPV, water (360 µL), 1M NaCl (60 µL), 200 µM double stranded DNA (120 
µL) and 0.1 M phosphate buffer pH 7 (60 µL) was prepared and degased by nitrogen 
gas for 30 minutes in a narrow-bottom conical glass vial with a stirrer bar to raise the 
liquid level in order to submerge the electrodes. Peptide dimers (44AA, 48AA, 50AA, 
52AA and 56AA) were added to the sample so that the final concentration was 40 µM 
for DPV (initial potential is -0.05 V, end potential is 0.7 V) at 3 mV/s. The data was 
processed by Autolab GPES software. 
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7.6 Circular dichroism of peptide monomers and ferrocene peptide dimers in 
the absence and presence of CRE and NS DNA. 
  For the circular dichroism (CD) of peptide monomers and ferrocene peptide dimers, 
a solution of 240 µL ultra-pure water, 30 µL 0.1 M phosphate buffer pH 7 and 30 µL 1 
M NaCl in pure water, was used as blank control. For the CD of peptides in the 
presence of DNA, a solution of 210 µL pure water, 30 µL 0.1 M phosphate buffer pH 
7, 30 µL 5 µM annealed double stranded DNA  and 30 µL 1 M NaCl in pure water, 
was used as blank control. Concentrated stock solutions of peptide monomers and 
ferrocene peptide dimers were added to the blank to make a final concentration of 5 
µM ferrocene peptide dimers or 10 µM peptide monomers. CD spectra were 
recorded between 200 and 300 nm in a 1 mm path length quartz cuvette and the 
spectra recorded as an average of 16 scans. All the CD experiments were repeated 
in triplicated with different peptide stock solutions to validate the data, see section 2.7 
in chapter 2. 
 
7.7 Molecular dynamic simulations of ferrocene peptide dimer bind to CRE 
DNA 
  The molecular dynamics (MD) models were prepared in insight software based on 
the modified crystal structure of complex including GCN4 and CRE DNA (PDB code: 
2DGC). The excess residues on the GCN4 peptide model were removed and N-
terminal groups and C-terminal Cp ring tagged cysteine were put into the correspond 
position on the peptide. Parameters for the ferrocene-cysteine unit were imported to 
define the ferrocene group structure. The solvent box TIP3PBOX 15 and sodium salt 
were employed to the centre of peptide-DNA complex to model the water solvent by 
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leap software. The simulations were all performed in energy minimisation and then 
MD simulation. All the simulation stages were carried out using the UoB Blue Bear 
computer cluster using amber version 12, with the all atom force field. In the initial 
0.5 ns MD simulation, the simulation was raised to 298 K from 0 K and then 
continues for the rest of the simulations up to 10 ns. Each complex simulation was 
performed in triplicate with different ig numbers to validate the results and the 
average model presented as the result. The 44AA, 48AA, 52AA and 56AA complex 
with CRE DNA were used for MD simulations. 
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